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Abstract 
 
Ageing research in model organisms has accomplished great strides in finding 
genes and pathways that modulate the ageing process. However, the mechanism through 
which organisms age still remains a mystery. An influential ageing theory views ageing 
as the result of damage accumulation throughout an organism’s lifespan, which 
eventually accumulates to noxious levels causing death. In this thesis we will explore an 
alternative theory proposed by M. Blagosklonny. The hyperfunction theory postulates 
that ageing is the result of the non-adaptive continuation of developmental and 
reproductive programmes in late adulthood. Thus, programmes that promote growth and 
reproductive fitness become quasi-programmes in later life that result in age-related 
pathologies, some of which cause death. In this thesis we examined two reproductive 
pathologies, yolk accumulation and gonad degeneration, to try to understand their causes 
and to test their role in age-related mortality. 
 A clear example of a quasi-programme in ageing worms is the run-on of yolk 
production in post-reproductive worms. During reproduction yolk is synthesized in the 
intestine to be transported to oocytes and provision embryogenesis. After reproduction 
ceases yolk protein accumulates in the body cavity of the worm. We found that yolk 
proteins accumulate to high levels during ageing. However, RNAi abrogation of 
vitellogenesis did not increase lifespan, implying that yolk protein accumulation does not 
cause mortality.  
 Gonad disintegration provides an intriguing example of how quasi-programmes 
can cause pathology via atrophy. We found that gonad disintegration, which occurs in 
post-reproductive hermaphrodite worms, is apoptosis dependant. At least half of all germ 
cells undergo “physiological” programmed cell death. Our results imply that the 
apoptotic program that ensures reproductive fitness to support oocyte growth continues in 
older worms giving rise to pathology. 
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Chapter 1: Introduction  
1.1 Ageing 
To date there is no single widely accepted definition of ageing. It can be defined as 
the functional decline of an organism which increases with age resulting in reduced 
survival and death. Ageing has also been defined by the following series of postulates 
proposed by Bernard Strehler (Viña et al., 2007): 1) ageing is universal in that processes 
recognized as ageing occur in all individuals of a species to varying degrees. 2) Ageing is 
intrinsic in that it occurs due to endogenous factors and can be influenced by, but does 
not depend on, external factors. 3) Ageing is progressive and changes associated with 
ageing will occur throughout the organism’s lifetime. 4) Ageing is deleterious and its 
associated phenomena will have a negative effect on the organism.  
Ageing is an affliction shared by most living organisms. However, ageing does not 
appear to be a necessary characteristic of metazoans and some organisms, such as Hydra 
vulgaris, appear to be non-ageing (Martínez, 1998). This raises an important question: if 
ageing is not inevitable why then do most organisms age? Is there a benefit to ageing? 
A very old notion is that ageing is the result of inevitable wear and tear of the body 
over time. This comes from the simple observation that structurally complex inanimate 
objects such as machines wear out and deteriorate with time. However, this reasoning 
misses the point that living organisms have endogenous repair mechanisms whereas 
machines do not. Darwin’s theory of evolution postulates that random heritable variations 
that bestow an advantage to fitness of the individual will accumulate in populations over 
time (Darwin, 1859). As Darwin’s evolutionary theory gained acceptance biologists 
began to ponder why natural selection was so adept at creating organisms that could 
survive and reproduce efficiently until adulthood and, yet was unable to prevent them 
from deteriorating and dying afterwards (Ljubuncic and Reznick, 2009). This led to the 
development of evolutionary theories of ageing to explain how a process that causes 
disease and death could be so widespread.  
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1.1.1 Evolutionary theories of ageing 
 A common question among biologists was how this maladaptive trait could be so 
widely conserved and why it evolved in the first place. One might think that natural 
selection should have resulted in the elimination of this apparently deleterious trait (Flatt 
and Schmidt, 2009).  An early idea proposed by the Roman philosopher Lucretius 
speculated that ageing is necessary to make room for younger generations (Fabian and 
Flatt, 2011).  Similarly, August Weismann proposed the idea of programmed death 
arguing that nature could produce a killing mechanism to remove old members of a 
population if this were to increase the success of the young population by freeing up 
resources, bestowing advantage to the population at the expense of the individual 
(Weismann, 1889). However, a long-lived variant individual could reproduce for longer 
thereby increasing reproductive fitness, arguing against Weismann’s model. Why then 
does ageing exist?  
In the 1940s and 1950s Haldane, Medawar, and Williams came to the conclusion 
that selective pressure is reduced in older adults. They argued that genes with early-acting 
deleterious effects are removed from the population by strong selection because they 
decrease fitness. On the other hand, genes that have deleterious effects in later life 
undergo weaker selection because reproduction has already taken place and genes have 
been passed to the next generation (Flatt and Schmidt, 2009).   In the wild, most animals 
do not experience ageing because most of them die as a result of extrinsic hazards such as 
infectious disease, starvation and predation (Flatt and Schmidt, 2009).  Thus, extrinsic 
hazards results in selection favouring genes conferring an early beneficial advantage 
assuring successful reproduction, more than favouring longevity (Kirkwood and 
Holliday, 1979; Medawar, 1952). If an organism has a mutation that confers a beneficial 
or harmful effect which is only expressed post-reproduction it will be out of the grasp of 
selection to favour or counteract and as such it is under the “selection shadow” because it 
will have already been passed on to the offspring (Fabian and Flatt, 2011) (Figure 1.1). 
This could explain the prevalence of some late life genetically dominant diseases such as 
Huntington’s disease (Haldane, 1941).  
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Figure 1.1 The force of 
natural selection decreases 
with age. Image reproduced 
from Fabian and Flatt 2011. 
 
 
 
 
 
 
 
The mutation accumulation theory, proposes that weak selective pressures at older 
ages allow late-acting deleterious mutations to accumulate in individuals and that over 
time these accumulate in the population (Medawar, 1952). The theory of antagonistic 
pleiotropy elaborates upon this, arguing that alleles which are detrimental in old age can 
be favoured by natural selection if they bestow a significant fitness advantage in early life 
(Williams, 1957). Thus, the selective value of a gene is measured by how it affects 
reproductive success far more than longevity. A new allele that increases reproductive 
output earlier in life but has deleterious late life effects and can be selected for because it 
can increase overall reproductive fitness (Williams, 1957). Together these theories form 
the core modern evolutionary theory of ageing.  
1.1.2 Disposable soma theory 
 The antagonistic pleiotropy theory proposes that ageing evolved as a by-product 
of selection of genes that benefit the organism at an early age but has negative effects on 
the organism post-reproduction (Williams, 1957). This theory also predicts trade-offs 
between reproduction and longevity, i.e. costs of from strong selection for genes that 
increase reproductive output at the expense of long term organismal health (Ljubuncic 
and Reznick, 2009). In the 1970s Thomas Kirkwood proposed a biological mechanism 
for antagonistic pleiotropy in his disposable soma theory.  
The disposable soma theory proposes that in nature organisms typically have a 
limited supply of energy and other resources and must choose to allocate resources to 
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reproduction or cellular maintenance.  A trade-off exists as evolution favours alleles that 
use energy to allow increased reproductive output at the expense of the long term 
organismal survival (Kirkwood 1977). Somatic maintenance is costly in energetic terms. 
for example, energy expenditure is necessary to monitor errors in DNA and protein 
translation. One idea is that, during development resources are allocated to the soma 
before reproduction, but this energy is later diverted to the germline resulting in poor 
maintenance of the soma, which result in ageing (Kirkwood and Holliday, 1979). This 
theory predicts a clear bias in energetic allocation that favours the reproductive cell 
lineage, which must be maintained to avoid damage that could affect subsequent 
generations, at the expense of somatic tissue maintenance which would only favour the 
individual (Ljubuncic and Reznick, 2009).  
 
1.2 C. elegans in ageing research 
Model organisms are species used to study conserved biological processes, 
including ageing. They are useful to researchers because they have been extensively 
studied, are inexpensive to breed and maintain in laboratory conditions, and have a 
relatively short generation time. Researchers can use model organisms to help elucidate 
ageing mechanisms, including the genes that control ageing, whilst maintaining them in a 
controlled environment. Model organisms can also be used to test the validity of 
mechanistic theories of ageing, which will be discussed later.  Commonly used organisms 
in ageing research include the yeast Saccharomyces cerevisiae, the nematode 
Caenorhabditis elegans, the fruit fly Drosophila melanogaster, and the mouse Mus 
musculus. We used C. elegans for our studies testing the hyperfunction theory of ageing, 
and my thesis will focus on this organism. 
1.2.1 Use of C. elegans as a model organism 
The use of C. elegans as a model organism was first proposed by Sydney Brenner 
due to its convenience for genetic analysis (Brenner, 1974a).  C. elegans is a small, soil-
dwelling nematode of that can reach about 1.2mm in length. It exists as both 
hermaphrodites, with 5 pairs of autosomal chromosomes and a pair of sex chromosomes 
(XX), and males which have 5 autosomal chromosomes but only one sex chromosome 
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(XO). Hermaphrodites are predominant in populations, with males arising by X-
chromosomal nondisjunction at a rate of ~ 0.02%. Males can be maintained by mating 
with hermaphrodites and can be used to carry out crosses to study multiple mutants. The 
self-fertilization of hermaphrodites leads to a population of genetically identical 
organisms (Brenner, 1974a).  
C. elegans are easy and inexpensive to maintain in laboratory conditions. Their 
small size and rapid breeding allows them to be stored in large quantities on Petri plates 
containing agar seeded with OP50, a uracil-requiring Escherichia coli strain. In addition 
they recover from freezing which makes it easy to store strains of interest indefinitely 
(Riddle et al., 1997). The adult has less than 1000 somatic cells and all cell lineages are 
know (Sulston and Horvitz, 1977), which is ideal for performing microsurgery on 
specific cells to study their function. C. elegans are transparent, which makes them ideal 
system for examining age-related changes in the body in response to genetic 
manipulation using differential interference contrast (DIC) microscopy (also known as 
Nomarski microscopy) (Riddle et al., 1997). Their development and ageing rate is 
temperature sensitive, and at 20C C. elegans worms live two 2-3 weeks (Klass, 1977). 
This short lifespan makes it a very advantageous organism for longevity studies. 
C. elegans was the first animal to have its whole genome was sequenced in 1998 
and a wealth of information on the organism is readily available on open source Internet 
sites such as WormBase, WormAtlas and WormBook. 
 
1.2.2 C. elegans anatomy  
C. elegans have a simple body plan made up of an outer tube with a fluid-filled 
body cavity known as the pseudocoelum, and two inner tubes. The cuticle, hypodermis, 
musculature, nervous system and excretory system compose the outer tube. The two inner 
tubes comprise: 1) the alimentary canal, made up of the pharynx and the intestine; 2) the 
gonad (Riddle et al., 1997) (Figure 1.2).  
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Figure 1.2 C. elegans anatomy. A) Schematic representation of C. elegans anatomy with 
labelled structures. B) Schematic cross-section with labelled tissues.  Image modified and 
reproduced from Altun and Hall, 2009. 
 
The body wall is made up of tough but flexible collagenous cuticle, which is 
secreted by the underlying hypodermis. Somatic musculature is striated and attached to 
the hypodermis forming long strips. Relaxation and contraction of these longitudinal 
strips cause the sinusoidal movement observed in C. elegans (Riddle et al., 1997). 
Muscles in the pharynx, vulva and excretory system are non-striated and contain only one 
sarcomere, in contrast to body wall muscle which may contain several (Altun and Hall, 
2009). Food is ingested through the mouth where it is ground up in the pharynx. The 
pharynx is separated from the outer body wall and has its own basal lamina, muscles and 
nerves. Food passes through the intestinal pharyngeal valve into the intestine, which is 
essentially a tube composed of 20 cells with a central lumen at the end of which is the 
rectal valve (Altun and Hall, 2009). The adult C. elegans nervous system is divided into 
the somatic nervous system made up of 282 neurons and the pharyngeal nervous system 
containing 20 neurons (Altun and Hall, 2009).  
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1.2.3 Sexual dimorphism 
C. elegans exist in nature as XX hermaphrodites or XO males. Hermaphrodites 
produce sperm and oocytes and can self-fetilize. If males are present they will mate with 
hermaphrodites and their sperm will outcompete hermaphrodite sperm (Ward and Carrel, 
1979). Males are rare and arise from non-disjunction in hermaphrodite mothers at a 
frequency of 0.02% (Brenner, 1974a). The two sexes differ from each other in anatomy 
and behaviour and can be distinguished from early larval development. Many C. elegans 
tissues exhibit sexual specialization, which occurs in response to the global sex 
determination pathway (Zarkower, 2006). Differences can be observed in the musculature 
and neurons in response to reproductive needs, such as male mating and egg-laying 
behaviour (Riddle et al., 1997; Zarkower, 2006). 
Hermaphrodites and males can be distinguished from each other under a dissecting 
microscope by using gross morphological differences. Males are thinner and shorter than 
hermaphrodites. Their gonads consist of a single J- shaped arm, which appear be clear 
and their tails contain the copulatory apparatus (Lints and Hall, 2009a). The main 
distinguishing factor is the copulatory apparatus in the tail, which arises from an 
extension of the cuticle to create the fan made up of 9 pairs of sensory rays. The 
proctodeum is located after the intestine, it contains the cloaca and protruding spicules 
which probe and latch on to the vulva (Lints and Hall, 2009b) (Figure 1.3 A). Males are 
very active in their search to mate, whereas hermaphrodites are sexually passive. When 
the male tail comes in contact with a hermaphrodite it begins to move backwards while 
pressing its ventral side against the hermaphrodites body to locate the vulva. Once the 
vulva has been located they use their spicules to transfer sperm (Riddle et al., 1997).  
Hermaphrodites have a U-shaped bilaterally symmetrical gonad consisting of two 
arms that produces both sperm and oocytes Compared to age-matched males they are 
longer and wider, which could be a result of their larger gonads and presence of embryos. 
They can be distinguished under a dissecting microscope by their simple, pointed tail, 
and the presence of a vulva and eggs (Figure 1.3 B).  
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Figure 1.3 Hermaphrodite versus male anatomy. A) Male worms are long and thin 
compared to age-matched hermaphrodites and can be identified by presence of the tail 
(copulatory apparatus). B) By comparison hermaphrodites are larger and have a pointed 
tail. Hermaphrodite worms have a visible vulva and embryos. Image reproduced from 
Lints and Hall, 2009. 
 
1.2.4 C. elegans life cycle 
The C. elegans life cycle is similar to that of other nematodes in that it comprises a 
series of larval stages which progress by moults where the cuticle is shed and a new 
stage-specific cuticle is synthesized by the hypodermis. The C. elegans life cycle 
comprises the embryonic stage followed by 4 larval stages (L1, L2, L3 and L4) 
culminating in adulthood.  The progression from egg to adult takes approximately three 
days at 20˚C, but varies with temperature. Post-embryonic development begins with food 
intake, in the absence of food worms arrest at the L1 stage until supplied with food where 
they will proceed through development normally. If environmental conditions are not 
favourable such as low food, overcrowding and high temperature C. elegans can enter an 
alternative larval stage known as dauer. The decision to enter this alternative dauer stage 
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occurs during late L1 and thus worms progress through an alternative L2 stage knows as 
pre-dauer or L2d. If conditions improve L2d worms progress to L3, otherwise they 
progress to form dauer (Altun and Hall, 2009). Dauer larvae are morphologically and 
behaviourally distinct from other larval states. Dauer larvae are very thin, long and have a 
thicker cuticle. They have no pharyngeal pumping and reduced locomotion, increased 
lipid, and are resistant to desiccation (Cassada and Russell, 1975).  These traits help 
confer dauer larvae with exceptional resistance to noxious conditions, e.g. by sheltering 
their internal environment from toxins. Dauer larvae can survive up to 4 months without 
food and appear to be non-ageing, since the length of time spent in dauer does not affect 
post-dauer life span or fertility (Klass and Hirsh, 1976).   
 
 
                 
 
Figure 1.4 C. elegans life cycle at 22˚C. This diagram shows the development of C. 
elegans from egg to adulthood. Arrows indicate the time spent at each stage. Image 
reproduced from Altun and Hall, 2009.  
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1.2.5 Genetics and nomenclature 
A simple, uniform genetic nomenclature for C. elegans was proposed in 1979 that 
was introduced by Brenner (Brenner, 1974a; Horvitz et al., 1979; Riddle et al., 1997). 
Most C. elegans mutants are derived from the Bristol N2 strain (Brenner, 1974a) which is 
referred to as the genetic wildtype. C. elegans nomenclature is as follows. 
Genes names consist of three or four italicized letters, which usually refer to an 
observed phenotype discovered by mutational analysis.  Genes with broadly similar 
phenotypic characteristics are differentiated from each other by a hyphen (-) followed by 
an Arabic number that corresponds to the order in which genes were discovered. For 
example, egl-1 and egl-2 are different genes that result in an egg-laying defect phenotype. 
Usually genes are followed by a roman numeral corresponding to its linkage group. 
Protein products of genes are denoted by using block capital letters of the relevant gene, 
for example DAF-2 for the protein encoded by the daf-2 gene.  
Mutations (alleles) are denoted using 1 to 3 italicized letters followed by an 
italicized Arabic number, e.g. e1370 or wu250. The 1 to 3 letter code specifies the 
laboratory of origin and is registered with CGC, e.g. the Gems lab code is wu. If a mutant 
allele has been specified in an account of the work, it can be sufficient to use the gene 
name to refer to the allele; e.g. ced-3(n717) may be subsequently refereed to as ced-3. 
Special characteristics of a mutation may be annotated as a non-italicized suffix after the 
allele; e.g. e1370ts, where ts refer to temperature sensitive. Wildtype alleles can be 
indicated by a plus sign (+), e.g. daf-2 (+). Animals carrying more than one mutation 
have genes listed by linkage group separated by semicolons, e.g. daf-2(e1370) III; daf-
13(m66) X. To specify differences between homologous chromosomes in heterozygote 
animals genes are separated by a forward slash (/). If both chromosomes contain a 
mutation this can be annotated as unc-32/dpy-18, if the mutation is only present on one 
chromosome it would be unc-32/+. Transformations of C. elegans by introducing DNA 
may lead to transmissible extra-chromosomal arrays or chromosomally integrated arrays. 
Transgenes are annotated in a similar manner to gene mutations. First there is the 1-2 
letter lab code followed by whether the array is extra chromosomal (Ex) or integrated (Is) 
and a description of the transgene in brackets, e.g. wuEx166[rol-6(su1006)]. 
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 A strain corresponds to a group of animals of a specific genotype with the 
capability of producing progeny with the same genotype. Strain numbers are given by 
using 2 or 3 uppercase letters followed by an Arabic number. The letters in a strain name 
correspond to a laboratory, e.g. GA is the Gems lab letter code.  
  
1.2.6 RNA interference mechanism  
Forward genetics is an approach through which worms are treated with a mutagen 
and animals with a desired phenotype are selected to identify the mutation affecting the 
trait of interest. In reverse genetics, a gene sequence is already known and can be used to 
disrupt gene function and study its effects on phenotype. Reverse genetics can de 
performed in C. elegans by perturbing gene function by gene deletion or RNA-mediated 
interference (RNAi) (Ahringer, 2006).  Gene inactivation using RNAi is inexpensive and 
less labour intensive than gene deletion and as such is a particularly powerful tool to 
study gene function. 
RNAi is a non-permanent technique that reduces gene expression by introducing 
double stranded RNA (dsRNA) which causes the degradation of its target mRNA 
(Timmons and Fire, 1998). This RNAi mechanism was first discovered in C. elegans in 
1998 and has since become an invaluable tool in cell biology (Fire et al., 1998). The 
RNAi mechanism of action involves the detection of exogenous dsRNA by the 
endonuclease Dicer which cleaves dsRNA to form small interfering RNAs (siRNA). The 
siRNAs are unwound and associate with the RNA-induced silencing complex (RISC) 
acting as a guide to target the protein complex to the appropriate mRNA sequence for 
degradation (Figure 1.5) (Azorsa et al., 2006).  
RNAi can be performed in C. elegans by injection of dsRNA, soaking in a solution 
containing dsRNA or feeding worms E. coli which produces the dsRNA for the gene of 
interest (Fire et al., 1998; Tabara et al., 1998; Timmons and Fire, 1998). Gene silencing 
by RNAi in C. elegans is both systemic and heritable (Fire et al., 1998). RNAi allows 
rapid and effective gene inactivation, which can be performed at different developmental 
stages. This allows scientists to study when a specific genes activity is necessary. It also 
allows inactivation of genes that are essential during early development, for which 
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mutations would be lethal, in later life. In this thesis we use the feeding protocol due to 
its simplicity and the availability of a feeding clone library (Kamath and Ahringer, 2003) 
kindly provided by S. Nurrish. 
  
 
Figure 1.5 RNAi mechanism. Schematic 
representation of RNAi in C. elegans. 
Double stranded RNA (dsRNA) is 
digested into small interfering RNAs 
(siRNA) by the enzyme Dicer. Unwound 
siRNA form the RNA induced silencing 
complex (RISC) complex, which targets 
complimentary mRNA for degradation. 
Figure reproduced from Azorsa et al 2006. 
 
 
 
 
 
 
 
1.3 Longevity pathways 
1.3.1 Discovery of long lived mutants 
Ageing is not an adaptive trait and is deleterious to the survival of the individual. 
This implies that it is not programmed in the sense that development is. This led to the 
assumption that there are no genes for ageing. It was not until the last few decades that 
the genetics of ageing was properly studied, and interest was sparked by a study 
published by Michael Klass in 1983. Klass conducted a genetic screen using ethyl 
methanesulphonate (EMS) and surprisingly was able to isolate long lived mutants (Klass, 
1983). However, amongst the long lived mutants he discovered several had decreased 
pharyngeal pumping so he concluded that their longevity was due to dietary restriction 
effects and that longevity genes must be extremely rare, if they exist at all (Klass, 1983). 
Tom Johnson continued to experiment on these mutants and found that by backcrossing 
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them with wildtype males the feeding defect could be separated from the longevity (Age) 
phenotype (Johnson, 1986). The Age phenotype was found to be caused by the recessive 
mutation age-1(hx546) which results in a lifespan extension of 40-65% and also reduced 
fertility (Friedman and Johnson, 1988). However, the possibility remained that the Age 
phenotype could be caused by the 75% reduction in fertility and not by reducing 
programmed ageing functions (Friedman and Johnson, 1988; Kenyon, 2011).  
A study from the lab of Cynthia Kenyon examined temperature sensitive mutations 
which induce dauer formation and found that mutations in daf-2 result in active, fertile 
hermaphrodites that live twice as long as wildtype even in the absence of a gonad 
(Kenyon et al., 1993). This proved that despite the low fecundity observed in daf-
2(e1370) mutants its longevity is not dependent on it. A later study examined many daf-2 
alleles and found that they can be separated into two classes based on behavioural defects 
and that reduced feeding and fertility can be uncoupled from the Age phenotype (Gems et 
al., 1998). The study by Kenyon et al also found that the longevity bestowed by daf-
2(e1370) was dependent on DAF-16 (Kenyon et al., 1993) which is also required for 
dauer formation (Riddle et al., 1981). Lifespan extension in age-1(hx546) was also found 
to require DAF-16, suggesting they were part of the same pathway (Dorman et al., 1995). 
It has since been discovered that DAF-2, AGE-1 and DAF-16 are components of the 
insulin/IGF-1 signalling (IIS) pathway in C. elegans.  
1.3.2 Insulin/IGF-1 signalling in C. elegans 
The first gene in this pathway to be indentified was age-1, which encodes the C. 
elegans homologue of the catalytic subunit of the phosphatidylinositol-3-OH kinase 
(PI(3)K), which generates phosphatidylinositol (3,4,5)-triphosphate (PIP3) (Morris et 
al.1996). daf-2 was found to encode the C. elegans homolog of the insulin and IGF-1 
receptors (Kimura, 1997). This was an important finding because it meant that conserved 
hormonal cues involved in nutrient sensing were also part of the ageing process (Kenyon, 
2011).  Cloning of daf-16 revealed it to be a member of the FOXO family of forkhead 
transcription factors (Kenyon et al., 1993; Lin et al., 1997; Ogg et al., 1997). When DAF-
2 is ligand bound it activates AGE-1 initiating a phosphorylation cascade involving AKT-
1, AKT-2 and SGK-1 protein kinases resulting in the phosphorylation of DAF-16 
(Hertweck et al, 2004; Paradis and Ruvkun, 1998). SGK-1 is crucial in mediating stress 
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responses, development and lifespan regulation, while AKT is necessary for regulating 
dauer formation (Hertweck et al, 2004).When DAF-16 is phosphorylated it cannot 
translocate to the nucleus and regulate its target genes (Lin et al., 2001).  Disruption in 
the IIS pathway by mutations in daf-2 or age-1 allows DAF-16 to enter the nucleus and 
regulate its target genes resulting in increased lifespan (Figure 1.6). 
The discovery that DAF-16 is a transcription factor that could regulate lifespan in 
C. elegans provoked a search for the DAF-16 gene targets that cause lifespan extension 
(Kenyon, 2011). Microarray data implies that DAF-16 regulates expression of as many as  
10% of C. elegans genes and RNAi knockdown of regulated genes, can cause small 
changes in lifespan (McElwee et al., 2004; Murphy et al., 2003; Partridge and Gems, 
2006). Evolutionary theory predicts that single genes will not evolve to cause ageing; 
however, a single mutation can have large effect on lifespan by regulating many genes at 
once each of which contributes small effects (Partridge and Gems, 2006).  
               
Figure 1.6 IIS pathway in C. elegans. a) Insulin-like ligands bind to the DAF-2 receptor 
activating a signalling cascade resulting in the phosphorylation of DAF-16 and its nuclear 
exclusion. b) When no ligands are bound, or there is a disruption in binding to DAF-2, 
DAF-16 is dephosphorylated and may translocate to the nucleus where it can regulate its 
target genes, increasing longevity. Figure reproduced and modified from Carter et al, 
2002. 
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1.3.3 TOR signalling pathway 
A soil sample collected from Easter Island in the 1970s contained the bacterium 
Streptomyces hygroscopicus that produces a strong anti-fungal metabolite. This 
metabolite, now called rapamycin, was found to inhibit cell division of mammalian cells 
and this intriguing effect prompted further studies on this compound (Wullschleger et al., 
2006). The genes TOR1 and TOR2 (Target of Rapamycin) which regulate the toxic 
effects of rapamycin were first discovered in yeast (Heitman et al., 1991). All eukaryotic 
cells, from slime molds to mammals, have since been shown to have at least one TOR 
complex (Wullschleger et al., 2006) and mutations in the TOR pathway increase lifespan 
in model organisms (Evans et al., 2011). The TOR kinase promotes cell growth in 
response to nutrient cues whilst blocking cell maintenance processes such as autophagy 
(Kenyon, 2010).  
TOR belongs to a family of kinases known as phosphatidylinositol kinase-related 
kinases (PIKK) (Wullschleger et al., 2006). The TOR protein is located in the centre of 
the signal transducing pathway and receives imputs from several other pathways which 
are relayed through TOR to regulate apoptosis, stress resistance, autophagy and protein 
translation (Evans et al., 2011). Thus, the TOR pathway is interconnected with other 
signalling pathways such as IIS forming a network (Gems and Partridge, 2013). Akt 
which is a kinase in the IIS pathway phosphorylates TOR/LET-363 antagonist proteins to 
allow Raptor/DAF-15 to form a complex with TOR (Jia et al., 2004; Kapahi et al., 2010). 
Once the TOR complex 1 (TORC1) is formed it activates its downstream target 
ribosomal p70 S6 protein kinase (S6K) which regulates protein translation (Kapahi et al., 
2010). Inhibition of the C. elegans S6K homologue RSKS-1 can extend lifespan, reduce 
fecundity, inhibit growth and reduce protein translation (Hansen et al., 2007; Pan et al., 
2007). TOR activation inhibits the activity of 4E-BP which antagonizes the translation 
initiation factor eIF4E, thus promoting protein translation and growth under nutrient rich 
conditions (Hay and Sonenberg, 2004; Sonenberg and Gingras, 1998) (Figure 1.7). 
However, to date no homologue of 4E-BP has been found in C. elegans (Syntichaki et al., 
2007).  
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Figure 1.7 TOR signalling pathway. Simplified representation of the TOR pathway 
with C. elegans protein homologues labelled in parenthesis. Under conditions of nutrient 
availability TOR1 is activated forming a complex with Raptor (TORC1). TORC1 
activates S6K by phosphorylation. TORC1 results in e1F4E being released from 
inhibition to initiate protein translation. If food is available the TOR pathway promotes 
protein translation and growth and blocks autophagy. 
 
1.4 Lifespan regulation by nutritional and reproductive cues 
The evolutionary theory proposes that trade-offs exist between reproduction and 
longevity (Ljubuncic and Reznick, 2009). In this section we discuss the effect of 
reproduction and nutrition on longevity. 
1.4.1 Ageing and reproduction 
The disposable soma theory sees ageing as the result of a trade-off between 
reproduction and somatic maintenance (Kirkwood and Holliday, 1979). Support for this 
notion comes from observations in animals that die shortly after reproduction (e.g. Pacific 
salmon) and a common thread among longevity mutants (IIS and TOR), which often have 
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lower fertility. However, there are examples in nature that seem to contradict the notion 
that reproduction will necessarily cause an organism to age. For instance, guppies in an 
environment where predation is removed as the main extrinsic hazard have higher 
fecundity and a longer lifespan, suggesting a short lifespan is not a necessarily the result 
of a trade-off with increased fecundity (Kenyon, 2005; Reznick et al., 2004). 
Furthermore, C. elegans longevity and low fecundity can also be uncoupled in some daf-
2(-) mutant strains, which can also extend the reproductive period (Gems et al., 1998; 
Kenyon, 2010). Thus, it is possible to attain a long life without lowering reproductive 
capacity. 
In C. elegans removal of the entire gonad does not affect lifespan in wildtype 
worms (Kenyon et al., 1993), but laser ablation of germ cell progenitor cells does (Hsin 
and Kenyon, 1999). Thus, an empty gonad appears to emit a pro-longevity signal which 
can extend lifespan by up to 60% (Hsin and Kenyon, 1999).  The extended lifespan in 
these germline-less worms is DAF-16 dependant, the loss of which completely abrogates 
the longevity effect (Hsin and Kenyon, 1999). The loss of germ cells results in an 
increase in nuclear localization of DAF-16 in the intestine (Lin et al., 2001). Intestinal 
rescue of DAF-16 in daf-16(-) germline-less mutants is enough to rescue around half of 
the longevity phenotype, indicating that DAF-16 activity in the intestine is the main site 
promoting lifespan extension in germline-less worms (Libina et al., 2003). A similar up 
regulation in FOXO activity was observed in Drosophila melanogaster following 
elimination of germ cells (Flatt et al., 2008). The somatic gonad, sensing a lack of germ 
cells, may send signals that increase longevity by modulating the IIS pathway to make 
the organism ‘wait’ until reproduction can begin (i.e. to promote reproductive diapause)  
(Yamawaki et al., 2008).  
Germline-less worms are also resistant to oxidative stress, implying that longevity 
in these worms could be the result of increased detoxification processes (Arantes-Oliveira 
et al., 2002). However, removal of both the somatic gonad and the germline also confers 
stress resistance without the benefit on a longer life, implying that stress resistance does 
not account for the longevity induced by germline removal (Yamawaki et al., 2008). 
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1.4.2 Dietary restriction and longevity 
During the great depression there was a concern that prolonged food shortages 
could have long term detrimental effects on human lifespan (Kenyon, 2010). The 
potential effect of DR on human lifespan was attempted to be addressed by experiments 
in rats. Surprisingly, studies using rats found the opposite to be true. Mice that were fed a 
diet of restricted calories where all other essential vitamins and minerals were supplied, 
had retarded growth but lived approximately 30% longer than mice fed ad libitum 
(McCay et al., 1935; Weindruch and Walford, 1988). While chronic malnutrition 
shortens lifespan, a moderate dietary restriction (DR) can provide health benefits and 
increased longevity. The effects of DR have been tested in other organisms ranging from 
yeast to primates and extension in lifespan was seen in most cases, perhaps reflecting 
evolutionary conservation (Houthoofd et al., 2007; Piper et al., 2011). If an organism can 
modulate its lifespan in response to nutritional cues this could tie in nicely with the 
lifespan extension observed in mutations in the IIS and TOR pathways, which are also 
nutrient sensitive. 
The mechanisms that lead to the lifespan benefits observed under dietary 
restriction are still unknown. A possible mechanism is that during times of scarcity 
resources are allocated to preserve the soma in lieu of reproduction, this would provide a 
useful strategy allowing the organism to survive now and reproduce later (Holliday, 
1989) Consistent with this, rodents under dietary restriction have reduced fecundity 
(Weindruch and Walford, 1988). Rodents under DR exhibit less incidence of cancer and 
autoimmune disease, in addition to an increase in heat shock factor suggesting the 
possibility that stress response is activated under DR (Heydari et al., 1993; Weindruch et 
al., 1986).  Another hypothesis links DR with the free radical theory by proposing that 
animals subjected to DR have lower production of reactive oxygen species (ROS), which 
might occur due to decreased mitochondrial respiration accompanying a DR-induced 
decrease in metabolic rate (Sohal and Weindruch, 1996). 
 
1.5 Mechanisms of ageing 
The ultimate causes of ageing, as explained by the evolutionary theory, provide a 
plausible account for the emergence of ageing; but its proximate cause, or mechanism of 
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action, remain unknown (Gems and Partridge, 2013). In the following section we will 
present a widely accepted mechanistic theory and discuss its shortcomings. We will then 
discuss a new theory that integrates the proximate and ultimate causes of ageing. 
1.5.1 The oxidative damage theory of ageing 
The free radical theory of ageing is a prominent mechanistic theory of ageing that 
was originally proposed by Denham Harman. He proposed that free radicals produced 
during normal metabolic processes within cells cause damage which accumulates with 
time and causes ageing (Harman, 1956). As the organism progresses in age, its innate 
antioxidant defences fail to counteract the increase in oxidative damage (Viña et al., 
2007). This theory has since developed into the oxidative damage theory of ageing; 
reactive oxygen species (ROS) such as superoxide (O2
-
) and hydrogen peroxide (H2O2) 
are by-products of mitochondrial respiration and other metabolic processes, which cause 
damage to cellular constituents. This molecular damage accumulates over time, causing 
ageing (Sohal and Weindruch 1996; Beckman and Ames 1998).  
The oxidative damage theory makes a number of predictions: 1) Molecular 
damage caused by ROS accumulates with time. 2) Antioxidant mechanisms should 
increase lifespan by reducing ROS and thus, molecular damage. 3) Long-lived animals 
have extended lifespan due to decrease of molecular damage (Sohal and Weindruch, 
1996). Many experimental results support the theory. For example, protein oxidation 
levels do increase with age (Adachi et al., 1998). Furthermore, levels of ROS generation 
the mitochondria is doubled in ageing flies (Sohal and Sohal, 1991). Long-lived 
insulin/IGF-1 signalling (IIS) mutants are resistant to oxidative stress and have increased 
antioxidant activity, lending further support for the theory (Honda and Honda, 1999; 
Vanfleteren, 1993). The increase in lifespan in these animals has long been thought to be 
a direct result of increased ROS detoxification.  
The oxidative stress theory of ageing is an attractive model because it is 
consistent with common sense (all things decay), supported by experimental data, and 
suggests the possibility of simple interventions in the form of antioxidant 
supplementation (Viña et al., 2007). However, problems arise when the role of 
antioxidant defence in ageing is put to the test. This can be done experimentally by 
examining effects of manipulation of antioxidant defence on damage and ageing. If the 
 34 
presence of ROS and its induced damage are the limiting factor for longevity one would 
expect that reducing antioxidant defence would lead to increased molecular damage and 
thus a shortened lifespan (Gems and Doonan, 2009). Some studies have found this to be 
the case. For example, increasing oxygen concentrations should cause an increase in ROS 
production. Worms treated under 60% oxygen, as expected, show reduced lifespan 
(Adachi et al., 1998; Honda et al., 1993). However, reduction of lifespan by hyperoxia 
may be reflecting a toxic effect in worms, and may not be indicative of normal ageing, 
consistent with this, worms under 40% oxygen were not short lived (Adachi et al., 1998; 
Honda et al., 1993).  
 On the other hand, decreasing ROS should cause a decrease in molecular 
damage, resulting in a longer-lived organism. The discovery of antioxidant enzymes 
allowed this prediction to be put to the test. To examine the role of endogenous 
antioxidant enzymes a number of studies used superoxide dismutase (SOD). For 
example, in C. elegans deletion of antioxidant gene sod-2 while increasing susceptibility 
to superoxide and increasing molecular damage has no effect on lifespan (Doonan et al., 
2008) or may even increase it (Van Raamsdonk and Hekimi, 2010). Additionally, effects 
of chemical treatments that increase ROS levels have been studied.  Exposure to low 
levels of ROS-generators such as 40 µM juglone (Heidler et al., 2010) and 0.1 mM 
paraquat (Yang and Hekimi, 2010a) can actually extend lifespan in C. elegans.  
 Tests on antioxidant supplementation in worms have garnered mixed results.  For 
example, vitamin E supplementation increased C. elegans lifespan in two out of three 
studies (Harrington and Harley, 1987; Ishii et al., 2004; Schulz et al., 2007). The 
antioxidant vitamin C did not have any effect on C. elegans lifespan in two studies 
(Schulz et al., 2007; Yang and Hekimi, 2010a). Administration of synthetic catalytic 
antioxidants, EUK-8 and EUK-134 (SOD mimetics), increased SOD activity in vivo and 
increased resistance to paraquat in C. elegans (Keaney et al., 2004; Sampayo et al., 
2003). One group reported that EUK-8 and EUK-134 increased lifespan in wildtype 
worms by up to 54% (Melov et al., 2000); however four other studied saw no increase in 
lifespan (Keaney and Gems, 2003; Keaney et al., 2004; Kim et al., 2008; Uchiyama et al., 
2005). In fact, at higher concentrations SOD mimetics shortened lifespan in a dose 
dependent manner (Keaney and Gems, 2003; Keaney et al., 2004; Kim et al., 2008).  
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The many studies that fail to support the oxidative damage theory suggest that 
ageing occurs by a mechanism other that ROS-induced damage. This opens the door to 
explore new possible theories to explain ageing in C. elegans. 
1.5.2 New theory: Ageing as hyperfunction 
An interesting theory by Mikhail Blagosklonny that provides an alternative to the 
oxidative damage theory was presented in a series of review papers (Blagosklonny, 2006, 
2007, 2008). In them he proposes that whilst oxidative damage does occur, it is largely a 
consequence of ageing and not its cause. He also proposes that unregulated biosynthesis 
or “hyperfunction” is driven by growth promoting pathways such as the insulin/IGF-1 
signalling (IIS) and target of rapamycin (TOR) pathways which promote early life fitness 
(Blagosklonny 2008). The idea of hyperfunction being the cause of ageing can be 
integrated conceptually with the antagonistic pleiotropy theory. The same processes that 
promote early life fitness in an individual also lead to its demise with increasing age, in 
this case, because evolution fails to switch-off these processes. 
Blagosklonny takes a stab at answering a long-standing conundrum in the ageing 
field: Is ageing, a deleterious process, programmed? He proposes that ageing is not 
programmed but ‘quasi-programmed’ in that it is genetically programmed, but is not 
programmed in the sense of being an adaptation (Figure 1.8 B). He illustrates the idea of 
quasi-programme with an analogy: “if you left water running after taking a bath, then a 
‘program’ for filling the bathtub would become a ‘quasi-program’ to flood your 
apartment” (Blagosklonny 2007). These developmental and reproductive programmes 
become quasi-programmes, which promote excess biosynthesis, or continuation of other 
needless processes, leading to hypertrophic pathologies associated with ageing. No 
programme has emerged to cause ageing because in the wild, most animals do not live 
long enough to age due to death from extrinsic hazards. Thus, ageing is the result of 
failure to optimally modulate fitness promoting programs in later life. Quasi-programmed 
ageing can be reconciled with the evolutionary theory because these are late-life side-
effects of early fitness promoting programmes that have been selected for and therefore 
have no intended purpose (Blagosklonny 2007).  
Blagosklonny also provides an explanation for the effect of dietary restriction on 
lifespan. Longevity observed in animals subjected to DR has been previously explained 
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in terms of the disposable soma theory as the result of diversion of energy away from 
reproduction towards somatic maintenance, in order to survive now for the possibility to 
reproduce later (Shanley and Kirkwood, 2000). Blagosklonny argues that reducing 
resource availability for somatic maintenance by DR should, according to the disposable 
soma theory, shorten lifespan (Blagosklonny, 2007, 2008). Moreover, trials in 
Drosophila manipulating amino acid composition during dietary restriction have been 
able to restore fecundity to levels similar to control fully fed animals without reducing 
longevity (Grandison et al., 2009). Mutations that inhibit the IIS and TOR pathways 
cause lifespan extension across different species (Kapahi et al., 2010; Kenyon, 2010). 
TOR has also been implied to have a role in mediating the dietary restriction response 
(Bishop and Guarente, 2007; Mair and Dillin, 2008). An alternative to the disposable 
soma theory interpretation is that the extended lifespan observed under dietary restriction 
is caused by reduced activity of these pathways (particularly TOR), resulting a decreased 
hyperfunction (Blagosklonny, 2007, 2008).  
Inhibition of TOR leads to reduced protein translation and increased autophagy. 
Several studies in C. elegans have shown that decreased mRNA translation can increase 
lifespan (Hansen et al., 2007; Pan et al., 2007). Moreover, lifespan extension by dietary 
restriction, IIS and TOR pathway mutants requires autophagy in C. elegans (Hansen et 
al., 2008). The oxidative stress theory suggested that autophagy could promote longevity 
by increasing somatic maintenance by removing damaged proteins, but it provides no 
simple explanation for why inhibition of protein synthesis extends lifespan (Gems and de 
la Guardia, 2013). The hyperfunction theory proposes that TOR, which increases protein 
synthesis and decreases autophagy, promotes biomass production thereby promoting 
hypertrophy and hyperplasia (Blagosklonny, 2008). When food is scarce TOR signalling 
is reduced which causes an increase in autophagy and decreased protein translation both 
of which increase lifespan (Hansen et al., 2007, 2008). Autophagy promotes longevity by 
removing excess biomass preventing hyperfunction rather than removing damaged 
molecules, as previously supposed (Blagosklonny, 2008). Reduced protein synthesis 
slows the emergence of diseases of hyperfunction by reducing biomass (Blagosklonny 
2008) (Figure 1.8 A). 
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Figure 1.8 Representation of the hyperfunction theory. A) Simplified diagram of how 
IIS and TOR promote ageing as explained by the molecular damage and hyperfunction 
theories of ageing. B) The hyperfunction theory proposes that the same developmental 
and reproductive programs promoting early life fitness become quasi-programs during 
ageing due to failure to “switch-off” these mechanisms. A) Figure reproduced and 
modified from Gems and de la Guardia 2013.  
 
1.5.2.1 Evidence of hyperfunction in C. elegans 
Despite being vastly studied, the mechanism by which C. elegans age is not 
known. During ageing many anatomical changes can be observed in old worms, some of 
which are clearly pathological (Figure 1.9). Is it possible that the cause of death in this 
organism can be traced back to hyperfunction? We reviewed the C. elegans literature and 
found the following age-related changes which are consistent with hyperfunction-driven 
pathology (Gems and de la Guardia, 2013) (Figure 1.9, Appendix 2). 
The reproductive system undergoes notable changes after reproduction stops. At 
about day 5 of adulthood hermaphrodite worms run out of sperm, causing reproduction to 
cease (Ward and Carrel, 1979). However, oocyte production is not tightly regulated with 
sperm availability and oocytes continue to be produced and are laid unfertilized (Ward 
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and Carrel, 1979). This continuation of oocyte production results in a two-fold increase in 
oocytes in the gonad and these excess oocyte become stacked (i.e. increase in number and 
density) inside the proximal gonad (Jud et al., 2007). Additionally, post-reproductive 
worms develop large uterine tumours (McGee et al., 2011). These tumours have 
increased DNA content and are thought to be a result of endoreduplication in unfertilized 
oocytes (Golden et al., 2007). Changes observed in the gonad of post-reproductive 
hermaphrodite adults are consistent with the idea of quasi-programmed hyperfunction.  
The nervous system of C. elegans was thought to maintain its integrity throughout 
old age (Garigan et al., 2002). However, it was recently discovered that neurons develop 
new branches in older worms (Pan et al., 2011; Tank et al., 2011). These additional 
extensions or branches correlate with age and decreased motility (Tank et al., 2011). 
These neuronal outgrowths are another potential example of hyperfunction in ageing 
worms. 
The cuticle in older worms has been observed to increase in thickness up to ten-
fold in certain areas with respect to young worms (Herndon et al., 2002). One possibility 
is that this increase in cuticle thickness is due to continued synthesis of collagen by the 
hypodermis (Herndon et al., 2002). Such cuticular hypertrophy is yet another potential 
example of hyperfunction. 
Yolk and lipid distribution changes in old worms. Vitellogenins are yolk proteins 
encoded by genes vit-1 through vit-6 (Spieth et al., 1985). Vitellogenins are synthesized 
in the intestine and transported to the gonad where they are taken up by oocytes (Kimble 
and Sharrock, 1983). In early adulthood yolk is observed in the intestine and oocytes, 
however after sperm depletes yolk is observed throughout the body cavity (Garigan et al., 
2002; Herndon et al., 2002). This increase in yolk observed in old worms suggests that 
yolk production is not regulated post-reproduction (Herndon et al., 2002). Lipid 
inclusions have been observed in muscle, intestine, and hypodermal tissue in ageing 
worms (Herndon et al., 2002). Inclusion of lipid in these tissues may reflect the 
redistribution of yolk to the body cavity.  Vitellogenins in C. elegans have domains 
homologous to human low-density lipoprotein (LDL) apoB-100 (Baker, 1988a), which 
contribute to atherosclerosis. Accumulation of lipid in non-adipose tissue in mammals is 
thought to be responsible for metabolic syndrome observed in obese individuals (Unger 
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and Scherer, 2010; Virtue and Vidal-Puig, 2008). Thus, hyperfunction of yolk could 
possibly contribute to age-related mortality by causing lipotoxicity in the worm 
(Ackerman and Gems, 2012). 
 
 
Figure 1.9 Examples of age-related hypertrophy in ageing C. elegans. 
Representations of previously published data (referenced under each figure) on age-
related phenomena in ageing hermaphrodites (clockwise): yolk redistribution pattern after 
sperm depletion (shading represents VIT-2: GFP); Oocyte stacking in post-reproductive 
worms, Tumour-like growth in the uterus (O, oocyte; T, tumour); Hypertrophy in the 
cuticle (C, cuticle; H, hypodermis); Neurite branching (NO, neurite outgrowth); Lipid 
deposition in muscle (M, muscle; L, lipid). Image reproduced from Gems and de la 
Guardia 2013.  
 
The hyperfunction theory provides a plausible explanation for the aforementioned 
anatomical changes in older worms. It is possible that molecular damage has a bigger role 
in ageing pathologies in mammals where cancer, which emerges at least in part through 
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DNA damage, is a big killer amongst the elderly (Gems and de la Guardia, 2013). 
However, in short-lived C. elegans where somatic tissues are post-reproductive DNA 
damage is not likely to be a major contributor to diseases of ageing. In support of this, 
adult C. elegans are highly resistant to UV radiation and ionizing radiation and lifespan 
was only shortened by very high doses (Johnson and Hartman, 1988; Klass, 1977). Thus, 
the hyperfunction theory might better explain C. elegans ageing pathologies. However, as 
this is a novel theory there should be more rigorous testing to establish its validity in both 
C. elegans and other model organisms.  
 
1.6 Aims 
The main goal of this thesis is to test ageing theories. To do this, I used the model 
organism C. elegans to conduct experiments due to its extensive use in biogerontology 
field and the wealth of available information on its biology and genetics. We took 
advantage of its transparency to examine age-related anatomical changes by observing 
ageing worms using differential interference contrast microscopy. This allowed us to 
study C. elegans age-related pathology and test possible mechanisms for their emergence. 
One of the most widely accepted mechanistic ageing theories is the oxidative 
damage theory. However as previously discussed rigorous testing of this theory argues 
against it (see section 1.5.1). Problems with the oxidative damage theory sparked our 
interest in testing the novel hyperfunction theory of ageing to explain age-related changes 
in C. elegans. We focused on the following potential reproductive quasi-programmes: 
yolk protein accumulation and germline hypertrophy and atrophy.  In chapter 3 we 
examine post-reproductive yolk synthesis and its accumulation in the body cavity of 
ageing C. elegans hermaphrodites. This has previously shown to not occur in IIS pathway 
mutants (DePina et al., 2011), which led us to test whether there is a link between yolk 
production and a pro-ageing phenotype. Chapters 4 and 5 focus on age-related changes 
that occur with ageing in the hermaphrodite germline. In chapter 4 we provide a detailed 
description of changes observed in the germline of ageing hermaphrodite C. elegans. 
Amongst these changes are the degradation of the reproductive organ – the gonad, the 
development of uterine tumour-like masses and the appearance of hypertrophic oocytes. 
In this chapter we propose a mechanism for gonad degradation, quasi-programmed 
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germline apoptosis. In Chapter 5 we examine gonad degeneration in greater detail and 
test its proposed causal mechanism.  
During my PhD I supervised and worked in close collaboration three students: Ann 
Gilliat, Eleanor Tyler and Josephine Hellberg. Therefore, the data generated from these 
collaborations has been included in this thesis in order to give a clear account of the 
entire story. Results that were obtained by these students or came from collaboration with 
students has been clearly attributed to them throughout this thesis. With their help we 
were able to gain a greater understanding of the ageing phenomena studied here. 
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Chapter 2: Materials and Methods 
 
2.1 C. elegans maintenance and methods 
2.1.1 Culture conditions 
Worms were grown and maintained on 60mm Petri dishes containing nematode 
growth medium (NGM) seeded with (~100µl) OP50 E. coli as a food source (Brenner, 
1974a). OP50 is an uracil auxotroph with limited growth on NGM agar, which allows for 
better visualisation of the worms. To avoid starvation individual worms were regularly 
transferred to fresh seeded plates using a thin platinum wire (worm pick), which is flame 
sterilized.  Picking individual worms allows for the precise selection of worms based on 
their larval stage or other relevant quality desired. 
The previous method is not ideal for quickly transferring a large amount of 
worms. An alternative technique is chunking, in which a small piece of agar is cut using a 
flame sterilized scalpel and transferred to a new plate.  
2.1.2 Male stock maintenance 
Male C. elegans occur at low frequency in wildtype populations (~0.02%). 
Picking L4 worms and mating with hermaphrodites at a 3 males: 1 hermaphrodite ratio 
maintained male populations. Males were also generated by heat shock in which L4 
hermaphrodite worms are incubated at 30C for 6 hours. For experiments performed 
using male worms, matings were set up on multiple NGM plates to get a high yield of 
males. After picking L4 males they were maintained in cohorts of 5 worms per plate to 
reduce life-shortening effects of homosexual mating behaviour (Gems and Riddle, 2000).  
 
2.1.3 C. elegans brief mating protocol 
Worms were mated as previously described (Gems and Riddle, 1996). Mating 
was performed by maintaining male stock plates and separating hermaphrodite and males 
at L4 onto separate plates and allowing them to reach adulthood overnight. Worms were 
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then placed in a ratio of 3 males: 1 hermaphrodite on NGM plates seeded with a small 
OP50 lawn (~2 cm width) to improve mating efficiency. Worms were allowed to mate 
for 3 hours before removing males from the plate. Mated hermaphrodites were 
transferred to fresh plates daily throughout their reproductive period.  
2.1.4 Freezing and thawing stocks 
 C. elegans strains can be maintained as frozen stocks indefinitely. To freeze 
strains, animals were allowed to grow on 100mm diameter plates until they run out of 
food. Recently starved plates contain a large amount of worms at the L1 larval stage, 
which survive freezing successfully. Worms were washed off plates with M9 buffer and 
transferred to a Falcon tube and allowed to settle at the bottom by gravity. Supernatant 
was removed, leaving worm in 2ml of M9 buffer. An equal amount (2ml) of freezing 
medium (see section 2.6.2) was added to the Falcon tubes. The worms were aliquoted 
into microcentrifuge Eppendorf tubes (1.5ml) and placed at -80°C in metal freezing racks 
within a styrofoam box to slowly lower the temperature.  
 To recover frozen strains the desired vial was removed from the -80°C freezer and 
allowed to thaw at room temperature. The contents of the vial were placed on a seeded 
NGM plate and worms were allowed to recover and grow.  
2.1.5 Removing sources of contamination 
The nutritious richness of NGM agar permits the growth of unwanted 
microorganisms such as non-E. coli bacteria, yeast, and mold. To remove fungal 
contamination a small chunk of agar or individual worms were transferred to a seeded 
plate, allowed to move around the OP50 lawn and retransferred to a new plate. To 
remove bacterial and yeast contamination worms were treated with alkaline hypochlorite, 
known as an egg prep. 
Egg prep 
Alkaline hypochlorite treatment was used to remove all types of contamination. 
This treatment kills the worms, but not the eggs which are protected by their eggshell. 
Plates with many gravid hermaphrodite adults were used to obtain a high yield of eggs. 
Worms were washed off plates using 2ml of M9 buffer and transferred to a 
microcentrifuge Eppendorf tube using a pipette. Worms were allowed to settle at the 
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bottom of the Eppendorf by gravity and supernatant was removed, leaving worms in 
~200 µl of M9. 125µl of 7:8 alkaline hypochlorite (700µl sodium hypochlorite: 800µl 
4M NaOH) was added to the Eppendorf and incubated at room temperature for 4 minutes 
inverting the Eppendorf at frequent intervals. Treatment was ended by adding 1ml of M9 
buffer, vortexing, and centrifuging at 3000 rpm for 30 seconds. Supernatant was removed 
and washing was repeated 2 more times.  After the last wash, the supernatant was 
removed leaving ~100µl, eggs were re-suspended and pipetted onto OP50 seeded plates. 
If high egg yields were not necessary a small-scale egg drop prep was performed. 
A small drop ~10µl of a 1:1 bleach solution (100µl sodium hypochlorite: 100µl 1M 
NaOH) was placed on the agar away from the bacterial lawn and gravid adults were 
picked directly onto the drop. The following day larvae were picked from the E. coli lawn 
and transferred to a fresh plate. 
2.1.6 Population synchronization 
Egg prep or egg drop procedures were used to obtain large numbers of worms 
synchronized to the same larval stage. An alternative method is the egg lay in which 20-
30 gravid adults were placed on a fresh seeded plate and allowed to lay eggs for 3-4 
hours. Gravid adults were then removed leaving only eggs on the plates. 
2.1.7 Lifespan measurements 
Animals were synchronised by one of the two methods previously described or by 
picking L4s from mixed stage cultures. Lifespans using RNAi to reduce gene expression 
were conducted on NGM plates supplemented with 1mM IPTG and 20mg/L carbenicillin 
and E. coli HT115 as a food source. For experiments conducted on RNAi worms were 
grown on OP50 plates and egg prepped onto IPTG plates seeded with HT115 to remove 
OP50. To prevent progeny contamination 5-fluoro-2′-deoxyuridine (FUdR) was added 
topically to the bacteria to make a 15µM concentration 1 day before worms were placed 
on agar plates. Lifespan measurement trials were set up by picking 100 hermaphrodite 
worms per strain and placing 25 worms per 60mm Petri Plate. L4 larval stage was taken 
as t=0 and worms were scored every two days.  Animals were transferred to fresh plates 
at least once a week. If an animal failed to respond to gentle prodding it was considered 
dead. Worms that were on contaminated plates, or suffered a non-ageing related death 
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such as internal hatching (bagging), severely extruding uterus (the rupture phenotype) or 
desiccation were censored.  
 
2.1.8 Whole animal staining methods 
DAPI staining 
Worms were stained as previously described (Angelo and Van Gilst, 2009). Adult 
worms were picked into a microcentrifuge Eppendorf tube with 1ml of M9 buffer and 
centrifuged a 6000 rpm for 3 minutes to pellet worms, as much of the M9 as possible was 
removed. Worms were then fixed by adding 200µl of ice cold 100% methanol and placed 
on ice for 5 minutes. Worms were washed with M9 buffer once, centrifuged, and M9 was 
removed. Fixed animals were incubated at room temperature for 40 minutes in 100µl of 
4’, 6’-diamino-2-phenylidole hydrochloride (DAPI) at a concentration of 500ng/ml 
protected from light. Worms were once again washed in M9 and pelleted by 
centrifugation. Glass pipettes were used to transfer worms to an unseeded NGM plate to 
lessen the amount of worms lost by sticking to plastic pipette tips. NGM plates were left 
to dry protected from light. Worms were then mounted on slides and imaged under the 
DAPI filter set (excitation: 350/50nm; emission 460/50nm) at 20X to obtain an image of 
the gonad arm.  
SYTO 12 staining 
SYTO 12 is a vital dye that permeates cells with reduced membrane integrity and 
stains nucleic acid allowing visualization of apoptotic corpses. To stain worms we 
modified a previously described protocol (Gumienny et al., 1999). A small piece of 
parafilm was placed on an agar slide and small round indentations were made using the 
back of a ballpoint pen. A drop (~10µl) of 33µM SYTO 12 was added to each 
indentation.15-20 worms along with some OP50 were placed onto each drop using a 
worm pick. Worms were incubated for 3-4 hours in a dark, humid chamber at room 
temperature. The humid chamber was constructed by using an empty pipette tip box 
wrapped in tin foil to reduce light exposure. Water was poured in the bottom of the box 
and the slide was put on top of the pipette tip holder. This was done to keep the SYTO 12 
drops from drying out and causing the worms to dissicate. After the 30-40 minute 
incubation time worms were transferred to a fresh seeded plate for an hour for the stain to 
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be expelled from the gut. We then imaged the worms under the GFP filter (excitation: 
470/40nm; emission 525/50nm) to count apoptotic corpses. 
                                                                                                                 
2.2 Microscopy 
2.2.1 Hardware and software 
C. elegans strain maintenance and lifespan measurements were conducted using a 
Nikon SMZ645 dissecting microscope attached to a Nikon super high-pressure mercury 
lamp. Differential interference contrast microscopy (DIC) and fluorescent microscopy 
images were obtained using one of the following systems: Leica DMRXA2 microscope 
connected to a Hamamatsu C10600 – Orca R2 camera or a Zeiss Axioskop2plus 
microscope connected to a Hamamatsu C10600 – Orca ER camera. Both microscopes are 
connected to iMac computers. The software used to acquire and analyse images is 
Volocity 5.2 for Macs (Improvision, Perkin Elmer). 
2.2.2 Slide preparation 
A 2% agar solution was prepared and aliquoted into several microcentrifuge 
Eppendorf tubes. To melt agar aliquots were placed in a heating block at 100°C until 
melted. A 50µl drop of the 2% agar solution was placed on a clean slide and pressed 
down using another clean slide to form a thin, circular agar pad. A 2µl drop of 0.2% 
anaesthetic (levamisole) was pipetted onto the pad and worms were picked onto the drop. 
A cover slip was placed carefully on top of the agar pad using tweezers. 
2.2.3 Fluorescence quantitation 
 Quantification of GFP in strains containing vit-2::GFP reporter was accomplished 
by taking images on a Leica DMRXA2 microscope. Images were taken at 10x 
magnification with bright field and epifluorescence using the GFP filter cube (excitation: 
470/40nm; emission: 525/50nm) and overlaid using Volocity acquisition. Exposure times 
were maintained constant between trials (500ms). After image acquisition GFP levels 
were obtained by tracing around the worm using Intuos 4 graphics tablet (Wacom) to get 
an intensity reading.  The worm outline was then dragged to the side to subtract 
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background reading for overall intensity. The mean pixel intensity readouts were 
exported to Microsoft Excel for further analysis. 
2.3 RNAi interference 
 In C. elegans RNAi can be induced by cloning a gene of interest into the L4440 
vector in E. coli HT115 and feeding it to the worms. All experiments performed on RNAi 
used HT115 containing the empty vector L4440 as a control. 
RNAi feeding clones were obtained from the Ahringer or Vidal libraries (Kamath 
and Ahringer, 2003; Rual et al., 2004) and were kindly provided by Dr. Stephen Nurrish 
(UCL). Clones obtained from frozen stocks were streaked on LB-ampicillin agar plates 
and incubated at 37C overnight. A single colony was selected and grown in LB media + 
ampicillin + tetracycline shaking at 37C overnight. The stock solution is 20ml LB, 20µl 
ampicillin (from a stock 50mg/ml), and 10µl tetracycline (from a stock of 10mg/ml). The 
working solution in which colonies are grown is 5ml.  The following day the culture was 
centrifuged at 4000rpm for 15 minutes to pellet bacteria and the supernatant was 
removed. The pellet was re-suspended in 10ml of LB + 20µl ampicillin. Agar plates 
containing IPTG are seeded with 200µl of culture and the bacteria lawn was allowed to 
grow for 2 days at room temperature. Plates were then stored at 4°C until use. 
2.4 Stress Assay 
2.4.1 Iron supplementation treatment 
 Increasing levels of free iron (III) via iron supplementation increases protein 
carbonylation in C. elegans (Valentini et al., 2012).  
 Worms were synchronized by egg prep and grown at 20°C on seeded NGM plates 
until they reached L4 larval stage. At this point, worms were washed off plates with M9 
buffer and transferred to 9mM ferric ammonium [iron (III)] citrate (FAC) NGM plates 
for the remainder of the experiment. NGM FAC plates were kept away from light to 
avoid reduction of iron (III) to iron (II). 
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2.5 Biochemistry  
2.5.1 Electrophoresis of C. elegans protein 
2.5.1.1 Sample collection 
Unless otherwise stated, worms were synchronized by performing an egg prep 
and allowing worms to grow at 15°C until they reach the L4 stage. For experiments using 
strains that develop at different rates, mutant and wildtype egg preps were staggered to 
ensure worms reached L4 on the same day. L4 worms were then transferred to fresh 
seeded plates and switched to 25°C for the remainder of the experiment. For samples of 
n=100 worms were washed off plates using M9 and transferred to microcentrifuge 
Eppendorf tubes using glass pipettes. If n=25-50 worms were used per sample worms 
were picked individually into microcentrifuge Eppendorf tubes containing M9 buffer. 
Worms washed 3 times using M9 and centrifuged for 1 minute at 6000 rpm. The 
supernatant was removed leaving worms in 25µl of M9 and samples were stored at -
80°C. 
2.5.1.2 Sample preparation 
 Samples were thawed and 25µl of 2x Laemmli sample buffer (Sigma) was added. 
Samples were incubated at 70°C and vortexed continuously for 15 minutes, they were 
then incubated at 95°C for 5 minutes. Samples were centrifuged for 15 minutes at 6000 
rpm. 
2.5.1.3 Protein gels 
We loaded 40μl of sample into Criterion XT Precast Gel 4-12% Bis-Tris (Bio-
rad) placed in and SDS-PAGE chamber. We added the running buffer which was 
prepared by mixing 25ml XT MOPS (Bio-rad) with 475ml distilled H2O. We used 
Precision Plus Protein Western Standard (Bio-rad) as a size marker ladder and loaded 5μl 
to the left and 10μl to the right of the gel to maintain orientation of gels after staining. 
The gels were run at 200V for 45 minutes.  
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2.5.1.4 Coomassie staining 
Gels were removed from plastic cassette and soaked in fixing solution for 30 
minutes in a plastic container. Fixing solution was poured out and gels were soaked 40 
minutes in Coomassie staining solution. Coomassie solution was replaced with destaining 
solution and gels were soaked for 20 minutes. Destaining solution was poured out and 
replaced before allowing gels to destain overnight. 
Densitometry 
 Gels were scanned and saved as 16 bit grayscale TIFF files. Scanned images of 
gels were analysed using 1D analysis option in ImageQuant TL software (GE Healthcare 
Europe). Lanes and/or bands of interest (e.g. myosin, actin, YP170, YP115, YP88) were 
detected manually and rubber band background removal was used. Lane and/or band 
densities were exported to Microsoft Excel for further analysis.  
2.5.2 Western blot/Oxyblot 
2.5.2.1 Sample collection 
 Synchronized day 1 adults were washed off 100mm plates with M9 and 
transferred to a 1.5ml Eppendorf tube. Worms were allowed to pellet by gravity and 
washed 3 times with M9. Supernatant was removed leaving worms in ~50μl of M9. 
Samples were stored at -80°C. 
Protein extraction 
 Samples were thawed, centrifuged and supernatant was removed. 100µl of protein 
buffer was added to samples and they were sonicated 3 times for 10 seconds using a 
Bioruptor (Cosmo Bio). Samples were checked visually to ensure complete 
fragmentation of the pellet. Between sonication steps samples were kept in an ice box. 
Samples were centrifuged for 30 minutes at 13000 rpm at 4°C and the supernatant was 
transferred to a new Eppendorf tube. The protein concentration of each sample was 
determined  by the Bradford assay; a typical concentration of 15-20 µg/µl was obtained. 
2.5.2.2 Oxyblot and western blot sample preparation 
 After the protein concentration was determined for each sample, the required 
volumes were transferred to new Eppendorf tubes. The volume for each sample was 
adjusted to 5µl by adding distilled H2O. 5µl of 12% SDS was added to samples for 
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protein denaturation. 10µl of a 1:10 dilution of dinitrophenylhydrazine (DNPH) was 
added and samples were incubated at room temperature for 15 minutes. After incubation, 
7.5µl of neutral solution was added to stop the reaction. At this point samples can be 
processed or stored at 4ºC for 1 week.  
2.5.2.3 Western blot 
 Hybond nitrocellulose membrane (Amersham Biosciences) was measured and cut 
roughly slightly bigger than the size of the gel.  The membrane was soaked for 5 minutes 
in transfer solution.  Two pieces of blotting paper were cut slightly larger than the 
membrane and were soaked in transfer solution for 5 minutes. For the transfer one piece 
of blotting paper was placed on the anode plate of a Trans-Blot Semi-dry electrophoretic 
transfer cell (Bio-Rad). The nitrocellulose membrane was placed above the blotting paper 
taking care to remove any air bubbles. The gel was placed on top of the membrane and 
the remaining piece of blotting paper was set on top. The cathode plate and safety cover 
were put on top and the cell was run for 45 minutes at 100V. 
  After the transfer, the membrane was incubated in PBS-Tween-milk solution in a 
tray on a shaker for 1 hour.  After incubation the membrane was soaked in fresh PBS-
Tween-milk solution containing primary antibody and left on a shaker at 4°C overnight. 
The following day, three 20 minute washes were performed on the membrane using PBS-
Tween buffer. The membrane was incubated in PBS-Tween-milk solution containing 
secondary antibody shaking for 1 hour at room temperature.  Again, three 20 minute 
washes were performed using PBS-Tween buffer. ECL Plus Western Blotting Detection 
System (Amersham Biosciences) was used to detect binding of the antibody as 
recommended by the manufacturer. Detection of actin, which was our internal control, 
was performed by washing the membrane with Restore Plus Western Blot Stripping 
Buffer as recommended by the manufacturer (Thermo Scientific).  
 ECL-treated membranes were placed in a developing cassette and taken to a dark 
room. A sheet of Hyperfilm (Amersham Biosciences) was placed on the membrane inside 
the developing cassette and exposed for 1 minute.  The sheet was developed using a 
Kodak X-Omat developer and exposed for longer or shorter amounts of time depending 
on the outcome of the first exposure 
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2.6 Reagents 
2.6.1 C. elegans strains used 
 N2 worms, obtained from the Caenorhabditis Genetics Center (CGC)  are used as 
the wildtype (WT) control thoughout this thesis.  
 
Strain  Genotype 
AV106 spo-11(ok79) IV/nT1[unc-?(n754) let-?] (IV;V). 
BE13  sqt-1(sc13) II. 
CB4037 glp-1(e2141) III. 
CF1442 daf-16(mu86) I; daf-2(e1370) III; muEx169[unc-119p::GFP::daf-16 + 
rol-6(su1006)]. 
CF1449 daf-16(mu86) I; daf-2(e1370) III; muEx176 [daf-16p::GFP::daf-16 + rol-
6]. 
CF1514 daf-16(mu86) I; daf-2(e1370) III; muEx211[pNL213(ges-1p::GFP::daf-
16) + rol-6(su1006)]. 
CF1515 daf-16(mu86) I; daf-2(e1370) III; muEx212[pNL212(myo-3p::GFP::daf-
16) + rol-6(su1006)]. 
CF1595 daf-16(mu86) I; daf-2(e1370) III; muEx227[pNL213(ges-1p::GFP::daf-
16) + rol-6(su1006)]. 
CY401  sqt-1(sc13) age-1(mg109)/mnC1 dpy-10(e128) unc-52(e444) II. 
DR1563 daf-2(e1370) III.  
DR1567  daf-2(m577) III.  
GA14  fog-2(q71) V.  
GA66 eat-2(ad1116) II.  
GA91  daf-16(mgDf50) I; daf-2(m577) III. 
GA184 sod-2(gk257) I    
GA507 daf-16(mgDf50) I; glp-4(bn2) I.  
GA1500 sqt-1(sc103) II; bIs1[vit-2::GFP + rol-6(su1006)] X.  
GA1501 sqt-1(sc103) II; daf-2(e1370) III; bIs1[vit-2::GFP + rol-6(su1006)] X.  
MD701 bcIs39 [(lim-7)ced-1p::GFP + lin-15(+)] V. 
MT1522 ced-3(n717) IV. 
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MT2547 ced-4(n1162) III. 
MT3002 ced-3(n1286) IV. 
MT4770 ced-9(n1950) III. 
MT8313 ced-3(n2885) IV. 
MT8354 ced-3(n2454) IV. 
MQ887 isp-1(qm150) IV. 
MQ1333 nuo-6(qm200) I. 
N2  wildtype 
RB1206 rsks-1(ok1255) III. 
SS104  glp-4(bn2) I. 
TG34  gld-1(op236) I. 
TJ1  cep-1(gk138) I. 
TJ1052 age-1(hx546) II. 
XR1  abl-1(ok171) X. 
 
2.6.2 Media 
Nematode growth media (NGM) 
Add 3g NaCl, 2.5g peptone, 20g agar to a clean glass bottle and make solution up 
to 1L with distilled H2O. Autoclave, allow to cool and add the following sterile solutions: 
1ml 1M MgSO4, 1ml 1M CaCl2, 1ml 5g/ml cholesterol and 25ml 1M KH2PO4. 
 
NGM IPTG agar 
Add 3g NaCl, 2.5g peptone, 20g agar to a clean glass bottle and make solution up 
to 1L with distilled H2O. Autoclave, allow to cool and add the following sterile solutions: 
1ml 1M MgSO4, 1ml 1M CaCl2, 1ml 5g/ml cholesterol, 25ml 1M KH2PO4, 1ml 1M 
IPTG and 400µl 50mg/ml carbenicillin. 
 
M9 solution 
 Add 7g Na2HPO4.2H2O, 5g NaCl, 3g KH2PO4, 0.25g MgSO4.7H2O to a clean 
glass bottle, make solution up to 1L with distilled H2O and autoclave. 
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OP50 growth medium 
 Add 5g tryptone and 2.5g yeast extract to a clean glass bottle, make solution up to 
1L with distilled H2O and autoclave. 
 
Luria-Bertani (LB) medium 
 Add 5g yeast extract, 10g NaCl and 10g tryptone to a clean glass bottle, make 
solution up to 1L with distilled H2O, adjust pH to 7.5 with 5M NaOH and autoclave. 
 
LB-ampicillin agar plates 
 Add 10g bactotryptone, 5g bacto yeast extract, 10g NaCl and 17g agar to a clean 
glass bottle, make solution up to 1L with distilled H2O, adjust pH to 7.5 with 5M NaOH. 
Autoclave, allow to cool and add sterile 1ml 50mg/ml ampicillin. 
 
Freezing medium 
 Add 20ml 1M NaCl, 10ml 1M KH2PO4 and 60ml 100% glycerol to a clean glass 
bottle and make solution up to 200ml with distilled H2O. Autoclave, allow to cool and 
add 0.6ml sterile 0.1M MgSO4. 
 
9mM Ferric ammoniun citrate (FAC) agar 
Add 3g NaCl, 2.5 g peptone, 20g agar to a clean glass bottle and make solution up 
to 500ml with distilled H2O. Autoclave, allow to cool and add the following sterile 
solutions: 1ml 1M MgSO4, 1ml 1M CaCl2, 1ml 5g/ml cholesterol, 25ml 1M KH2PO4, 
4.5ml 1M FAC. 
 
Fixing solution 
 Mix 500ml methanol, 100ml acetic acid and 400ml distilled H2O in a clean glass 
bottle by inverting 3 times. 
 
Coomassie staining solution 
 To make stock solution add 12g brilliant blue R-250, 300ml methanol and 60ml 
acetic acid to a clean glass bottle and mix by inverting 3 times. For working solution mix 
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500ml methanol, 30ml Coomassie stock solution, 400ml distilled H2O and 100ml acetic 
acid and mix by inverting 3 times. 
 
Destaining solution 
 Mix 450ml methanol, 100ml ascetic acid and 450ml distilled H2O in a clean glass 
bottle by inverting 3 times. 
 
PBS-Tween buffer (1X) 
 Mix 100ml 10X PBS, 1ml Tween-20 and 900ml distilled H2O in a clean glass 
bottle and mix by inverting 3 times.  
 
Running buffer (10X) 
 Add 30.3g Tris-base, 144g glycine and 10g SDS to a clean glass bottle and make 
solution up to 200ml with distilled H2O. To make working solution (1X) mix 100ml 
running buffer and make up to 1L with distilled H2O. 
 
PBS-Tween-milk solution 
 Add 100ml 1X PBS, 0.5ml Tween and 2.5g milk powder to a clean bottle and mix 
by inverting 3 times. 
 
Western transfer buffer (10X) 
 Add 144g glycine and 30.2g Tris-base to a clean glass bottle, make solution up to 
1L with distilled H2O. To make working solution (1X) mix 200ml transfer solution and 
200ml ethanol make solution up to 1L with distilled H2O. Keep refrigerated. 
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2.7 Statistics 
Survival analysis 
Statistical comparison of mean lifespan were performed using JMP 9 (SAS 
Institute Inc.) the non-parametric Log-rank test was executed to obtain p-values.  
 
Students t-test 
Experiments in which several treatments were compared to a single control were 
analysed for statistical significance by performing pair wise Student’s t-tests (Excel) to 
obtain p-values. 
 
ANOVA-Tukey Kramer 
Turkey’s HSD (honestly significance difference) test is a statistical analysis  that 
allows for multiple comparisons. First a one-way ANOVA was performed on the data to 
determine if there were differences among means. The Tukey HSD test was then 
performed to obtain comparisons between the means of all treatments. ANOVA and 
Tukey HSD tests were performed using JMP 9 (SAS Institute Inc.) to obtain p-values. 
 
Wilcoxon-Mann Whitney test 
The non-parametric Wilcoxon-Mann Whitney test was used in experiments 
measuring ageing tissues to determine if there were statistical differences in population 
mean ranks between samples. The Wilcoxon-Mann Whitney test was performed using 
JMP 9 (SAS Institute Inc.) to obtain p-values. 
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Chapter 3: Quasi-programmed yolk overproduction in 
ageing C. elegans 
3.1 Introduction to yolk protein 
Yolk is a lipoprotein produced by most egg-laying organisms to provide nutrients 
necessary for developing embryos. The main protein component of yolk is known as 
‘vitellogenin’, a term that was first used in insects (Pan et al., 1969). Sequencing of 
vitellogenin (Vtg) genes have revealed striking similarities in morphologically distinct 
oviparous animal groups such as chickens, frogs and nematodes (Nardelli et al., 1987; 
Spieth et al., 1985) implying evolutionary conservation.  
An additional study found that vitellogenin of chickens, Xenopus laevis, 
Drosophila melanogaster and C. elegans contain domains homologous to human genes 
for the apoprotein of low density lipoprotein (LDL), apoB-100, and to Von Willebrand 
factor (Baker, 1988a, 1988b). In C. elegans, yolk proteins bind and transport lipids such 
as triglycerides and cholesterol to oocytes, thereby showing a similar function to LDL in 
mammals (Matyash et al., 2001). The similarity in function between apoB-100 and 
vitellogenin suggests that vitellogenin may be an ancestral relative of apoB-100. Von 
Willebrand factor has adhesive properties allowing it to bind platelets, collagen and 
proteins, suggesting a similarity with vitellogenin adhesion to oocyte receptors for uptake 
(Baker, 1988b). The similarity between C. elegans vitellogenin and vertebrate blood 
clotting factor Von Willebrand may also reflect an unknown role apart from nourishment 
of developing embryos (Baker, 1988b).   
3.1.1 C. elegans yolk protein  
In response to hormonal cues, yolk proteins are synthesized in different tissues 
(such as the intestine, ovary and liver) across oviparous species (Byrne et al., 1989). Yolk 
proteins are synthesized in the fat body and ovary of Drosophila (Bownes et al., 1983) 
and in the liver of frogs (Wiley and Wallace, 1981) and chickens (Jost et al., 1978). A 
common feature among all egg-laying organisms is that yolk is synthesized in tissues 
outside of its intended final destination, the egg (Byrne et al., 1989). 
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  In C. elegans yolk proteins are synthesized outside of the gonad (Kimble and 
Sharrock, 1983). Worms in which gonad precursor cells have been ablated and thus are 
gonad-less still accumulate yolk proteins, ruling out the gonad as the tissue of yolk origin 
(Kimble and Sharrock, 1983). The production of yolk proteins is a sex-specific trait, as 
male worms do not produce yolk proteins, regardless of whether they possess a gonad or 
not (Kimble and Sharrock, 1983). Male C. elegans live  ~19% longer than hermaphrodite 
worms (Gems and Riddle, 2000). This poses the interesting question whether differences 
in mortality reflect detrimental effects of yolk in hermaphrodites. Yolk production in 
hermaphrodite worms begins at L4, to ensure an abundant supply before egg production 
begins (Kimble and Sharrock, 1983). Tissue examination by dissection of the body wall, 
gonad, intestine and embryos revealed the intestine as the site of yolk synthesis by a 
process of elimination (Kimble and Sharrock, 1983). Vitellogenin precursors are 
synthesized in the intestine and then secreted into the pseudocoelum, from which yolk is 
taken up by developing oocytes by endocytosis via the LDL-like receptor RME-2 (Grant 
and Hirsh, 1999). 
Vitellogenin can be synthesized by a single gene as in echinoderms (Shyu et al., 
1986) or from multiple genes as in Drosophila and chickens, both of which have 3 
vitellogenin genes (Terpstra and Ab, 1988). Curiously, C. elegans has more vitellogenin 
genes than more complex oviparous species. C. elegans vitellogenins are divided into two 
distinct subclasses named according to their molecular weight: the large yolk proteins 
YP170A and YP170B and the smaller proteins YP115 and YP88. Of these YP170, 
YP115 and YP88 are electrophoretically distinct (Kimble and Sharrock, 1983; Spieth and 
Blumenthal, 1985).  
Yolk proteins are coded for by six genes vit-1 through vit-6, vit-1 is thought to be 
pseudogene with a stop codon in the protein-coding region of the gene (Spieth et al., 
1985). However, a more recent study suggests that the sequence encoded by vit-1 is 
translated into protein, arguing against it being a pseudogene (Depuydt et al., 2013). 
There is a high degree of homology between C. elegans vit genes. Genes vit-3, vit-4 and 
vit-5 have 96% sequence similarity, and these three genes are 68% homologous to vit-2 
(Spieth et al., 1985). The sequence of vit-6 is 50% similar to the other 5 vit genes (Spieth 
et al., 1985). Genes vit-3, vit-4 and vit-5 contribute to make YP170A, while vit-2 
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produces YP170B (Spieth and Blumenthal, 1985).  Both YP170A and YP170B are taken 
up by oocytes intact. The two smaller yolk proteins are encoded for by vit-6, which 
produces the precursor protein YP180 (Spieth and Blumenthal, 1985). After leaving the 
intestine and before being taken up by oocytes YP180 is cleaved to produce YP115 and 
YP88 (Figure 3.1) (Spieth and Blumenthal, 1985).  
The four yolk proteins associate into two lipoprotein particles. These lipoproteins 
are composed of vitellogenin, 8% phospholipids, 3% triglycerides and 3% other lipids 
(Sharrock et al., 1990). The ‘A complex’ contains YP170A, YP115 and YP88 and the ‘B 
Dimer’ contains YP170B (Sharrock et al., 1990).  
                   
 
Figure 3.1 C. elegans vitellogenin genes and their encoded yolk proteins. Reproduced 
and modified from Spieth and Blumenthal, 1995; Spieth et al, 1985.  
3.1.2 Yolk proteins in ageing C. elegans 
Using a VIT-2::GFP reporter allows visualisation of YP170 yolk protein. Prior to 
sperm depletion yolk protein is observed within the intestine and oocytes of young 
hermaphrodite worms. After sperm runs out, oocyte production ceases and yolk protein 
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accumulates throughout the body cavity (Brandt et al., 2005; Herndon et al., 2002) 
(Figure 3.2). Consistent with the redistribution of yolk protein, lipid inclusions have been 
observed in the muscle and hypodermis of old worms (Herndon et al., 2002). Late life 
yolk accumulation implies that it continues to be synthesized in post-reproductive worms 
in a “tap left on” (or open faucet) type mechanism (Herndon et al., 2002). C. elegans 
vitellogenin has been found to be similar in structure and function to mammalian LDL 
protein apoB-100 which is a risk factor in the development of arteriosclerosis (Contois et 
al., 2011). This poses the question whether yolk accumulation may also have a lipotoxic 
effect in C. elegans (Ackerman and Gems, 2012). The continuous production of yolk in 
post-reproductive worms is consistent with the notion of a quasi-programme. 
 
 Figure 3.2 Accumulation of 
yolk protein in the body 
cavity of post-reproductive 
worms.  Using VIT-2::GFP to 
visualize yolk protein revealed 
that at 20°C day 4 worms have 
yolk protein in the intestine and 
oocytes (top panel). On day 12 
yolk protein is redistributed accumulating throughout the body cavity (lower panel). 
Figure reproduced from Herndon et al 2002. 
 
Increased yolk production in ageing worms could have a toxic effect and thus 
limit their lifespan. In support of this, microarray data found an apparent reduction in vit-
2 and vit-5 mRNA in day 1 of adulthood long-lived daf-2(-) worms compared to wildtype 
(Murphy et al., 2003). Furthermore, RNAi of vit-2 or vit-5 have been reported to 
modestly extend lifespan (Murphy et al., 2003). When worm lysates were run on 
Coomassie-stained gels a large increase in yolk protein was observed in wildtype worms 
between day 1 and 4, but this increase was absent in long lived daf-2(e1370) mutants 
(DePina et al., 2011). In contrast, vit-2, vit-5 and vit-6 mRNA have been shown to decline 
with age in wildtype (Fabian and Johnson, 1995). Another study found mRNA levels of 
vit-2 and vit-5 to decline progressively from day 1 to day 6 and a similar pattern was 
observed in daf-2(e1368), and daf-2(e1370) showed similar mRNA levels to wildtype on 
day 1 to 4 but a stronger reduction on day 6  (DePina et al., 2011). The disparity between 
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the general trend of reduction in vit mRNA in both wildtype and daf-2(-) and the 
observation that yolk protein is reduced in daf-2(-) with respect to wildtype, in which a 
large increase is observed between day 1 and 4,  argues against a simple model in which 
DAF-16 represses vit gene transcription. More plausibly, vit genes are transcribed at high 
levels during early adulthood and DAF-16 can block translation of these transcripts 
(DePina et al., 2011).  
Accumulation of yolk protein in wildtype worms is a potential example of post-
reproductive unregulated biosynthesis and is consistent with Blagosklonny’s 
hyperfunction theory. In this chapter we test the possibility that lifespan in C. elegans is 
limited by yolk accumulation. We examine genetic interventions that increase lifespan to 
assess their effect on yolk protein levels and tested whether manipulating yolk protein 
levels has an effect on lifespan. 
The data in this chapter was collected by myself and Eleanor Tyler. Eleanor was a 
masters student who worked closely with me and whom I directly supervised. Data that 
was collected by Eleanor is ascribed to her as follows: Figure 3.4, 3.5 (B-D), 3.7, 3.8, 3.9, 
3.10, 3.11, 3.14, 3.15, 3.16, 3.17, 3.18, 3.19, 3.20. Her contributions are also noted in the 
corresponding figure legends. 
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3.2 Results 
3.2.1 Measuring yolk protein levels in ageing worms 
We asked whether yolk production acts as “tap left on”, continuing its synthesis in an 
unregulated fashion throughout adulthood. In this study we used the following methods 
to measure yolk protein (YP) levels. 
3.2.1.1 VIT-2::GFP fluorescence measurements 
To examine changes in yolk protein levels and where yolk is located in the worm 
a VIT-2::GFP reporter strains were used.  The VIT-2::GFP reporter strains used for these 
experiments are GA1500 bIs1[vit-2::GFP + rol-6(su1006)] and GA1501 daf-2(e1370), 
bIs1[vit-2::GFP + rol-6(su1006)]. GA1500 derived from DH1033 sqt-1(sc103) II, 
bIs1[vit-2::GFP + rol-6(su1006)] mated with N2 males to remove sqt-1(sc103) from the 
background by segregating away the sqt-1(sc103) mutation. We then used GA1500 and 
crossed it with daf-2(e1370) males and selected for plates in which all worms formed 
dauer at 25C and are rollers. Unless otherwise stated, worms were raised at 15ºC and 
transferred to 25ºC at L4 larval stage (see section 2.2.3). The exposure time used for 
microfluorimety was maintained at 500ms throughout the experiments. This exposure 
was selected because it is long enough to detect fluorescence in young adults without 
leading to image saturation in micrographs of older worms. 
3.2.1.2 Coomassie stained SDS-PAGE gels  
Yolk levels were also quantified by running worm protein extracts on Coomassie-
stained gels (see section 2.4.1). Myosin, YP170, YP88 and YP115 bands were recognized 
using published data (DePina et al., 2011; Kimble and Sharrock, 1983). The actin band 
was identified by western blotting (see section 2.5.2). Bands of interest were analysed 
using densitometry to obtain abundance measurements.  Levels of yolk proteins YP170, 
YP115 and YP88 were normalized to myosin as an internal standard. Actin is a 
housekeeping gene and its expression should be constant, and the ratio of actin to myosin 
was used to give an indication of the reliability of myosin as a standard (DePina et al., 
2011). Protein abundance (YP170/myosin, YP115/myosin, YP88/myosin and 
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actin/myosin) on days 4, 8 and 12 are shown as a ratio to their respective day 1 wildtype 
control levels.   
Unless otherwise stated, worms were grown at 15°C to L4 larval stage and then 
transferred to 25°C for the duration of the experiment. Worms were collected in 
microcentrifuge Eppendorf tubes and immediately stored at -80°C until samples were 
processed.  
3.2.1.3 New yolk terminology 
For convenience in this study we propose a new terminology to describe yolk 
accumulation (Yol) phenotype observed. In accordance with C. elegans nomenclature we 
propose the use of Yol-o for yolk over-accumulation and Yol-d for yolk accumulation-
deficient using wildtype yolk protein levels as a baseline.  
3.2.2 Yolk synthesis continues throughout adulthood 
A previous study observed an increase in yolk protein levels in ageing C. elegans 
from day 1 to day 4 of adulthood (DePina et al., 2011). The hyperfunction theory would 
suggest that after reproduction ceases, yolk synthesis is not regulated and continues being 
produced, resulting in its accumulation in a tap left on type mechanism. To examine if 
this is the case, and how long the tap is left on, GA1500 worms were observed on slides 
and levels of GFP were measured on day 1, 4 and 8 of adulthood. On day 1 GFP was 
observed mainly in the oocytes. By day 4 a large increase in GFP is observed throughout 
the body cavity, indicating a major increase in yolk levels and change in distribution, 
consistent with earlier observations (DePina et al., 2011). However, on day 8 GFP was 
observed mainly in the intestine and there is a significant decrease in fluorescence levels 
between day 4 and day 8 (Figure 3.3 A,B). This suggests that VIT-2::GFP accumulates in 
the body cavity at high levels during reproduction and from then on declines post-
reproduction but remains at levels twice as high as those observed on day 1. 
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Figure 3.3 Yolk levels increase in ageing worms. A) An increase in level and change in 
distribution of yolk was observed using the VIT-2::GFP reporter strain GA1500. B) A 
significant increase in VIT-2::GFP fluorescence was observed between day 1 and 4, after 
which there was a reduction. Data is the mean of 35-45 worms; error bars, SEM; 
ANOVA (p<0.0001) and post-hoc Tukey’s (HSD) test on consecutive days *** p<0.001. 
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As a more direct measure of yolk accumulation, wildtype worms were collected 
on days 1, 4, 8, and 12 and relative YP170, YP115 and YP88 levels were measured by 
running whole worm lysates on SDS-PAGE gels (Figure 3.4 A). We found a constant 
increase in YP170 levels from day 4 to day 8, but no further significant increase on day 
12 (Figure 3.4 B).  A similar trend was observed for YP115 and YP88, however it is not 
statistically significant, probably reflecting variability between trials (Figure 3.4 C,D).  
The magnitude of the increase in YP170 between day 1 and 4 was double in this 
experiment; results by DePina et al showed a 4-fold increase (DePina et al., 2011). The 
difference in the magnitude of the effect of age on YP170 abundance may reflect 
saturation due to overloading of the gels in our trials. 
 
 
Figure 3.4 Yolk proteins remain constantly high after day 4 of adulthood. A) 
Coomassie stained SDS-PAGE gels showing yolk protein abundance. B) YP170 levels 
continue to increase up to at least day 8. C,D) YP115 and YP88 follow the same trend. 
Data is the mean of three biological replicates (100 worms per replicate); error bars, 
SEM; ANOVA (p<0.0001), Tukey’s (HSD) test on consecutive days, ** p<0.01, * 
p<0.05. 
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Thus, using protein lysates to measure yolk levels showed a gradual increase in 
YP170 with age, which is similar to what was observed using VIT-2::GFP, where levels 
increased approximately 10-fold between day 1 and 4. However, VIT-2::GFP data 
suggests a decrease in YP170 on day 8. Worm lysates provide a more reliable method 
than VIT-2::GFP because GFP may give a less reliable indication of protein 
accumulation, e.g. due to GFP degradation with age. Additionally, VIT-2::GFP only 
reflects YP170B, whereas measuring YP170 bands on gels gives a readout of levels of 
YP170A and YP170B. In conclusion, yolk accumulation continues until at least day 8. 
The reduced accumulation after that could reflect effects of senescence on yolk 
biosynthetic capacity. 
3.2.3 No age increase in yolk levels in daf-2(-) worms 
It has been previously reported that daf-2(e1370) mutation suppresses the increase 
in yolk protein levels that otherwise occurs in wildtype worms between day 1 and day 4 
of adulthood (DePina et al., 2011). Mutations in daf-2 extend lifespan in worms (Kenyon 
et al., 1993). Could the absence of yolk accumulation contribute to this? We wanted to 
investigate how DAF-2 controls yolk levels. First, we set out to verify the results of 
DePina et al. We first tested the effect of daf-2(e1370) on the age increase in yolk by 
looking at VIT-2::GFP levels on days 1, 4 and 6.  On day 1 VIT-2::GFP levels were the 
same in daf-2(+) and daf-2(e1370). However, daf-2(e1370) worms showed no age 
increase in GFP levels, implying that IIS promotes yolk accumulation (Figure 3.5 A). 
This confirms the finding by DePina et al that daf-2(e1370) blocks yolk accumulation on 
day 4 and extends the finding to day 6.  
We then sought to verify the reduced yolk phenotype of daf-2(e1370) worms by 
studying protein gels. In addition daf-2(m577) was also tested to rule out the feeding 
defect and reduced fertility present in daf-2(e1370) as the cause of yolk reduction. daf-
2(m577) is a class 1, less pleiotropic allele, which does not exhibit fertility or feeding 
defects (Gems et al., 1998). Both daf-2(-) alleles show a marked reduction in YP levels 
on day 4 relative to wildtype (Figure 3.5 B,C,D ; Appendix 1, Figure A-1.1).  
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Figure 3.5 No age increase in yolk levels in day 4 daf-2(-) worms (25˚). A) VIT-
2::GFP  levels are reduced in daf-2(e1370) worms. B) Coomassie stained SDS-PAGE 
gels showing YP abundance. C,D) daf-2(e1370) and daf-2(m577) both have reduced 
levels of YP on day 1 and 4 compared to wildtype. Data is the mean of (A) one replicate 
(10 worms), (C-D) three biological replicates (100 worms per replicate); error bars, SEM; 
Student’s  t-test ***p<0.001, **p<0.01, *p<0.05 (versus age-matched control). B-D) 
Data collected by E. Tyler. 
 
 Having found that yolk accumulates throughout adulthood we wanted to observe 
whether daf-2(m577) suppresses yolk accumulation throughout life, or whether yolk 
accumulates after day 4. To this end we compared yolk levels at day 1, 4, 8 and 12 of 
adulthood in wildtype and daf-2(m577) worms at 25˚C.  
 In this trial we saw a significant increase in YP170 between day 1 and 4 in 
wildtype worms, but no further significant increase was observed on days 8 and 12, 
probably due to high variability between gels (Figure 3.6 A,B). A similar trend was 
observed for YP115 and YP88 but, again, increases did not reach statistical significance. 
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Additionally it should be noted that the actin to myosin ratio fluctuated on day 12 (Figure 
3.6 C).  
Yolk did not accumulate in daf-2(m577) worms from day 1 to day 12. YP170 
levels remained similar to those of day 1 wildtype worms. YP115 and YP88 mostly 
followed a similar trend than YP170 (Figure 3.6 A,B). With the exception that YP115 
was lower than wildtype on day 1 and YP88 was lower than wildtype levels in day 4 
worms (Figure 3.6 C). These results imply that YP does not accumulate at all in ageing 
daf-2(-) worms, though the possibility remains that YP accumulates at a later age.  
 
Figure 3.6 Yolk does not accumulate in daf-2(-) worms between day 1 and 12. A) 
Coomassie stained SDS-PAGE gels showing yolk protein abundance. Panels on same gel 
were rearranged for clarity. B) Age increase in YP170 levels in wildtype worms, but not 
daf-2(m577) mutants. C) YP115 and YP88 do not accumulate in daf-2(m577) mutants. 
Data is the mean of three biological replicates (25 worms per replicate); error bars, SEM; 
ANOVA (p<0.0001), Tukey’s (HSD) test compared to day 1 control *p<0.05. 
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3.2.4 Other IIS mutants also prevent yolk accumulation 
AGE-1 is the C. elegans ortholog of phosphatidylinositol-3-kinase catalytic 
subunit (PI3K) which acts downstream of the DAF-2 receptor (Morris et al., 1996). To 
further test the role of IIS in yolk regulation we examined age-1(hx546) mutants which 
are ~40% longer lived than wildtype and exhibit a 75% decrease in fecundity at  20°C 
(Friedman and Johnson, 1988). A previous study reported that age-1(hx546) mutants 
show a wildtype yolk distribution pattern (Herndon et al., 2002). However, effects of 
age-1(hx546) on overall YP levels have not been reported. Yolk protein levels were 
measured for this mutant and were found to be lower than wildtype on day 1 but not day 
4 for YP170 (Figure 3.7 A,B). A similar trend was observed for YP115 and YP88 
(Appendix 1, Figure A-1.2). 
The age-1(hx546) is a weak reduction of function allele containing a missense 
mutation (Ayyadevara et al., 2008), which could explain why YP levels are only weakly 
reduced in this strain. We performed tests on stronger allele age-1(mg109) which is a 
missense mutation resulting in a non-functional protein (Morris et al., 1996). In the 
absence of maternal rescue, age-1(mg109) homozygotes form dauers at all temperatures 
(Gottlieb and Ruvkun, 1994), so the balancer strain GY401 [sqt-1(sc13) age-
1(mg109)/mnC1 dpy-10(e128) unc-52(e444)] was used. sqt-1(sc13) homozygotes are 
rollers (Rol). Rol segregants were found among progeny of heterozygous mothers. These 
worms were homozygous for age-1(mg109) but did not form dauers due to maternal 
rescue thanks to the presence of wildtype AGE-1. A sqt-1(sc13) control was used to 
check that this marker mutation did not affect yolk protein levels. Consistent with the 
results seen in daf-2(-), age-1(mg109) shows a reduction in YP170 levels on day 4 
(Figure 3.7 C,D). Levels of YP115 and YP88 follow a similar trend but did not attain 
statistical significance (Appendix 1, Figure A-1.2).  
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Figure 3.7 Yolk protein levels in age-1 mutants. A,B) Lysates of age-1(hx546) mutants 
show reduced levels of YP on day 1 worms compared to wildtype, but not on day 4. C,D) 
Lysates of age-1(mg109) mutants show a reduction in YP levels on day 4 compared to 
wildtype. Data is the mean of three biological replicates (100 worms per replicate); error 
bars, SEM; Student’s t-test **p<0.01, *p<0.05 (versus age-matched wildtype). Data 
collected by E. Tyler. 
 
3.2.5 Suppression of yolk protein accumulation in daf-2(-) is DAF-16 dependent 
DAF-16 is required for the lifespan extension observed in daf-2(-) mutants 
(Kenyon et al., 1993). A previous study showed that the reduced YP levels observed in 
daf-2(e1370) mutants is dependent on DAF-16 (DePina et al., 2011). We previously 
showed a decrease in yolk protein levels in daf-2(m577) mutants. We sought to replicate 
the results obtained by DePina et al by using daf-16(mgDf50); daf-2(m577) and found 
similar results. daf-16(mgDf50), daf-2(m577) mutants have wildtype YP levels on day 1 
and 4 (Figure 3.8; Appendix 1, Figure A1.3). These findings verify that IIS stimulates 
yolk accumulation, perhaps by inactivating DAF-16. 
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Figure 3.8 Yolk protein levels in daf-16(mgDf50); daf-2(m577). A) Coomassie stained 
SDS-PAGE gels showing yolk protein abundance. B) YP levels in daf-16(mgDf50); daf-
2(m577) worms are similar to wildtype on day 1 and 4. Data is the mean of three 
biological replicates (100 worms per replicate); error bars, SEM; Student’s t-test (versus 
age-matched wildtype). Data collected by E. Tyler. 
 
 
3.2.6 Effects of tissue-specific expression of DAF-16 in the intestine, muscle and 
neurons on yolk protein levels 
Our data so far suggests that IIS promotes yolk protein synthesis. Longevity of 
germline ablated and daf-2(-) worms is dependent on DAF-16 activity (Hsin and Kenyon, 
1999; Kenyon et al., 1993). A previous study constructed strains in which daf-16 
expression in daf-16(mu86); daf-2(e1370) mutants was rescued either in the intestine, 
musculature or nervous system using transgene arrays (Libina et al., 2003).  To further 
examine how and where yolk synthesis is regulated we these used strains with tissue-
specific rescue of daf-16 expression. 
The strain CF1449 in which daf-16 expression is driven ubiquitously by its own 
promoter has been shown to rescue lifespan of daf-16(mu86); daf-2(e1370) mutants to 
nearly daf-2(e1370) levels (Libina et al., 2003). We first tested this strain to see if it had 
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the Yol-d phenotype previously observed in daf-2(e1370) worms, and found that it did; 
YP levels were reduced on day 1 and 4 compared to wildtype. However, actin levels were 
slightly higher relative to myosin on day 1 (Figure 3.9; Appendix 1, Figure A-1.4). Only 
two replicates were obtained due to high frequency of bagging (maternal hatching of 
larvae) in this strain. A comparison with effects of daf-2(e1370) on YP levels (Figure 3.5 
C) suggests greater suppression of yolk synthesis in CF1449, perhaps reflecting higher 
daf-16 copy number resulting in further activation of DAF-16. 
 
 
Figure 3.9 daf-16 expression by its own promoter causes Yol-d in daf-16(mu86); daf-
2(e1370). A) Coomassie stained SDS-PAGE gels showing yolk protein abundance. B) 
DAF-16 driven by its own promoter causes a reduction in YP levels on day 1 and 4 
compared to wildtype. Data is the mean of two biological replicates (100 worms per 
replicate); error bars, SEM; Student’s t-test **p<0.01, *p<0.05 (versus age-matched 
wildtype). Data collected by E. Tyler. 
 
Yolk is synthesized in the intestine in C. elegans hermaphrodites (Kimble and 
Sharrock, 1983). Transgenic strains CF1595 and CF1515 that have DAF-16 rescued in 
the intestine of daf-16(mu86); daf-2(e1370) worms restore lifespan extension to 
approximately 50-60% that of daf-2(e1370) worms (Libina et al., 2003). We examined 
both transgenic strains by running worm lysates on Coomassie stained gels. In CF1595 
YP levels were reduced on day 1. In both strains there was an apparent reduction (~30%) 
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of YP on day 4, however in neither case did this reach statistical significance (Figure 
3.10; Appendix 1, Figure A-1.5). That both pges-1::daf-16 strains show an apparent 
reduction in yolk levels suggests that these trials may have failed to detect an existing 
effect on YP levels due to high inter-trial variance. Further trials would be required to 
establish whether this is the case.  
 
Figure 3.10 Intestinal daf-16 expression does not rescue Yol-d phenotype in day 4 
daf-16(mu86); daf-2(e1370) worms. A) Coomassie stained SDS-PAGE gels showing 
yolk protein abundance. B) DAF-16 activity in the intestine restored Yol-d phenotype on 
day 1 but not day 4 compared to wildtype. C) DAF-16 activity in the intestine does not 
reduce yolk to statistically significant levels in CF1514. Data is the mean of three (B) or 
two (C) biological replicates (100 worms per replicate); error bars, SEM; Student’s t-test 
*p<0.05 (versus age-matched wildtype). Data collected by E. Tyler. 
 
We also looked at YP levels in CF1515 and CF1442 daf-16(mu86); daf-2(e1370) 
with DAF-16 rescued in muscle and neurons, respectively. Of these strains DAF-16 
rescue in the muscle has no effect on lifespan, and neuronal DAF-16 has a mild beneficial 
effect (Libina et al., 2003). DAF-16 rescue in the muscle caused a decrease in YP170 
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levels on day 1 but not day 4 compared to wildtype (Figure 3.11 A,B). Levels of YP 
similar to wildtype were observed for YP115 and YP88 (Appendix 1, Figure A-1.6). For 
worms with DAF-16 rescued in the neurons only one replicate was performed due to 
problems with bagging, thus no statistics can be conducted but the trend suggests no 
difference in YP levels compared to wildtype (Figure 3. B, C ; Appendix 1, Figure A-
1.6).  
 
 
Figure 3.11 Muscle and neuronal DAF-16 do not rescue Yol-d phenotype in day 4 
daf-16(mu86); daf-2(e1370) worms. A,C) Coomassie stained SDS-PAGE gels showing 
yolk protein abundance. B) DAF-16 activity in the muscle reduced yolk protein levels on 
day 1 but not day 4 compared to wildtype. Data mean of two biological replicates (100 
worms per replicate). D) DAF-16 activity in the neurons does not reduce yolk levels in 
daf-16(mu86); daf-2(e1370). Data is the mean of one (D) or two (B) biological replicates 
(100 worms per replicate); error bars, SEM; Student’s t-test *p<0.05 (versus age-matched 
wildtype). Data collected by E. Tyler. 
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3.2.7 RNAi screening for genes mediating effects of daf-2 on yolk synthesis 
Understanding IIS and how DAF-16 affects yolk accumulation might provide 
insight into how this pathway controls ageing. We therefore tried to identify additional 
downstream mediators of the effect of DAF-2 on yolk synthesis. To do this we used 
RNAi and VIT-2::GFP reporter strains. We tested whether daf-2(-) Yol-d could be 
reversed by RNAi knockdown of selected genes involved in longevity (Figure 3.12). 
Worms were grown at 15°C on control RNAi (L4440) and transferred at L4 larval stage 
to 25C onto plates seeded with the RNAi clone of interest and 10µM FUdR.  
daf-16 RNAi was used as a positive control because it was previously shown to be 
necessary for yolk reduction observed in daf-2(-) worms (DePina et al., 2011). In daf-2 
mutants autophagy is increased, and daf-2(-) longevity is autophagy dependant (Hansen 
et al., 2008; Meléndez et al., 2003). To probe whether yolk reduction in daf-2(-) worms 
involves enhanced yolk removal by autophagy we used bec-1 (BECLIN) RNAi 
(Meléndez et al., 2003). daf-18 (PTEN) RNAi was expected to increase yolk levels in 
daf-2(-) worms because wildtype DAF-18 negatively regulates IIS by reducing PIP3 
levels (Ogg and Ruvkun, 1998). RNAi clones for additional downstream regulators were 
also tested: aak-2 the -subunit of AMP kinase, which is a downstream effector of daf-2 
(Apfeld et al., 2004), skn-1, which is a Nrf-2 type transcription factor involved in stress 
response (Tullet et al., 2008) and daf-12, a nuclear receptor for dafachronic acid involved 
in dauer formation (Antebi et al., 1998). 
Out of the RNAi treatments tested, only daf-16 RNAi caused an increase in VIT-
2::GFP levels in day 4 GA1501 worms (Figure 3.12). This suggests that suppression of 
yolk protein in daf-2(-) worms requires DAF-16 but not bec-1, aak-2, skn-1, daf-12, or 
daf-18. GFP levels were normalized to GA1500 on day 1 and treatments were compared 
to GA1500 day 1 to determine if statistically different from wildtype. The result of daf-18 
RNAi is unexpected, as it should suppress reduction of yolk levels by GA1501. It 
remains a possibility that RNAi treatments did not rescue wildtype yolk levels due to 
maternal rescue effect. Tests could be repeated by placing worms on RNAi for two 
generations to reduce the possibility of maternal rescue.  Another possibility is that RNAi 
is being hindered by the feeding defect (Eat) of daf-2(e1370). Additionally, daf-2(m577) 
is more susceptible to suppression than daf-2(e1370) (Gems et al., 1998). This 
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experiment could be repeated using daf-2(m577) to exclude this possibility. These 
questions could also be better addressed by running worm lysates on Coomassie stained 
gels, and by using double mutants containing daf-2(-) and the suppressor of interest. 
 
Figure 3.12 Effect of RNAi on VIT-2::GFP on day 4 of adulthood. A) Images of 
worms showing localization of YP170 using VIT-2::GFP. On day 4 GA1500 worms 
show yolk throughout the body cavity. This accumulation is absent in GA1501, this 
suppression is dependent on daf-16. B) An RNAi screen was conducted to examine if 
knockdown of genes involved in longevity restored wildtype yolk levels in GA1501. 
RNAi of aak-2, daf-12, daf-18, skn-1 and bec-1 did not increase yolk levels. RNAi of 
daf-16 did cause an increase in YP, above those of wildtype. One trial was perfomed (10 
worms); error bars, SEM; Student’s t-test ***p<0.001, **p<0.01, *p<0.05 (versus age-
matched control). 
 
3.2.8 Effect of the germline on yolk protein 
3.2.8.1 Effect of FUdR on yolk protein 
5-fluoro-2′-deoxyuridine (FUdR) is a drug commonly used to treat cancer (e.g. colon 
cancer). It is also widely used by C. elegans researchers in lifespan assays as it inhibits 
DNA synthesis, inducing sterility in hermaphrodite worms (Mitchell et al., 1979). We 
were interested in the effect sterility has on YP levels. We wanted to test if reduction of 
the main yolk sink (oocytes) would cause an increase in yolk protein levels. To avoid 
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blocking development worms were raised without FUdR to the L4 larval stage, and they 
were then transferred to plates containing 10µM FUdR for the remainder of the 
experiment. GFP levels in GA1500 worms were observed on day 1 and 4. Because of the 
use of some temperature sensitive mutations, e.g. glp-4(bn2), worms were raised at 15˚C 
and switched to 25˚C at the L4 stage. As predicted, FUdR treatment caused a significant 
increase of VIT-2::GFP on day 1 and 4 compared to worms on control plates (Figure 3.13 
A).  
 
Figure 3.13 Effect of 10µM FUdR on yolk protein levels. A) Worms on 10µM FUdR 
have higher VIT-2::GFP levels on both day 1 and 4 compared to worms on control plates. 
B,C) Protein gels show no increase in yolk protein in day 4 worms on FUdR compared to 
control. Data is the mean of (A) one trial (40 worms) (B,C) two biological replicates (25 
worms per replicate); error bars, SEM; Student’s  t-test ***p<0.001 (versus age-matched 
control). 
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The effects of FUdR on yolk were also examined by running worm lysates on 
Coomassie stained gels. Surprisingly, no increase in YP levels was observed with FUdR 
treatment as of day 4 (Figure 3.13 B,C; Appendix 1; Figure A-1.7). Protein lysate 
analysis should provide a more accurate depiction of changes in YP170 levels because 
VIT-2::GFP only shows abundance of YP170B, whereas on YP170 bands on gels reflect 
total amount of YP170A and YP170B. Taken together these results could imply that 
FUdR increases abundance of the less abundant YP170B, but not the more abundant 
YP170A. However, it is unknown how FUdR could do this. 
 
3.2.8.2 Signals from the germline stimulate yolk protein production 
Removal of gonad and germline precursor cells by laser ablation results in loss of 
the entire gonad structure and these worms have a wildtype lifespan (Hsin and Kenyon, 
1999; Kimble and Hirsh, 1979). Worms without a somatic gonad or a germline have been 
previously shown to produce large amounts yolk protein (Kimble and Sharrock, 1983). 
We were interested in observing the effect of the germline on yolk protein levels by using 
temperature sensitive germline proliferation glp-4(bn2) mutants. When raised and 
maintained at 15°C glp-4 mutants have a complete germline, wildtype lifespan and 
reduced fertility (Beanan and Strome, 1992; Qiao et al., 1995). If raised at 25°C from 
hatching glp-4 mutants have an extended lifespan and few to no germ cells (Arantes-
Oliveira et al., 2002). However, if glp-4 mutants are raised at 15°C to L4 and then 
transferred to 25°C they will develop a germline but proliferation will be arrested after 
sperm production (no oocytes), these worms exhibit a wildtype lifespan (Arantes-Oliveira 
et al., 2002; McElwee et al., 2004).  
To account for changes in developmental rate at different temperatures worms 
which were maintained at 15°C were collected on day 1 and 8 of adulthood. We 
calculated that given the slower development of worms at 15°C day 8 would be an 
equivalent to a day 4 worm cultured at 25°C and worms should be at the end of their 
reproductive period (Byerly et al., 1976). We found that at 15°C, day 1 glp-4 mutants 
have higher levels of yolk than wildtype (Figure 3.14). This is likely due to the reduced 
fecundity of this strain as there are less oocytes to take up the yolk produced. By day 8 
there is no difference in YP levels between glp-4 mutants and wildtype worms (Figure 
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3.14; Appendix 1, A-1.8 A,B). Worms shifted from 15°C to 25°C at L4 have increased 
levels of YP170 on day 1 and 4 compared to wildtype (Figure 3.15). However, this 
increase was not observed in YP115 and YP88 (Appendix 1, Figure A-1.8 C,D). Worms 
raised at 25°C had increased YP170 levels on day 1 but wildtype levels of YP115 and 
YP88 (Figure 3.16; Appendix 1, Figure A-1.9 A,B).  
The difference between glp-4 worms raised at 15°C versus 25°C is the presence 
of a germline. The increase in YP170 observed in glp-4 mutants shifted from 15°C to 
25°C on day 4 suggest that germ cells signal to increase YP170 production. This should 
result in less YP being produced in worms at 25°C, however loss of the main yolk sink 
(oocytes), results in day 1 YP170 accumulation.  
 
 
Figure 3.14 Increased levels of YP on day 1 glp-4(bn2) at 15°C. A) Coomassie stained 
SDS-PAGE gels showing yolk protein abundance. B) glp-4(bn2) with a complete 
germline, but reduced fertility, has higher levels of yolk protein on day 1 compared to 
wildtype. Data is the mean of three biological replicates (100 worms per replicate); error 
bars, SEM; Student’s  t-test ***p<0.001 (versus age-matched wildtype). Data collected 
by E. Tyler. 
 
 79 
 
Figure 3.15 Increased levels of yolk protein on day 1 and 4 in glp-4(bn2) shifted at 
L4 from 15°C to 25°C. A) Coomassie stained SDS-PAGE gels showing yolk protein 
abundance. B) glp-4(bn2) shifted to 25°C posses an arrested germline and no oocytes, 
glp-4 worms have higher levels of yolk protein on day 1 and day 4 compared to wildtype. 
Data is the mean of three biological replicates (100 worms per replicate); error bars, 
SEM; Student’s  t-test **p<0.01, *p<0.05 (versus age-matched wildtype). Data collected 
by E. Tyler. 
 
 
 
Figure 3.16 Increased levels of yolk protein on day 1 in glp-4(bn2) hatched at 25°C. 
A) Coomassie stained SDS-PAGE gels showing YP abundance. B) glp-4(bn2) at 25°C 
from egg posses no germline, have higher levels of yolk protein on day 1 compared to 
wildtype. Data is the mean of three biological replicates (100 worms per replicate); error 
bars, SEM; Student’s  t-test **p<0.01(versus age-matched wildtype). Data collected by 
E. Tyler. 
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3.2.9 Effect of germline signalling on yolk protein levels is DAF-16 dependent 
Loss of the germline in hermaphrodite worms results in a 60% lifespan extension, 
which is DAF-16 dependent (Hsin and Kenyon, 1999). This suggests that under normal 
conditions signals from the germline accelerate ageing of the animal (Hsin and Kenyon, 
1999). We wanted to know if the reduced yolk protein levels we observed in germline-
less glp-4(bn2) worms at 25°C with respect to worms shifted to 25°C at L4 was DAF-16 
dependent. 
To do this we used daf-16(mgDf50); glp-4(bn2) worms and raised them at 25°C 
to block development of the germline. We found that in the absence of DAF-16 YP170 
accumulates at higher levels in daf-16(mgDf50); glp-4(bn2) mutants with respect to 
wildtype (Figure 3.17). Levels of YP115 and YP88 remain similar to wildtype (Appendix 
1, Figure A-1.9 C,D). Thus, as in daf-2 mutants, the reduction in yolk levels in 
germlineless worms is DAF-16 dependant.  
 
Figure 3.17 Yolk protein levels in daf-16(mgDf50), glp-4(bn2) worms. A) Coomassie 
stained SDS-PAGE gels showing yolk protein abundance. B) Levels of yolk protein in 
daf-16(mgDf50), glp-4(bn2) mutants were higher on day 1 and 4 with respect to wildtype. 
Data is the mean of three biological replicates (100 worms per replicate); error bars, 
SEM; Student’s  t-test **p<0.01, *p<0.05 (versus age-matched wildtype). Data collected 
by E. Tyler. 
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3.2.10 Tor, DR and Mit longevity mutants are not typically Yol-d 
We examined whether a reduction in yolk protein synthesis is a hallmark of 
mutant strains with an increased longevity phenotype. 
3.2.10.1 TOR pathway mutant 
The target of rapamycin (TOR) pathway is a conserved, nutrient sensing pathway 
that modulates ageing. Inhibition of TOR causes a decrease in protein synthesis and 
inhibition of genes that regulate mRNA translation can increase lifespan (Hansen et al., 
2007; Kapahi et al., 2010; Pan et al., 2007). RSKS-1 is the worm homologue of 
ribosomal S6 kinase (S6K), which is directly downstream of TOR. Mutation in this gene 
in worms causes slower development, reduced fecundity and increased  lifespan (Pan et 
al., 2007; Hansen et al., 2007). Surprisingly, despite having lower levels of protein 
synthesis rsks-1(ok1255) mutants had higher levels of YP170 on day 1 and wildtype 
levels of yolk protein on day 4 (Figure 3.18). Levels of YP115 and YP88 remained 
similar to wildtype (Appendix 1, Figure A-1.10). Increased YP170 on day 1 may reflect 
reduced fecundity observed in rsks-1 mutants. It may be that due to a lessening of the 
main yolk sink (oocytes) yolk levels accumulate to higher levels on day 1. It remains 
possible that in the absence of oocytes (e.g. glp-4 background), rsks-1(-) would reduce 
YP levels. 
 
Figure 3.18   Effect of rsks-1(ok1255) on yolk protein levels. A) Coomassie stained 
SDS-PAGE gels showing yolk protein abundance. B) rsks-1(ok1255) worms have higher 
levels of YP on day 1 but not day 4 compared to wildtype. Data is the mean of three 
biological replicates (100 worms per replicate); error bars, SEM; Student’s t-test 
***p<0.001 (versus age-matched wildtype). Data collected by E.Tyler. 
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3.2.10.2 Dietary restriction mutant 
Dietary restriction can extend lifespan in a wide range of organisms (Weindruch 
and Walford, 1988). In C. elegans, eat-2 mutants that have a defect in pharyngeal 
pumping resulting in reduced food intake can be used as a genetic model for dietary 
restriction (Lakowski and Hekimi, 1998). Mutations in eat-2 can increase lifespan by 
more than 50%, and the more severe the mutation, the bigger the extension (Lakowski 
and Hekimi, 1998). The lifespan extension in eat-2 worms does not require DAF-16, 
suggesting the longevity in these strains are caused by a mechanism distinct from IIS 
(Lakowski and Hekimi, 1998).  We examined whether eat-2(ad1116) had a reduction in 
YP levels and found that they had wildtype levels for day 1 and 4 (Figure 3.19; Appendix 
1, Figure A-1.11). These results imply that longevity observed in eat-2 mutants is not 
dependent on reduced levels of yolk. It is surprising, given the global protein reduction 
observed in eat-2 mutants (Hansen et al, 2007) that YP levels remained similar to WT. 
This raises the possibility that YP production may be prioritized, despite lower fecundity 
(Crawford et al, 2007), given its importance in oocyte viability (Andux and Ellis, 2008). 
 
Figure 3.19 Effect of eat-2(ad1116) on yolk protein levels. A) Coomassie stained SDS-
PAGE gels showing yolk protein abundance. B) eat-2(ad1116) has wildtype yolk protein 
levels on day 1 and 4. Data is the mean of three biological replicates (100 worms per 
replicate); error bars, SEM; Student’s t-test (versus age-matched wildtype). Data 
collected by E. Tyler. 
 
3.2.10.3 Mit mutants 
C. elegans mitochondrial (Mit) mutants have disruptions in the electron transport 
chain but are long-lived. The longevity in these worms is thought to be a result of 
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differences in metabolism, supported by the fact that clk-1(qm30) and isp-1(qm150) have 
a common metabolic profile which is distinct to that of wildtype worms (Butler et al., 
2010). We tested two Mit mutants: nuo-6(qm200) and isp-1(qm150) which are loss-of-
function mutations of the mitochondrial complex subunit I and III, respectively (Feng et 
al., 2001; Yang and Hekimi, 2010b). Both of these mutations result in low oxygen 
consumption, slow development, low fecundity and increased lifespan (Feng et al., 2001; 
Yang and Hekimi, 2010b). Due to slow development our protocol had to be modified and 
for this experiment worms were synchronized to L4 at 20°C instead of 15°C.  
We found that nuo-6(qm200) and isp-1(qm150) worms had wildtype YP levels on 
day 4 (Figure 3.20; Appendix 1, Figure A-1.12). However, nuo-6(qm200) had slightly 
lower levels of YP on day 1, which is surprising due to their low fecundity phenotype. 
One possibility is that lower YP levels day 1 may reflect an early deficit in ATP, 
resulting in lower energy levels, due to mitochondrial disruption (Figure 3.20).  
 
Figure 3.20 Effect of nuo-6(qm200) and isp-1(qm150) on yolk protein levels. A) 
Coomassie stained SDS-PAGE gels showing yolk protein abundance. B) nuo-6(qm200) 
and isp-1(qm150) have wildtype yolk protein levels on day 4, but yolk protein levels in 
nuo-6(qm200) are slightly lower on day 1. Data is the mean of three biological replicates 
(100 worms per replicate); error bars, SEM; Student’s t-test **p<0.01(versus age-
matched wildtype). Data collected by E. Tyler. 
 
 We saw no overall Yol-d pattern amongst other longevity mutant strains. 
However, reduced yolk production could be masked by reduced oocyte production in 
these strains. 
 84 
 
 
 
3.2.11 Reduction in levels of yolk protein does not increase lifespan 
After finding that yolk is continuously produced throughout adulthood we wanted 
to verify that yolk accumulation has an effect on lifespan as suggested by previous RNAi 
studies of vit-2 and vit-5 (Murphy et al., 2003). We used RNAi of vit-5, vit-6 and double 
RNAi (1:1 mixture) of vit-5/vit-6. We obtained the vit-5 feeding clone from the Ahringer 
library kindly shared with us by the Nurrish lab (UCL). The vit-6 feeding clone was not 
available in this library but was sent to us by the Ahringer lab. Wildtype worms were 
placed on RNAi treatment from egg and raised at 15°C until L4. Worms were then 
transferred to plates containing 15µM FUdR. 
3.2.11.1 Reduction in one yolk protein leads to an increase in others 
We first checked the effect of vit-5(RNAi), vit-6(RNAi) and vit-5/vit-6(RNAi) on 
yolk protein by collecting samples and running them on Coomassie stained SDS-PAGE 
gels. We found that vit-5(RNAi) greatly reduced yolk protein levels on day 1 and 4 of 
adulthood compared to wildtype (Figure 3.21 A,B). It also blocked the accumulation of 
YP170 which otherwise occurs on day 4 (Figure 3.21 A). Unexpectedly, we found that 
RNAi of vit-5 caused a marked increase in YP115 and YP88 on day 4 (Figure 3.21 A,C). 
Similarly, RNAi of vit-6 greatly reduced YP115 and YP88 on day 4 while causing a 
marked increase in YP170 (Figure 3.21 A,B). vit-5/vit-6(RNAi) decreased levels of 
YP170, YP115 and YP88, blocking their day 4 accumulation. Increased YP levels 
resulting from RNAi could reflect either a compensatory increase in vit gene transcription 
or competition between vit RNAs for access to ribosomes. The former is more likely as if 
it is mostly a matter of clogging up the translational machinery one would expect an 
increase in other proteins as well. 
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Figure 3.21 Effect of RNAi on YP abundance levels. A) Coomassie stained SDS-
PAGE gels showing yolk protein abundance. B) Quantitation of YP170 bands show Yol-
d phenotype on vit-5(RNAi) and vit-5/vit-6(RNAi) and a Yol-o phenotype on vit-6(RNAi) 
compared to age-matched L4440 control. C) Quantitation of YP115 and YP88 show Yol-
d phenotype on vit-6(RNAi) and a Yol-o phenotype on vit-5(RNAi) compared L4440 
control. Data is the mean of three biological replicates (25 worms per replicate); error 
bars, SEM; Student’s t-test ***p<0.001, **p<0.01, *p<0.05 (versus age-matched 
wildtype). 
 
3.2.11.2 vit-2 is a minor contributor to YP170 levels 
There is high sequence similarity between vit-3, vit-4, and vit-5, and our data 
suggests that vit-5(RNAi) knocksdown all three mRNA transcripts. There is less sequence 
similarity between vit-2 and vit-5 (Figure 3.1), so knockdown by vit-5(RNAi) seems 
unlikely. We examined the effect of vit-5(RNAi), vit-6(RNAi) and vit-5/vit-6(RNAi) on the 
VIT-2::GFP translational reporter strain GA1500. We found that vit-5(RNAi) did reduce 
fluorescence levels on day 1 and 4, but only slightly (Figure 3.22). This implies that vit-
5(RNAi) only slightly reduces VIT-2 protein levels, possibly due to a small degree of 
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sequence similarity. This in turn  suggests that VIT-2 is not a major contributor of the 
YP170 yolk protein. 
On day 4, VIT-2::GFP worms on vit-6(RNAi) and vit-5/vit-6(RNAi) treatments do 
not show increased fluorescence. Interestingly, vit-5/vit-6(RNAi) slightly increased 
fluorescence on day 1 (Figure 3.22). vit-6(RNAi) alone did not have this effect, nor did 
vit-5/vit-6(RNAi) on day 4. Thus, the combined absence of vit-5 and vit-6 mRNA is 
sufficient to increase VIT-2 protein levels on day1, perhaps by increasing vit-2 mRNA 
access to ribosomes. 
 
 
Figure 3.22 Effect of vit-5, 
vit-6, vit-5/vit-6 RNAi on 
VIT-2::GFP expression. 
Worms on vit-5(RNAi) 
show a slight reduction of 
fluorescence on day 1 and 4 
compared to worms on 
L4440 (control RNAi). vit-
6(RNAi) and vit-5/vit-
6(RNAi) did not affect VIT-
2::GFP on day 4, but 
caused a slight increase on 
day 1. One replicate was performed. Data is the mean (15-25 worms); error bars, SEM; 
Student’s t-test ***p<0.001, **p<0.01, *p<0.05 (versus age-matched wildtype). 
 
3.2.11.3 Effects of vit RNAi on lifespan 
A previous study found that vit-2 and vit-5 gene expression is down regulated in 
daf-2(-) worms and that RNAi of these genes modestly extends lifespan in daf-2(+) 
worms (Murphy et al., 2003). This result suggests that yolk accumulation has a harmful 
effect on worms. We set out to replicate this finding using vit-5(RNAi), which greatly 
reduces YP170 levels (Figure 3.5). We could not obtain the vit-2 clone from the Ahringer 
library nor the lab that conducted the earlier study.  To test the full extent of the effect of 
yolk accumulation on lifespan we used vit-6(RNAi), which lowers YP115 and YP88, and 
vit-5/vit-6(RNAi), which lowers levels of all three yolk proteins (Figure 3.21).  We 
conducted 4 trials with varied results (Table 3-1). We observed increased variation in 
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lifespan in worms subjected to vit-6(RNAi), which suggests that an increase in YP170 
may result in lifespan fluctuations. Surprisingly we could not replicate previous findings 
in which vit RNAi extends lifespan. Instead our combined data implied that none of our 
RNAi treatments extend lifespan. This implies that yolk accumulation does not limit 
lifespan. 
 
 
Figure 3.23 RNAi of vit genes does not extend lifespan. In all assays worms were 
hatched on to RNAi treatment and raised at 15˚C to L4. Worms were then transferred to 
plates with 15µM FUdR applied topically and maintained at 25˚C for duration of the 
experiment. Data mean of 4 biological replicates (100 worms per treatment). 
 
 
 
 
 
 
 
 
 
 88 
RNAi treatment Mean 
lifespan 
[median] 
(days) 
% of 
control 
lifespan 
 
Log Rank 
(p vs. 
control) 
Deaths 
[censored] 
L4440 (control) Combined 12.7 [13]   371 [29] 
Trial 1 13.7 [13]   97 [3] 
Trial 2 12.5 [13]   85 [15] 
Trial 3 11.9 [12]   93 [7] 
Trial 4 12.5 [13]   96 [4] 
vit-5(RNAi) Combined 12.3 [13] -4 0.09 361 [39] 
Trial 1 12.9 [13] -6 0.01 82 [18] 
Trial 2 12.6 [13] +0.7 0.49 93 [7] 
Trial 3 12.3 [12] +3 0.62 89 [11] 
Trial 4 11.8 [13] -6 0.06 97 [3] 
vit-6(RNAi) Combined 13.1 [13] +3 0.30 364 [36] 
Trial 1 12.8 [13] -8 0.0002 96 [4] 
Trial 2 13.6 [13] +9 0.002 90 [10] 
Trial 3 13.6 [12] +14 0.005 92 [8] 
Trial 4 12.5 [13] +0.7 0.98 86 [14] 
vit-5/vit-6(RNAi) Combined 12.9 [13] +2 0.72 346 [54] 
Trial 1 14.6 [15] +7 0.04 68 [32] 
Trial 2 12.2 [13] -2 0.21 87 [13] 
Trial 3 12.5 [12] +5 0.30 95 [5] 
Trial 4 12.3 [13] -1 0.31 96 [4] 
 
Table 3-1 Effect of vit RNAi treatments on lifespan. This table contains data 
corresponding to Figure 3.23. 
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3.3 Discussion 
3.3.1 Yolk protein accumulation in post-reproductive worms is consistent with 
hyperfunction 
The accumulation of yolk protein throughout the body cavity in wildtype worms 
is consistent with the idea that biosynthesis is not regulated in ageing worms. By 
following changes in YP in wildtype worms we observed an increase in yolk protein 
levels in post reproductive worms until an apparent peak level is reached at around day 
12, after which levels remain high. This YP accumulation was absent in daf-2(-) worms. 
Though yolk production is part of an evolved reproductive program the 
accumulation of YP in post-reproductive worms suggests there is no evolutionary 
mechanism to switch off vitellogenesis (Herndon et al., 2002). Is the yolk accumulation 
we observe in older worms a quasi-programme? In order for it to be deemed so, 
accumulation of yolk should not bestow a benefit in post-reproductive worms. One study 
found that YP115, one of the two proteins encoded for by vit-6 is the major carbonylated 
protein in older worms, suggesting a role as a ROS scavenger (Nakamura et al., 1999). 
However, observing our Coomassie stained gels of whole worm lysates, yolk protein 
bands seem to make up a large proportion of the total protein. So, it’s not surprising that 
they would turn up in an experiment looking for carbonylated proteins in older worms. 
 A second study found that in insects vitellogenins can store free iron, potentially 
acting as a chelator (van Heusden et al., 1991). These studies suggest a beneficial effect 
of YP accumulation as it could store toxic compounds, protecting the worm. This could 
be tested by seeing if RNAi of vit genes makes worms more sensitive to drug toxicity.
 Another possibility is that to maintain yolk production at such high levels to 
ensure reproductive output is costly to the worms and diverts resources from somatic 
maintenance (DePina et al., 2011). If this were true it could be probed by placing worms 
on vit RNAi and examining whether worms under this treatment have increased 
resistance to stress, on the assumption that increased stress resistance reflects increased 
somatic maintenance. 
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3.3.2 IIS/IGF-1 strongly represses yolk protein translation 
Accumulation of yolk protein was strongly reduced in long lived daf-2(e1370) 
mutants. The daf-2(e1370) mutation is a class 2 allele; these are pleiotropic and have 
decreased fecundity and feeding rate in addition to the Age phenotype (Gems et al., 
1998). To rule out the possibility that Yol-d in daf-2(e1370) worms is a result of 
pleiotropy we also tested the less pleiotropic allele daf-2(m577) and found that it was also 
Yol-d. Reduction in YP levels in daf-2(-) mutants was dependent on DAF-16, the lack of 
which restored wildtype YP levels. Other long-lived IIS mutants tested were age-
1(hx546) and age-1(mg109). The weak allele age-1(hx546) caused a reduction in YP 
levels on day 1 but not day 4. The stronger null allele age-1(mg109) was also tested and 
caused a reduction in YP levels on day 4 compared to wildtype, to a lesser extent than in 
daf-2(-) worms. This may be due to maternal rescue of age-1 (Gottlieb and Ruvkun, 
1994). Thus, there is a strong correlation between the effects of IIS on yolk production 
and lifespan, suggesting a close connection between these two traits. 
Two possible scenarios of how IIS mutants reduce YP levels are that DAF-16 
activity can decrease YP synthesis or increase its degradation. As a test whether YP was 
being degraded we used RNAi of bec-1, a gene required for C. elegans autophagy 
(Meléndez et al., 2003). Results of our RNAi screen found bec-1(RNAi) did not increase 
VIT-2::GFP levels in a daf-2(e1370) background. This suggests that daf-2(-) worms are 
not Yol-d due to increased autophagy, but does not rule out that other yolk degradation 
mechanisms may be activated in IIS mutants; e.g. proteosome-mediated protein 
degradation. Additionally, dietary restriction mutant eat-2(ad1116) activates autophagy 
(Hansen et al., 2008) but did not suppress YP accumulation.  
The alternative possibility is that DAF-16 promotes longevity by decreasing 
protein synthesis. Arguing against this, one study found that daf-2(-) worms show no 
reduction in global translation, measured by 
35
S-methionine incorporation (Hansen et al., 
2007). However, a more recent study used 
35
S-labelled bacteria and found that protein 
synthesis was greatly reduced in daf-2(-) worms (Depuydt et al., 2013). Vitellogenin 
protein abundance was also examined and all six vit genes were strongly reduced in daf-
2(-), and vit-1, vit-3 and vit-4 were reduced in DR worms (Depuydt et al., 2013; Stout et 
al., 2013). A global reduction in protein synthesis could account for the Yol-d in daf-2(-).  
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3.3.3 Germline regulation of yolk protein 
In this study we sought to identify the tissue in which DAF-16 activity regulates 
yolk protein synthesis. We used daf-16(mu86); daf-2(e1370) transgenic strains in which 
DAF-16 was rescued in the neurons, intestine and muscle (Libina et al., 2003).  Of these 
strains DAF-16 expression in the intestine partially restores lifespan of daf-2(-), neuronal 
DAF-16 does so marginally and muscular DAF-16 had no effect on lifespan (Libina et 
al., 2003). We found that none of these strains were able to strongly suppress day 4 YP 
accumulation. It is somewhat surprising that intestinal DAF-16 rescue only partially 
restored daf-2(-) Yol-d as this is the tissue where yolk is synthesized (Kimble and 
Sharrock, 1983). This implies that one or more tissues other than the intestine act to 
reduce yolk levels. One possibility is that the gonad plays a role in to signalling the 
intestine to regulate yolk protein synthesis. Our examination of germline effects on YP 
levels suggests the gonad to be a likely candidate for the tissue which signals to regulate 
YP synthesis. Another hint comes from the finding by DePina et al in which mating daf-
2(e1370) mutants with wildtype worms increases vit-2/5 mRNA but not YP levels 
(DePina et al., 2011). This suggests that presence of sperm in the spermatheca triggers a 
signal to increase YP gene transcription. This would be a good strategy as after the L4 
stage hermaphrodite worms switch from sperm production to oocyte production 
(Hubbard and Greenstein, 2005).  In this way a surplus of mRNA is transcribed to ensure 
there will be enough yolk availability to supply developing oocytes. It is possible DAF-
16 activation in the spermatheca or other regions of the somatic gonad represses YP 
translation in the intestine in daf-2(-) worms. 
DePina et al also found that feminized fem-1(hc17) mutants that produced no 
sperm had lower levels of vit-2/5 mRNA yet higher YP levels on day 1 but not day 4, 
while masculinised fem-3(q20gf) mutants that only produce sperm had wildtype vit-2/5 
mRNA and higher levels of YP on day 1 and 4 (DePina et al., 2011). We found similar 
results with respect to YP levels in our experiments with glp-4 worms. glp-4 worms 
grown at 15˚C and switched to 25˚C make sperm but not oocytes (Arantes-Oliveira et al., 
2002) and similar to masculinised fem-3(q20gf) mutants these worms had increased 
levels of YP on day 1 and 4. At 25˚C glp-4 germline-less worms are Yol-o on day 1 but 
have wildtype YP levels on day 4. This is consistent with early observations in which 
 92 
yolk protein was present at high levels in worms with laser ablated gonads in young 
adults (Kimble and Sharrock, 1983). Germline ablation causes a DAF-16 dependent 
increase in lifespan, it also causes nuclear localization of DAF-16 in the intestine (Hsin 
and Kenyon, 1999; Lin et al., 2001). We found that daf-16(mgDf50);glp-4(bn2) raised at 
25˚C had levels of YP higher than glp-4(bn2) controls. This increase in YP in the absence 
of DAF-16 suggests that glp-4(bn2) worms raised at 25˚C may have reduced levels of YP 
synthesis, but this is masked by the lack of oocytes to take it up. Thus, absence of a 
germline may induce a DAF-16 dependent signal in the somatic gonad, which is relayed 
to the intestine to repress translation.  
 
 
Figure 3.24 Model for YP 
translational regulation. IIS regulates 
YP synthesis in the intestine via 
signals from the germline or somatic 
gonad, which activate DAF-2 in an 
unidentified tissue (Tissue X). In the 
absence of a germline a DAF-16 
dependent signal causes a decrease in a 
regulatory factor, which reduces YP 
translation in the intestine. 
 
 
 
 
The finding that yolk accumulates in hermaphrodites without a gonad hints that a 
signal outside of the gonad stimulates yolk protein synthesis (Kimble and Sharrock, 
1983). In Drosophila, vitellogenins synthesis is regulated in response to 20-
hydroxyecdysone and juvenile hormone (JH) (Jowett and Postlethwait, 1980) which is in 
turn regulated by IIS (Tatar et al., 2001). It is possible that C. elegans also have a 
regulatory factor, which is produced in early adulthood in anticipation of reproductive 
needs, and hence worms without a gonad still produce yolk.  One possible scenario is that 
the germline or somatic gonad generates a signal to increase DAF-2 activity in a currently 
unidentified tissue, which in turn stimulates a further increase in a regulatory hormone, 
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conveying a signal to increase yolk translation to the intestine (Figure 3.24).  Presumably 
daf-2(-) worms are Yol-d because the production of regulatory factor is repressed from 
early adulthood. 
3.3.4 Yolk accumulation is not a life limiting pathology 
During the course of our studies we examined a range of longevity mutants and 
found that in most cases they did not repress YP accumulation on day 4 (Table 3-2). 
Some of these mutants such as glp-4(bn2) and rsks-1(ok1255) had  higher levels of YP on 
day 1 which likely result from their reduced fecundity.  
Strain Lifespan 
(% Wildtype) 
Fecundity 
(% Wildtype) 
YP170 
Yol 
YP115 
Yol 
YP88 
Yol 
Source 
daf-2(e1370) +
b
30,+
a
110% -
b
61% Yol-d Yol-d Yol-d 1,2 
daf-2(m577) +
b
59% +
b
14% Yol-d Yol-d Yol-d 2 
age-1(hx546) +
a
40%,+
b
60% -
a
75% Yol-d 
(day 1) 
WT WT 3 
age-1(mg109) +
b
40% N.A. Yol-d WT WT 4 
glp-4(bn2)  +
b
17% sterile Yol-o 
(day 1) 
WT WT 5 
rsks-1(ok1255) +
a
9% -
a
46% Yol-o 
(day 1) 
WT WT 6,7 
eat-2(ad1116) +
a
45% -
a
51% WT WT Yol-d 
(day 1) 
8,9 
nuo-6(qm200) +
a
73
 
-
a
79%
 
Yol-d 
(day 1) 
WT WT 10 
isp-1(qm150) +
a
77%
 
-
a
75% WT WT WT 11 
 
Table 3-2 Lifespan, fecundity and Yol phenotype of longevity mutants. Data on mean 
lifespan and fecundity was compiled from various sources (
a20˚C or b25˚C): [1](Kenyon 
et al., 1993), [2](Gems et al., 1998),  [3](Friedman and Johnson, 1988), [4](Gami et al., 
2006), [5](Arantes-Oliveira et al., 2002), [6](Pan et al., 2007), [7](Selman et al., 2009), 
[8](Lakowski and Hekimi, 1998), [9](Crawford et al., 2007), [10](Yang and Hekimi, 
2010b), [11](Feng et al., 2001). 
 94 
We also lowered YP levels in wildtype worms using RNAi of vit-5, vit-6 and vit-
5/vit-6 to test whether reduction in yolk protein increased longevity. We measured YP 
levels using Coomassie stained SDS-PAGE gels and found that RNAi of vit-5 greatly 
reduced levels of YP170, while causing a large increase in YP115 and YP88. RNAi of 
vit-6 showed a similar effect, resulting in a reduction of YP115 and YP88 but an increase 
in YP170. Combined RNAi of both vit-5/vit-6 lowered the levels of all three YP bands. 
Our results could imply that because vit genes are transcribed and translated at high 
levels, removal of one frees the translational machinery to allow increased translation of 
other vit transcripts. By performing lifespans we found that RNAi of vit genes did not 
increase lifespan. These results contradict earlier findings in which vit-2 and vit-5 RNAi 
increased lifespan (Murphy et al., 2003). It is possible that failure to replicate previous 
finding reflect differences in culture conditions between labs. In a third lab where tests of 
vit RNAi on lifespan were performed, no consistent increases in lifespan were seen 
(Cathy Wolkow, personal communication). 
The accumulation of yolk protein, of which the only known function is the 
nourishment of oocytes, after reproduction is consistent with a biosynthetic open faucet 
model. Yolk accumulation appears pathological, but our data in this study strongly 
suggests that it does not in itself toxic to worms and is not a predictor of longevity. Thus, 
lifespan must be limited by a different pathology- perhaps the same that limits lifespan in 
male C. elegans, where yolk is not synthesized.  
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Chapter 4: Ageing in the C. elegans germline 
 
4.1 Introduction to C. elegans reproductive system 
In this chapter we will describe changes that occur in the hermaphrodite 
reproductive system with age. We will then examine age-related changes in the germline, 
particularly gonad degeneration, to determine if their origin is linked to quasi-
programmes. 
4.1.1 C. elegans hermaphrodite reproductive system 
The hermaphrodite reproductive system is comprised of three main components: 
the somatic gonad, the germline and the egg-laying apparatus. Together they form two 
symmetrical U-shaped gonad arms with an egg-laying apparatus in the mid-body (Lints 
and Hall, 2009c). Each gonad arm consists of the distal tip cell (DTC), gonadal sheath 
and spermatheca; the egg-laying apparatus includes the uterus, vulva and its respective 
muscles; and the germline includes cell lineages that create sperm and oocytes (Lints and 
Hall, 2009c) (Figure 4.1). In C. elegans the germline is arranged in a distal to proximal 
orientation with germ cells near the DTC undergoing mitosis, while as the germ cells 
move proximally, away from the DTC, they enter meiosis (Kimble and Crittenden, 2005).  
      
 
Figure 4.1 C. elegans hermaphrodite reproductive system. Depiction of the germline 
and somatic gonad with labelled structures: distal tip cell (DTC), distal gonad (DG), 
proximal gonad (PG) spermatheca (Sp). Image modified from Lints & Hall, 2009. 
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Hermaphrodite worms have a soma that is female, but a gonad that produces 
approximately 300 sperm cells during the L4 stage before switching to oocyte production 
in early adulthood (Hirsh et al., 1976; L’Hernault, 2006). Spermatids accumulate at the 
end of the proximal arm until they are pushed into the spermatheca by the first oocyte 
where they undergo spermiogenesis (Ward and Carrel, 1979).  At 20˚C a hermaphrodite 
worm lays approximately 300 fertilized eggs, which coincides with the amount of self-
sperm available, thus sperm is the limiting factor for reproduction (Singson, 2001; Ward 
and Carrel, 1979). Introducing male sperm by mating increases the brood size and 
duration of progeny production, in addition to doubling total oocyte production (Ward 
and Carrel, 1979).  
Germ cells in the distal gonad are not completely cellularized and share a common 
core (rachis) (Gilbert et al., 1984). As germ cells move toward the loop region apoptosis 
takes place, and surviving cells exit pachytene and move down the proximal arm in a 
linear manner (Greenstein, 2005). Oocytes in diakinesis contain a nuclear envelope, the 
most proximal oocyte (terminal oocyte) completes meiotic maturation and loses the 
nucleolus in response to stimulus from sperm (McCarter et al., 1999) (Figure 4.2). The 
mature oocyte passes through the spermatheca, becomes fertilized and is ovulated in a 
process that is repeated approximately every 23 minutes (Greenstein, 2005; McCarter et 
al., 1999).  
 
Figure 4.2 Position of 
terminal oocyte. DIC 
image depicting loss of the 
nucleolus (nl) from the 
nucleus (N) in the terminal 
oocyte, which is located 
prior to the spermatheca 
(Sp). DG, distal gonad. 
Image reproduced from 
Lints & Hall, 2009 and 
modified. 
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4.1.2 C. elegans male reproductive system 
The male reproductive system of worms is a J-shaped arm, consisting of the 
somatic gonad, the germline and the proctodeum (Lints and Hall, 2009a). The male C. 
elegans germline only produces sperm, which progresses in a linear sequence of 
spermatogenesis from the distal arm continuously throughout adulthood (Klass et al., 
1976). As in hermaphrodites, germ cells near the DTC undergo mitosis, and as they move 
away progress through the different stages of meiosis (Kimble and Hirsh, 1979). Germ 
cells are connected to the rachis until pachytene at which point spermatocytes (spermatid 
precursor cells) detach and complete meiosis to generate spermatids, which are stored in 
the seminal vesicle (Lints and Hall, 2009a). The cloaca and spicules are located in the 
proctodeum, and during copulation spicules are used to find and anchor the 
hermaphrodite vulva after which ejaculation occurs via the cloaca (Ward and Carrel, 
1979). Spermiogenesis, the process through which sessile spermatids become motile 
spermatozoa, takes place in the hermaphrodite vulva after mating (L’Hernault, 2006; 
Ward and Carrel, 1979). Male derived sperm crawl into the hermaphrodite spermatheca 
were they outcompete the smaller hermaphrodite sperm (LaMunyon and Ward, 1998; 
Ward and Carrel, 1979).  
   
Figure 4.3 C. elegans male reproductive system. Depiction of male germline and 
somatic gonad with labelled structures: proximal gonad (PG), distal gonad (DG), distal 
tip cell (DTC). Image reproduced from Lints & Hall, 2009 and modified. 
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4.1.3 Loss of germline integrity in ageing hermaphrodites 
Oocyte production is not tightly linked to sperm availability. When sperm count 
drops to ~40, hermaphrodites continue to produce oocytes which pass through the 
spermatheca and uterus, being laid unfertilized (Ward and Carrel, 1979). These 
unfertilized oocytes undergo several rounds of nuclear division becoming highly 
polyploid (Ward and Carrel, 1979). Shortly after reproduction halts there is a two-fold 
accumulation of unfertilized oocytes (compared to day 1 adults) in the proximal arm 
which become stacked in a columnar fashion (Jud et al., 2007). This continued oocyte 
production in the absence of sperm shows that oocyte production is relatively unregulated 
in post-reproductive adult hermaphrodite worms. 
Germlines in older worms show significant signs of deterioration from around day 
5 of adulthood and this deterioration increases with age (Garigan et al., 2002). In older 
animals, germline nuclei in the distal arms become more widely spaced and cavities 
begin to appear between them (Garigan et al., 2002). Germ cells, which in young worms 
are connected in a syncytium, become increasingly cellularized (Garigan et al., 2002). In 
later stages of deterioration the gonad shrivels (Garigan et al., 2002). The mechanism by 
which this striking deterioration occurs is not yet known. One possibility is that 
disintegration of the gonad is caused by molecular damage. In this chapter and the next 
we will explore an alternative possibility: that it is caused by hyperfunction.  
Examination of the germline of adult hermaphrodites using Nomarski microscopy 
revealed condensed structures which were not observed at larval stages or in male worms 
(Gumienny et al., 1999).  By using vital DNA-staining dyes such as Hoechst 33342, 
SYTO 12, and DAPI these condensed structures were recognised as apoptotic cells. The 
number of apoptotic cells increased during the reproductive life of worms (Gumienny et 
al., 1999). A central hypothesis explored in this thesis is that due to an age reduction in 
the force of natural selection, no mechanism exists to switch off germline apoptosis at the 
end of reproduction. We postulate that the resulting apoptotic tap left on contributes to 
age-related gonad disintegration.  
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4.2 Results 
4.2.1 Measurement of gonad degeneration in post-reproductive hermaphrodites 
In unmated wildtype hermaphrodites reproduction ceases after sperm depletion at 
around day 5 of adulthood (Lints and Hall, 2009c). After this the germline shows 
progressive decline with age (Garigan et al., 2002). To quantify gonad degeneration (GD) 
we developed a protocol modified from the study by Garigan et al. (2002).  We captured 
images of wildtype worms maintained at 20˚C (unless otherwise stated) on days 1, 8, and 
12 of adulthood using DIC microscopy. For each worm, only one gonad arm was clearly 
visible, the other arm being usually hidden beneath the intestine. One image was selected 
per worm and images were compiled into a Microsoft PowerPoint file, which was then 
examined and each image given a score of 1-5 representing different degree of gonad 
degeneration. Scoring of each image was performed blindly by three individuals. 
 We defined 5 stages of gonad degeneration as follows. Worms given a score of 1 
had gonads that appeared youthful and healthy. If the gonad showed slight atrophy and 
subtle signs of deterioration, having lost some of its diameter, but the general structure 
remained intact it received a score of 2. Gonads showing signs of impending breakage, 
such as markedly reduced diameter, and reduction in size (shrivelling) were given a score 
of 3. Gonads that fragmented, forming islands of gonad tissue were given a score of 4 
(Figure 4.4). Worms with no recognizable gonad received a score of 5. 
For each image a mean score was calculated and the data assembled into a scatter 
diagram, as shown in Figure 4.5, in which each dot represents one worm. For statistical 
comparisons the non-parametric Wilcoxon-Mann Whitney test was performed.    
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Figure 4.4 Scoring levels of gonad degeneration. Class 1 worms had intact, healthy 
gonads. Class 2 worms had gonads showing slight distal gonad (DG) atrophy. Class 3 
worms showed a marked reduction in diameter of gonad arm (PG and/or DG), 
shrivelling, a ragged appearance and signs of impending fragmentation. Class 4 worms 
contained gonads that had broken into fragments.  
 
To characterize this pathology, worms were examined on day 8 and 12 at 20˚C, at 
which time reproduction has long ceased. Worms showed a progressive increase in gonad 
deterioration. By day 8 all worms had undergone some degree of atrophy, exhibiting a 
spread in GD between classes 2-4 with the majority of worms scored at the higher levels 
of disintegration (classes 3-4). By day 12 most hermaphrodite worms showed severe 
gonad disintegration, some of which had no remnants of gonad tissue (Figure 4.5).   
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Figure 4.5 Hermaphrodite 
worms exhibit increasing levels 
of gonad degeneration with age. 
Each dot in this scatter diagram 
represents an individual worm. A 
progressive degeneration of the 
gonad was observed between day 1 
and 12 in wildtype hermaphrodite 
worms. Statistical comparisons 
were performed using the 
Wilcoxon-Mann Whitney test  
***p<0.001. 
 
 
 
 
 
 
4.2.2  Uterine tumour formation in older worms 
In our observations collecting data for gonad deterioration studies we noted the 
presence of uterine tumours in ageing worms. The appearance of DAPI-stained masses in 
the uterus of ageing worms has been previously noted apparently as the result of 
endoreduplication of unfertilized oocytes (Golden et al., 2007). This age increase in DNA 
content was not observed in male worms, hermaphrodite worms treated with FUdR or, to 
a lesser extent, in daf-2(e1370) hermaphrodites (Golden et al., 2007). The growth of 
uterine tumours can case squashing of the intestine (Golden et al., 2007; McGee et al., 
2011). Such tumours likely represent a form of hyperfunction in the gonad, from non-
adaptive run-on of a reproductive programme (specifically, embryonic development). 
Unfertilized oocytes undergo nuclear division without cytokinesis, which fertilization 
would otherwise allow (Ward and Carrel, 1979).  
We developed a scoring system to quantify tumour development during ageing by 
placing worms into 4 uterine status categories (Figure 4.6). Worms receiving a score of 1 
had mostly (not exclusively) young-looking gonads with no visible tumour. If a small 
tumour mass was visible, it received a score of 2. Large masses which took up more than 
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half the diameter of the worms were scored as 3. Large tumours filling the diameter of 
the worm received a score of 4.  
 
Figure 4.6 Scoring of uterine tumour formation in ageing hermaphrodites. (1) 
Worms that have no visible tumour (T). (2) Worms with small tumours. (3) Medium 
sized tumours. (4) Large tumours, filling the whole worm diameter.  
 
 We followed a similar protocol to analyse tumour formation as we did with our 
gonad degeneration experiments.  One image of a tumour was collected per worm and 
scored blindly by three people. The average of these scores was compiled into a scatter 
diagram and statistical comparisons were obtained using the Wilcoxon Mann-Whitney 
test. We found a similar trend in tumour formation as seen with gonad degeneration, 
namely there was a progressive increase in tumour size between day 1 and 12 (Figure 
4.7). By day 8 there was a range of tumour sizes, scoring between 1-3 with most worms 
exhibiting small tumours. By day 12 all worms examined had developed tumours (score 
2-4) most of which had medium-sized tumours (score 3).  
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Figure 4.7 Uterine tumour 
size increases with age. Each 
dot in this scatter diagram 
represents an individual worm. 
A progressive increase in 
tumour size was observed 
between day 1 and 12 in 
wildtype hermaphrodite 
worms at 20˚C. Statistical 
comparisons were performed 
using the Wilcoxon-Mann 
Whitney test  ***p<0.001. 
 
 
 
 
 
4.2.3 Yolk protein accumulation does not promote tumour growth 
During our experiments we noticed that large amounts of lipid-like substance, 
potentially yolk, accumulates in the body cavity in older worms (Figure 4.8). Other 
research groups have also noted the appearance of yolk-like shiny mobile droplets in 
older worms (Angelo and Van Gilst, 2009; Garigan et al., 2002; Herndon et al., 2002; 
McGee et al., 2011). Studies using the VIT-2::GFP translational reporter implied that this 
lipid-like often contains VIT-2, though not all lipid pools do (Marina Ezcurra, personal 
communication).  In our yolk protein study we found that VIT-2 contributes relatively 
little to the YP170 band. Thus, it is possible that the lipid pools that do not contain VIT-
2::GFP contain different yolk protein. 
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Figure 4.8 Yolk pools appear in ageing worms. DIC image showing accumulation of 
yolk in the body cavity of ageing hermaphrodite worms, indicated by red arrowheads.  
 
 DAPI staining confirmed an increase of DNA content with age, which correlates 
with the appearance of uterine tumours, and results from endoreduplication of 
unfertilized oocytes (Golden et al., 2007). The yolk receptor RME-2 continues to be 
expressed in fertilized oocytes (Grant and Hirsh, 1999), implying that unfertilized 
oocytes retain the ability to take up yolk. This suggests the possibility that the availability 
of large quantities of yolk in the body cavity in old worms provides a nutrient source 
promoting tumour growth. Additionally, studies of the VIT-2::GFP reporter revealed 
large amounts of GFP in the mid-body of post-reproductive worms (Marina Ezcurra, 
personal communication). 
To test this idea, we conducted a small trial using vit-5(RNAi), vit-6(RNAi) and 
vit-5/vit-6(RNAi) treatments, to probe for an effect of yolk accumulation on tumour 
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formation. We previously found that reduction on YP170 by vit-5(RNAi) caused an 
increase in YP115 and YP88 levels. Similarly, if YP115 and YP88 were lowered, causing 
an increase in YP170 (Figure 3.21). This allows us to see which one (if any) of the YP 
has an effect on tumour growth.  We used the vit-5/vit-6(RNAi) treatment to lower all 
three YP and thereby test if in the absence of yolk you can ‘starve’ tumour growth. We 
performed this experiment at 25˚C and examined worms on day 1 and 4, which were the 
conditions previously used for the YP experiments. We found that none of these 
treatments block tumour formation; all day 4 worms examined had developed minor 
tumours (Figure 4.9).  This argues against yolk accumulation as a driver of tumour 
growth. However, it remains possible that effects might be detected at later ages. 
Tumour growth is likely promoted by increased DNA content in unfertilized 
oocytes. FUdR inhibits the increase in DNA content observed in ageing hermaphrodites 
(Golden et al., 2007) and also inhibits tumour growth in a dose dependent manner 
(Riesen et al., 2014).  
 
 
Figure 4.9 Lowering YP levels does not inhibit tumour formation. Reducing YP 
levels using vit-5(RNAi), vit-6(RNAi) and vit-5/vit-6(RNAi) treatment does not block 
tumour formation. There was a significant increase in all four treatments with respect to 
their day 1 control (p<0.01), but no difference between treatments. Statistical 
comparisons were obtained performed using the Wilcoxon-Mann Whitney test, n.s.=not 
significant. 
 
 
 106 
4.2.4 Apoptosis carries on in post-reproductive hermaphrodites 
Why does the distal gonad of ageing worms atrophy and disintegrate? The 
hyperfunction theory suggests that continuation of developmental and reproductive 
processes in late life contributes to age-related pathology. During reproduction, apoptosis 
in the germline results in loss of at least half of all germ cells, possibly acting as nurse 
cells (Gumienny et al., 1999). While another study estimates that up to 95% of germ cells 
are lost via apoptosis (Jaramillo-Lambert et al., 2007). Germline apoptosis begins during 
adulthood and levels increase during the first 60 hours (Gumienny et al., 1999). The 
period measured coincides with the peak of reproduction at 20˚C (Byerly et al., 1976); 
however, levels of germline apoptosis in post-reproductive worms have not been studied. 
To test whether apoptosis continues in later life, we used a CED-1::GFP strain (MD701), 
which allows visualization of sheath cells as they engulf apoptotic germ cells 
(Schumacher et al., 2005a). This strain provided a sensitive method for detection of early 
apoptotic corpses, which are not visible using DIC (Gartner et al., 2008). We found that 
apoptosis continues in hermaphrodite worms throughout adulthood. Numbers of 
apoptotic corpses increased between day 1 and 2, remained high on day 4 and there was a 
decline on day 8. However, day 8 levels were similar to those observed on day 1 in which 
worms are reproductively active and have an intact, healthy gonad (Figure 4.10 A,B). 
The numbers of apoptotic corpses on day 8 may reflect the reduction in germ cells 
previously observed to occur after day 6 of adulthood (Figure 4.13). 
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Figure 4.10 Apoptosis continues in post-reproductive hermaphrodites. 
Representative image of A) CED-1::GFP reporter strain showing engulfed germ cells 
(white arrowheads) and C) SYTO 12 stained apoptotic cells. B) Quantification of 
apoptotic germ cell corpse number increases during the reproductive period between day 
1 and 2 and remain high until day 4, dropping back to day 1 levels on day 8. D) Bar graph 
showing reduction in levels of apoptosis with age. Data is the mean of mean of number of 
gonads examined indicated inside bar; error bars, SEM; ANOVA (p<0.0001), Tukey’s 
(HSD) test ***p<0.001, *p<0.05 (consecutive days). C,D) Data obtained by J. Hellberg. 
 
We verified that apoptosis continues in late life using SYTO 12, a vital dye used 
in previous studies (Gumienny et al., 1999; Pinkston et al., 2006). SYTO 12 staining is 
convenient as it facilitates observation of apoptotic cells in different strains. Age changes 
in the number of apoptotic corpses were observed using SYTO 12. Levels of apoptosis 
remained high during the first two days when the gonad is young and at height of 
reproductive capabilities. At day 4 there was a significant reduction in apoptotic corpses 
and a further reduction was observed on day 8 (Figure 4.10 C,D). Thus, estimates of 
apoptosis levels differed using SYTO 12 versus CED-1::GFP. One possibility is that 
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SYTO 12 stains both early and late apoptotic corpses, whereas CED-1::GFP is better for 
early apoptotic corpse detection (Gartner et al., 2008), this would explain the higher 
apoptotic germ cell numbers observed using SYTO 12. A second possibility is that 
because of the protocol we used in which live worms were placed on SYTO 12, the 
reduction in stained apoptotic corpses reflects reduction in pharyngeal pumping that 
occurs in ageing worms.  
             
Figure 4.11 Apoptosis ratio in the distal gonad increases with age. A) Representative 
image of DAPI stained day 4 CED-1::GFP worms, white arrows indicate . B) Bar graph 
showing an age-increase in the ratio of germ cells to apoptotic cells between days 1 an 4, 
after which apoptotic ratio returns to levels similar to day 1.  Data is the mean of (number 
of gonads examined indicated inside bar); error bars, SEM; ANOVA (p<0.0001), 
Tukey’s (HSD) test *p<0.05 (consecutive days). 
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 The age-related changes in apoptosis does not give a clear picture of the changes 
in rate of apoptosis, as total germ cell number decreases with age. Apoptosis levels 
decrease with age in conjunction with germ cells, suggesting that the overall rate of germ 
cell removal may remain the same. To test this we used DAPI staining to count germ 
cells in the CED-1::GFP strain to obtain a ratio of germ cells/apoptotic cells per worm 
(Figure 4.11 A). We found that the ratio of apoptosis increases slightly between day 1 
and 2 (p=0.06) and a further increase was observed on day 4. We observed a reduction in 
the apoptosis ratio on day 8 to levels similar than those observed on day 1 (Figure 4.11 
B). However, a smaller sample size was obtained for day 8 as the DAPI did not properly 
mark germ cells and was very faint and had to be discarded as it would make germ cell 
counts inaccurate. One reason could be that the appearance of uterine tumours takes up a 
lot of the dye and thus the staining protocol should be adjusted for longer incubation in 
older worms. It is also possible that the thickening of the cuticle in older worms (Herndon 
et al., 2002) causes the dye to permeate less. 
 
4.2.5 Gonad degeneration is apoptosis dependant 
The gonad in C. elegans has been shown to atrophy in response to starvation 
during a process termed adult reproductive diapause (ARD) (Angelo and Van Gilst, 
2009). ARD-associated gonad atrophy allows the germline to survive starvation and 
requires apoptosis, and was not observed in ced-3(n1286) mutants undergoing ARD 
(Angelo and Van Gilst, 2009). These results point to a link between germline apoptosis 
and gonad atrophy. Based on the hyperfunction theory, we postulated that gonad 
disintegration could be caused by quasi-programmed continuation of programmed cell 
death. To explore whether continuation of apoptosis caused gonad degeneration we first 
blocked apoptosis using the ced-3(n717) mutation, which abrogates both somatic and 
germline cell death (Gumienny et al., 1999). We found that ced-3(n717) worms were 
protected from gonad disintegration (Figure 4.12). The gonad of these mutants developed 
a ‘grainy’ appearance, but failed to fragment (Figure 4.12 A). The ‘graininess’ observed 
may be caused by deterioration of germ cells which, in the absence of apoptosis, 
accumulate at higher levels and are pushed down the proximal gonad due to 
overcrowding (Gumienny et al., 1999). 
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By day 8 the gonads of ced-3(n717) worms were mostly intact, although they had 
lost some of their integrity. By day 12 ced-3(n717) worms exhibited further loss of gonad 
integrity, and gonad fragmentation occurred in a few cases, but protective effect was still 
clearly evident.  
  
 
Figure 4.12 ced-3(n1717) hermaphrodites are protected from gonad degeneration. 
A) Diagram showing protective effect of ced-3(n717) worms on GD. There is a 
progressive increase in GD in wildtype and ced-3(n717) though it occurs at a slower rate 
in the absence of apoptosis. B) Representative images of day 8 wildtype and ced-3(n717) 
worms. Statistical comparisons were obtained performed the Wilcoxon-Mann Whitney 
test  n.s.=not significant, ***p<0.001. 
 
4.2.6 Reduced germ cell number in ageing worms 
To further characterise age changes in the distal gonad, we visualized germ cell 
nuclei using DAPI staining to measure age changes in nuclear number (Figure 4.13 A). 
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Germ cell number remained at similar levels between day 1 and 6 in wildtype worms. 
There was a slight reduction in germ cell count on day 6, but it did not attain statistical 
significance (p=0.09). There was a reduction in germ cell number by day 8 (p=0.04), 
consistent with the gonad degeneration observed at this age.   
 
Figure 4.13 Germ cell number decreases with age. A) Representative images of DAPI 
stained wildtype and ced-3(n717) worms on days 1 and day 8. The gonad has been 
outlined in white. Arrowheads label DAPI stained masses (tumours) in the proximal 
gonad (PG) of day 8 worms. B) Bar graph showing increased levels of germ cells in the 
DG of ced-3(n717) with respect to wildtype on days 2 to 8.  Data is the mean of (number 
of gonads examined indicated inside bar); error bars, SEM; Student’s t-test (age-matched 
control); ANOVA (p<0.0001), Tukey’s (HSD) (consecutive days) **p<0.01, p<0.05. 
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We also tested the effect of apoptosis on germ cell population during ageing by 
using ced-3(n717) mutants. There was an increase in germ cell number between ced-
3(n717) and wildtype of 20-35% from day 2 onward (Student’s t-test, p<0.05) (Figure 
4.13 B). The total germ cell number for ced-3(n717) increased on day 2 (p=0.0004) and 
remained at similar levels on day 4. On day 6 there was a reduction in germ cell count 
(p=0.038), and a further decrease was observed on day 8 (p=0.0016). Our results suggest 
that during the reproductive period germ cells are produced at a constant rate in wildtype 
worms. The increase in germ cells in ced-3(n717) worms reflect the surplus of cells in the 
absence of apoptosis. After day 4 germ cell production slows down resulting in lower 
germ cell counts in the distal gonad. Statistical significance on consecutive days was 
detected using the Tukey Kramer honest significant difference (HSD) test 
 
4.2.7 Male C. elegans do not exhibit gonad degeneration 
Male worms do not show germline apoptosis (Gumienny et al., 1999). Our working 
hypothesis suggests that male worms should therefore not exhibit gonad disintegration. 
We compared changes in gonad integrity during ageing in hermaphrodites and males. As 
predicted, we found that in males, the gonad does not fragment. Between day 1 and 8 of 
adulthood the male gonad shows only slight deterioration (p=0.007) but retains overall 
structural integrity (Figure 4.14 A,B). From day 8 to 12 no significant change was 
observed. Fragmentation of the gonad was not observed in male worms, i.e. no class 4 
worms were observed.  
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Figure 4.14 Male gonads do not disintegrate. A) Diagram comparing wildtype 
hermaphrodite and male worms. The male gonad deteriorates slightly between day 1 and 
12, but does not fragment. B) Representative image of day 1 and day 8 worms showing 
little change in gonad integrity.  Statistical comparisons were by performing the 
Wilcoxon-Mann Whitney test n.s.=not significant, ***p<0.001. Data for these 
experiments was collected in collaboration with A. Gilliat.  
 
 We also examined ced-3(n717) males on day 8 and found no difference from 
wildtype worms in terms of gonad disintegration (Figure 4.15). The minor signs of tissue 
ageing observed between day 1 and 8 in wildtype (p=0.004) were also observed in ced-
3(n717) male worms (p=0.003). These results reveal a major sex difference in age-related 
pathology in C. elegans. Absence of germline apoptosis in males has been postulated to 
reflect the disparity between male and female gamete size (Gumienny et al., 1999). Males 
produce sperm which are much smaller than oocytes and thus require less cytoplasm 
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(Gumienny et al., 1999). Our results revealed that gonad disintegration is restricted to 
hermaphrodite worms, perhaps due to the absence of germline apoptosis in males. 
 
Figure 4.15 No difference in 
gonad degeneration in ced-
3(n717) males. Diagram 
comparing wildtype and ced-
3(n717) male worms. 
Statistical comparisons were 
performed using the Wilcoxon-
Mann Whitney test, n.s.=not 
significant. Data for these 
experiments was collected in 
collaboration with A. Gilliat.  
 
 
 
 
 
4.2.8 Oocyte size variation in ageing hermaphrodites 
During observations of gonad atrophy we noticed that in ageing worms terminal 
oocytes appear to vary greatly in size (Figure 4.16 A). It has been previously shown that 
apoptosis plays an important role in maintaining oocyte size and ced mutants exhibit a 
faster decline in oocyte size than wildtype worms (Andux and Ellis, 2008). Curiously, 
during our studies we noted that in some worms oocytes would become enlarged relative 
to those in young adults. Such enlarged oocytes showed slight twitching movement and 
were often attached to the remains of the proximal gonad arm, within the gonad sheath. 
By contrast with surrounding tissues, these oocytes appear quite healthy and vigorous. 
We wondered whether changes in oocyte size in older worms were due to apoptotic run-
on, specifically whether continuation of germline apoptosis leads to further release of 
nutrients, which provisions the remaining terminal oocyte, resulting in an enlarged 
oocyte.  
To quantitate age-related changes in oocyte size, we measured the cross sectional 
area of the terminal oocyte in adult hermaphrodite worms on days 1, 8, and 12. We 
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recognized terminal oocytes based on the following criteria: 1) position, near the end of 
the proximal gonad, prior to the spermatheca; and 2) mature oocyte, only one visible 
nucleus, without a nucleolus. Terminal oocytes were visible in 100% of day 1 adult 
worms, however with increasing age the proportion of worms with visible oocytes 
declined. One reason for this decline in oocyte visibility is that tumours developed in 
older worms taking up much of the body cavity.  
 
Figure 4.16 Variation in terminal oocyte size with age. A) Representative image of 
variation in day 8 terminal oocyte size compared to day 1 young adults (left). The middle 
panel shows a hypertrophic oocyte while the right panel shows a hypotrophic oocyte. B) 
No increase was observed in mean terminal oocyte size. An increase in maximum size of 
30% and a decrease of 40% was observed between day 1 and day 8, with no further 
change on day 12. Data is the mean of number of worms examined indicated inside bar; 
error bars, SEM; ANOVA (p<0.0001), Tukey’s (HSD) test (consecutive days). C) Scatter 
plot showing oocyte size on day 1, 8 and 12. Oocytes with means above 895µm
2
 (red 
line) are considered hypertrophic and means below are considered hypotrophic (green 
line). The black line marks oocyte mean size. D) Graph showing that percentages of 
hypertrophic and hypotrophic oocytes increase with age. E) Scatter graph showing 
terminal oocyte size relative to gonad ageing in day 8 worms.  
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We measured the cross-sectional area of the terminal oocytes observed and found 
no increase in the mean size of terminal oocytes with age. This is likely due to large 
variation between terminal oocyte size among worms. An increase in maximum size of 
approximately 30% was observed between day 1 and 8, with no further increase on day 
12 (Figure 4.16 B). Additionally, we observed a decrease of 40% in the minimum oocyte 
size between day 1 and 8, and only a small decrease thereafter (6%). We then estimated 
the age increase in proportion of hypertrophic and hypotrophic oocytes. We defined 
hypertrophic oocytes as those being 1 standard deviation above the mean in day 1 adults, 
which was approximately 895µm
2 
(Figure 4.16 C). In the same way, we defined 
hypotrophic oocytes as those being 1 standard deviation below the mean in day 1 adults, 
or 620µm
2
. By this measure the percentage of both hypertrophic and hypotrophic oocytes 
increased with age (Figure 4.16 D). Thus, terminal oocyte size varies greatly with 
increased age.  
To determine if variation in oocyte size could be linked to the level of gonad 
degeneration we compared the two traits in worms of the same age. We examined 
terminal oocytes on day 8 where there is large variation in the level of deterioration. As 
expected, there was a high degree of variation in oocyte sizes within each gonad class 
(Figure 4.16 E). We then calculated percentages of both hypertrophic and hypotrophic 
terminal oocytes for each gonad class in day 8 worms. This revealed an increase in 
percentage of hypertrophic oocytes with degree of gonad fragmentation (Class 2:20%, 
Class 3: 25% and Class 4: 55%). On day 8 hypotrophic oocytes were observed only in 
worms with Class 4 gonads (Figure 4.16 E). Our results suggest that gonad disintegration 
may be associated with the fluctuations in oocyte size. One possibility is that apoptosis 
levels, which show a reduction on day 8, may cause differences in cytoplasmic streaming 
which can affect oocyte volume.  
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4.2.9 Extending reproductive period does not delay gonad degeneration. 
We have verified previous results showing that the gonad progressively deteriorates 
in hermaphrodite worms (Garigan et al., 2002), and identified a link between gonad 
degeneration and germline apoptosis. We next sought to test the effect degeneration of 
the gonad of extending the reproductive period by mating. Arguably, a delay in the end of 
the reproductive period should cause a delay in the transition from the germline apoptosis 
program to a post-reproductive quasi-programme and thus result in a protective effect on 
gonad degeneration. By the same token, causing more rapid gonad quiescence should 
accelerate gonad degeneration. To test this prediction we used fog-2(q71) mutation that 
causes feminization in hermaphrodites, which only produce oocytes, but has no effect on 
male spermatogenesis (Schedl and Kimble, 1988). This strain was maintained by co-
culturing with fog-2 males. Unfertilized oocytes accumulate in unmated fog-2 worms, 
which have a very low ovulation rate producing approximately 20 oocytes before 
entering quiescence (Miller et al., 2003). Thus,  unmated fog-2 worms can be used to test 
the effect of shortening the reproductive period on gonad ageing.  
We first examined the effect of fog-2 on germline apoptosis and found that 
unmated fog-2 worms had lower levels of apoptosis compared to mated fog-2 worms 
(Figure 4.17 A). This is somewhat expected as unmated fog-2 worms have less active 
gonads and the low apoptosis rate could reflect germline quiescence.  Mated fog-2 worms 
had increased levels of apoptosis compared to unmated worms but significantly lower 
levels than unmated wildtype. On day 4 onwards there was no significant difference 
between wildtype and fog-2 worms following a similar trend of reduced levels of 
apoptosis with age. The decrease in apoptosis from day 4 onwards in wildtype and mated 
fog-2 may be caused by sperm depletion.   
We also looked at the effect of fog-2 and mating on gonad degeneration. 
Expectations here were unclear: in unmated fog-2 hermaphrodites the transition to quasi-
programme should occur sooner, resulting in faster gonad disintegration; but lower 
germline apoptosis should delay gonad disintegration. Gonads of unmated fog-2 worms 
disintegrated at a similar rate that wildtype worms (Figure 4.17 B). In contrast, mated 
fog-2 had an accelerated gonad degeneration phenotype.  
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Figure 4.17 No clear effect of timing of reproduction cessation. A) SYTO 12 staining 
implies fog-2(q71) causes reduced levels of germline apoptosis. Data is the mean of 14-
25 worms; error bars, SEM. B) Scatter diagram showing unmated fog-2 mutants, in 
which quiescence is accelerated, has gonad degeneration levels similar to wildtype. Brief 
mating of fog-2 hermaphrodites resulted in a faster rate of gonad degeneration compared 
to unmated worms.   Statistical comparisons were obtained performing (A) ANOVA 
(p<0.0001), Tukey’s (HSD) test, (B) Wilcoxon Mann-Whitney test ***p<0.001, ** 
p<0.01, *p<0.05. Data was obtained in collaboration with J. Hellberg. 
 
To further test the effect of timing of the reproductive period on gonad ageing we 
mated wildtype hermaphrodite worms to extend the reproductive period. We also reduced 
germline proliferation by treating worms with 15 µM FUdR from the L4 stage. We found 
no difference in germline apoptosis between mated and unmated wildtype worms. In 
contrast, levels of apoptosis were significantly lower on day 1 and 2 in worms treated 
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with FUdR (Figure 4.18 A). Lower levels of apoptosis in worms with reduced germ cell 
proliferation imply that apoptotic rate is not fixed, and is instead linked to germ cell 
proliferative rate. Surprisingly, on day 8, both mated and FUdR-treated worms had 
apoptosis levels higher that the unmated control.  This raises the possibility that FUdR 
may have been metabolized by bacteria after a few days leading to loss of the protective 
effect on germline apoptosis. To avoid this issue worms should be maintained on fresh 
OP50 seeded plates in which FUdR has been added one day prior to transferring the 
worms. 
                  
Figure 4.18 Extending the reproductive period does not delay gonad degeneration. 
A) SYTO 12 staining revealed similar apoptosis levels between mated and unmated 
wildtype worms. Worms treated with 15µM FUdR have reduced levels of germline 
apoptosis. Data is the mean of 20-30 worms; error bars, SEM. B) No significant 
difference in GD was observed between mated and unmated wildtype worms. Worms 
treated with 15µM FUdR had a transient protective effect on GD on day 8.  Statistical 
comparisons were obtained performing using (A), Student’s t-test (compared age-
matched unmated WT control), (B) Wilcoxon Mann-Whitney test n.s.=not significant 
***p<0.001, **p<0.01, * = p<0.05. Data was obtained in collaboration with J. Hellberg. 
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Despite our initial theory that extending the reproductive period would delay 
gonad degeneration, we found no protective effect from mating. We did observe slower 
gonad degeneration in worms treated with FUdR on day 8, though this protection was 
lost by day 12, perhaps due to reduced apoptotic rate (Figure 4.18 B). Taken together, our 
mating experiments show that extending or delaying the timing of the end of 
reproduction does not have the postulated effect on gonad degeneration. 
 
4.2.10 Blocking apoptosis in post-reproductive worms reduces lifespan. 
Findings in this study suggest that quasi-programmed apoptosis contributes to an 
age-related decline in one of the major organs in C. elegans, the gonad. A previous study 
has found that inhibition of CED-3 by RNAi at the L4 larval stage causes an increase in 
lifespan (Curran and Ruvkun, 2007). Such a lifespan increase was not present in ced-
3(n1286) mutants (Garigan et al., 2002). This suggests the possibility that ced-3 mutation 
may mask a lifespan extension due to loss of essential somatic cells during early 
development. An interesting possibility is that selective inhibition of germline apoptosis 
extends lifespan by suppressing age-related pathology in the germline. 
We first tested if ced-3(RNAi) from L4 larval stage had the same protective effect 
as ced-3(n717). We examined the gonads of day 8 hermaphrodite worms and verified that 
apoptosis inhibition exclusively during adulthood is enough to protect against gonad 
degeneration (Figure 4.19 A). We sought to replicate the lifespan extension observed by 
Curran et al (2007) by placing wildtype worms on ced-3(RNAi) at L4. FUdR was not 
used to avoid the inhibitory effects it has on DNA replication in the germline.  Notably, 
we saw an opposite effect to the previous studies. In neither of the two trials conducted 
was there an increase in lifespan. Analysis of pooled data from the two trials showed that 
ced-3(RNAi) from L4 slightly reduced lifespan (Figure 4.19 B).   
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Figure 4.19 Treatment of ced-3(RNAi) from L4 larval stage reduces lifespan. A) 
Protective effect of ced-3(RNAi) from L4 on GD compared to control. Statistical 
comparisons were obtained using the Wilcoxon-Mann Whitney test  ***p<0.001. B) ced-
3(RNAi) from L4 causes a slight lifespan reduction. Assays were conducted at 20˚C,  
worms were raised on L4440 to L4 and transferred to ced-3(RNAi) treatment for the 
duration of the experiment. Data mean of 2 biological replicates.  
 
Treatment Mean lifespan 
[Median] 
(days) 
% of control 
lifespan 
 
Log rank 
(p vs. control) 
Deaths 
[censored] 
L4440 (control) 19.8 [20]   100 [100] 
ced-3(RNAi) 18.6 [20] -6% 0.0006 144 [56] 
 
Table 4-1 Effect of ced-3(RNAi) treatments on lifespan. This table contains data 
corresponding to Figure 4.20 B. 
 
 Subsequent to the above trial, another study reported that ced-3(n717) mutants 
show extended lifespan (Judy et al., 2013), an effect that was not observed in the 
different allele ced-3(n1286) (Garigan et al., 2002). We therefore conducted another 
lifespan trial to compare the lifespan effect of ced-3(n717), and ced-3(RNAi) treatment 
from hatching and from L4. We wanted to test if timing of exposure of worms to ced-
3(RNAi) had an effect on lifespan. We tested ced-3(RNAi) treatment from egg and from 
L4 larval stage. Consistent with our previous findings, ced-3(n717) and ced-3(RNAi) 
resulted in slight decreases in lifespan (Figure 4.20). Together these results suggest that 
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gonad disintegration, despite being a severe pathology of a major organ, does not 
contribute to age-related mortality. This indicates that pathology in other organs limits C. 
elegans lifespan. The reason for the discrepancy in the observed effects of ced-3(n717) is 
unclear. Possibly, genetic background differences shorten control lifespan in the Judy et 
al study (2013). 
 
Figure 4.20 Inhibition of apoptosis shortens lifespan. Assays were conducted at 20˚C 
and worms were transferred to IPTG plates with the desired RNAi treatment (control or 
ced-3) containing 15µM FUdR at L4. Data mean of 1 biological replicate. 
Treatment Mean lifespan 
[Median] 
(days) 
% of control 
lifespan 
 
Log Rank 
(p vs. 
control) 
Deaths 
[censored] 
WT, L4440 (control) 22.5 [24]   86 [11] 
ced-3(n717), L4440 20.9 [22] -7% [-8%] 0.008 94 [5] 
WT, ced-3(RNAi) from egg 21.4 [22] -5% [-8%] 0.0001 84 [16] 
WT, ced-3(RNAi) from L4 20.4 [20] -9% [-17%] 0.06 89 [11] 
 
Table 4-2 Effect of timing of ced-3(n717) ced-3(RNAi) treatments on lifespan. This 
table contains data corresponding to Figure 4.21. 
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4.3 Discussion 
4.3.1 Germline atrophy and hypertrophy in hermaphrodite worms 
During the course of our studies we found that the germline is prone to gross 
morphological change with age, and these changes are consistent with hyperfunction. As 
worms aged we commonly observed the appearance of uterine tumours, fluctuations in 
size of the terminal oocyte and gonad degeneration (Figure 4.21). 
 
Figure 4.21 Age-related changes in the hermaphrodite reproductive system. 
Representative image of a day 8 worm showing changes that occur in the germline such 
as gonad atrophy, oocyte enlargement and tumour formation (distal gonad, DG; proximal 
gonad, PG). Red arrowhead indicating gonad sheath surrounding the spermatheca (Sp). 
 
4.3.1.1 Gonad atrophy may result from quasi-programmed apoptosis 
 Gonad disintegration is interesting as a potential example of hyperfunction 
resulting in atrophy. In C. elegans apoptosis increases reproductive fitness by removing 
around half of germ cells to ensure that those that will develop into oocytes have 
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sufficient cytoplasm, increasing oocyte quality (Gumienny et al., 1999). We conducted a 
quantitative characterization of gonad degeneration by defining stages of increased 
atrophy between 1 and 5. Using this system we compared germline status on day 1, 8 and 
12 at 20°C and found a progressive measurable increase in gonad disintegration. In this 
study we found that germline apoptosis does not halt after reproduction as apoptotic 
corpses were still detected in day 8 hermaphrodite worms. We propose that post-
reproductive continuation of the apoptotic program causes the gonad to fragment and 
atrophy. This atrophy does not occur if apoptosis is absent, in the case of male worms, or 
if apoptosis is blocked by the ced-3(n717) mutation.  Additionally, lowering germline 
proliferation by using DNA synthesis inhibitor FUdR resulted in lower apoptosis levels 
and slowing of gonad degeneration.  
We also tested the effect of changes in the timing of the reproductive period. We 
speculated that increasing the length of reproduction might result in a protective effect on 
gonad disintegration and causing reproduction to halt sooner should accelerate it. We 
tested this using unmated fog-2(q71) worms that only produce oocytes and thus become 
quiescent sooner and mated wildtype worms to extend their reproductive period by 
removing sperm depletion as a limiting factor. We found that unmated fog-2(q71) 
exhibited slower gonad degeneration when compared to mated fog-2(q71), contradicting 
our initial hypothesis.  We also observed that mating wildtype worms had no effect on 
gonad degeneration. Thus, changing the timing of the transition from programme to 
quasi-programme did not have the expected effect on germline ageing. 
Gonad disintegration is a striking age-related pathology in ageing worms. 
However, it seems not to be life-limiting as removal of the entire gonad by laser ablation 
does not extend lifespan (Kenyon et al., 1993). An additional study found that apoptotic 
defective mutants ced-3(n1286) had wildtype lifespan (Garigan et al., 2002). A third 
study found that worms on ced-3(RNAi) after L4 has a slightly increased lifespan 
(Curran and Ruvkun, 2007). A more recent study found that ced-3(n717) mutants extend 
lifespan by increasing resistance to environmental stress (Judy et al., 2013). In our study 
we examined the effect of post-developmental treatment of ced-3(RNAi), ced-3(RNAi) 
from hatching and ced-3(n717) mutants and found a slight reduction in lifespan. Our 
results support the conclusion that apoptosis does not promote age-related mortality. 
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4.3.1.2 Gonad hypertrophy: tumour formation  
 The development of large DAPI stained masses correlate with the formation of 
uterine tumours (Golden et al., 2007; McGee et al., 2011).  During our studies we found 
that these DAPI stained masses were visible as early as day 6 of adulthood. The 
appearance of uterine tumours is the result of endomitosis in unfertilized oocytes and the 
timing of their formation correlates with the end of the reproductive period (Golden et al., 
2007). Furthermore, tumour formation could be blocked with FUdR treatment (Golden et 
al., 2007; Riesen et al., 2014). In unmated fog-2(q71) worms, in the absence of sperm, 
unfertilized oocytes are produced faster forming tumours earlier from day 4 (Josephine 
Hellberg, unpublished). Thus, tumour formation is dependent on the timing of the 
formation of unfertilized oocytes, which corresponds with the end of the reproductive 
period. We therefore postulate that reproductive processes such as nuclear division carry 
on in the oocyte in the absence of fertilization resulting in quasi-programmed formation 
of uterine tumour-like masses (Gems and de la Guardia, 2013). Thus, the timing of the 
switch from programme to quasi-programme affects the timing of pathogenesis in tumour 
formation but not GD. However it should be noted that that uterine tumours are not life-
limiting to the worm, since FUdR treatment, which reduces tumour formation, does not 
extend lifespan (Gandhi et al., 1980; Golden et al., 2007; Riesen et al., 2014). One 
possibility is that yolk overproduction feeds tumour formation. Preliminary experiments 
found that reducing total yolk protein levels using vit-5/vit-6(RNAi) did not block tumour 
formation as of day 4 at 25°C. Future experiments could be conducted using a 
combination of rme-2(RNAi) and FUdR to properly determine the role of yolk and DNA 
synthesis on tumour and hypertrophic oocyte formation. 
The post-reproductive continuation of apoptosis, which may contribute to gonad 
fragmentation, could also result in the continuous release of cytoplasm giving rise to 
hypertrophic oocytes. In support of this, the percentage of hypertrophic oocytes steadily 
increased with the levels of gonad degeneration (Class 2-4). However, we also found a 
high percentage of hypotrophic oocytes in worms with fragmented gonads (Class 4). 
During reproduction oocyte enlargement is the result of streaming of cytoplasm from the 
germ cell rachis to the first three oocytes of the proximal gonad before complete 
cellularization takes place (Wolke et al., 2007) (Figure 4.22). This argues against 
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apoptosis as a cause of oocyte enlargement as oocytes undergoing hypertrophy have 
undergone maturation and should have severed the connection to the core. However, 
images of hypertrophic oocytes suggest that in 8 and 12 day old worms oocyte number in 
the proximal gonad drops to ~2-3 (Figure 4.21). It is possible that as tumours form, 
pushing back the spermatheca from the mid-body region, these few remaining oocytes 
stay connected to the rachis for longer periods of time resulting in their increased size. On 
the other hand, worms in which hypotrophic oocytes were observed had a higher oocyte 
density in the proximal arm (see Figure 4.16 A). Thus, these smaller oocytes were farther 
away from the gonad loop and have severed their connexion to the rachis. Their smaller 
size could result from lower apoptosis levels with age which decreases the pool of 
cytoplasm resulting in less of it being incorporated to these oocytes while they were 
connected to the rachis. Thus, changes in apoptosis levels with age in relation to gonad 
ageing could explain the variation in oocyte size observed in ageing worms. 
Furthermore, hypertrophic oocytes were not observed in ced-3(n717) worms which 
are protected against gonad degeneration. These ced-3 worms show an increased density 
of hypotrophic oocytes in the proximal arm (Gumienny et al, 1999). This supports our 
hypothesis that in the absence of apoptosis oocytes do not have a continuous release of 
cytoplasm from apoptotic hyperfunction and causing a decrease in size.  
As is expected with quasi-programmes, gonad degeneration, tumour-like mass size 
and terminal oocyte size was highly variable between worms. This is due to the fact that 
being a non-intended continuation of developmental and reproductive programme it has 
not been fine-tuned by evolution. 
 
Figure 4.22 Cytoplasmic streaming in the hermaphrodite gonad. The image on the 
left shows particle movement (white box) through the rachis towards the loop of the 
gonad. The image on the right uses white arrows to indicate movement of cytoplasm into 
oocytes that remain attached to rachis. Image reproduced from Wolke et al., 2007. 
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4.3.2 Apoptosis levels reflect proliferative state of the germline 
Apoptosis levels have previously shown to increase in hermaphrodites during the 
first 2.5 days of adulthood (Gumienny et al., 1999). In this study we confirmed the 
increase of apoptotic germ cells between day 1 and 2 and the continuation of apoptosis on 
day 4 and 8 using CED-1::GFP and SYTO 12 staining. The presence of apoptotic corpses 
implies that germline apoptosis continues in post-reproductive worms. Additionally, 
mating experiments revealed that unmated fog-2(q71) hermaphrodites which enter 
germline quiescence faster had reduced levels of apoptosis. Similarly, blocking DNA-
synthesis in the germline by treating worms with FUdR at L4 also reduced levels of 
apoptosis. These results unveil a relationship between germline activity, reproductive 
timing and apoptosis.  
The methods used to measure apoptosis in the germline allow us to estimate the 
number of apoptotic cell corpses, but this is not indicative of the frequency at which 
apoptosis takes place and DIC microscopy clearly suggests a reduction in germline 
nuclear number. Using DAPI staining we could estimate age changes in germ cell 
number in the distal arm. We found a trend of increasing germ cell number between day 
1 and 4, which coincides with the reproductive period and a decrease thereafter. To test 
the actual ratio of germ cells to apoptotic cells remains constant we DAPI stained CED-
1::GFP expressing worms to obtain the apoptotic ratio of each worm. These results show 
that the ratio of apoptosis increases in the first 4 days of adulthood and goes back down 
to day 1 levels by day 8. However, this result does not take into account the rate at which 
new cells are being produced. The ideal scenario would be to measure the proliferative 
state of the gonad and compare that to the rate of apoptosis. 
A further caveat is that our experiments do not measure the rate of apoptotic corpse 
removal. In young adults apoptotic cells were observed to disappear within an hour of 
formation (Gumienny et al., 1999). It is possible that in older worms apoptotic corpses 
form at an earlier stage but are not engulfed. To rule out the possibility that apoptotic 
corpses detected on day 8 are not remnants of earlier apoptotic events time course assays 
should be performed to look for changes in the rate of engulfment. 
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 In this chapter we have described changes that occur in the germline in ageing 
hermaphrodites such as gonad degeneration, uterine tumour formation and oocyte 
enlargement. We also proposed a possible mechanism for gonad disintegration, quasi-
programmed germline apoptosis. In the next chapter we will seek further evidence to 
support our hypothesis that germline apoptosis run-on is the main driver of gonad 
disintegration. 
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Chapter 5: Gonad disintegration is driven by germ cell 
apoptosis in C. elegans 
5.1 Introduction to apoptosis in C. elegans  
In the previous chapter we explored changes in the ageing hermaphrodite gonad 
and found a connection between germline apoptosis and gonad atrophy. In this chapter 
we will test a model in which run-on of germline apoptosis in post-reproductive worms 
results in gonad fragmentation. 
The model organism C. elegans has been a very useful tool to elucidate the genetics 
of conserved biological processes. It was in C. elegans that the evolutionary conserved 
genes involved in programmed cell death were first identified by John Sulston, Sydney 
Brenner and Robert Horvitz (Conradt and Xue, 2005). C. elegans provides a valuable tool 
for the study of this process due to the ability to view apoptotic cells in live C. elegans 
using Differential Interference Contrast (DIC) microscopy, also known as Nomarski 
microscopy (Robertson and Thomson, 1982). Changes in the morphology of apoptotic 
cells in C. elegans resemble those described in mammals such as condensation of the 
cytoplasm and chromatin, followed by cell fragmentation (Kerr et al., 1972; Robertson 
and Thomson, 1982). Similar to mammals, programmed cell death is C. elegans is 
essential during development, and of the 1090 somatic cells in the hermaphrodite, 131 
undergo programmed cell death (Sulston et al., 1983).  
 The regulation of somatic programmed cell death involves the interaction of key 
components EGL-1, CED-9, CED-4 and CED-3 (Conradt and Xue, 2005) (Figure 5.1). 
The small protein EGL-1 is an activator of apoptosis that shares common motifs with 
mammalian BH3 (Bcl-2 Homology region 3) which is present in pro-apoptotic Bcl-2 
proteins (Conradt and Horvitz, 1998; Conradt and Xue, 2005). Inhibition of EGL-1 
results in the survival of nearly all somatic cells that would normally undergo apoptosis 
(Conradt and Horvitz, 1998). The genes ced-3 and ced-4 (cell death abnormal) are the 
essential for programmed cell death to occur and blocking either of these results in the 
survival of the 131 cells that die during development (Ellis and Horvitz, 1986; 
Hengartner, 1997). The ced-4 gene encodes a product similar to human Apaf-1 (apoptotic 
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protease activating factors) which activates caspases (Zou et al., 1997). The CED-3 
protein resembles mammalian interleukin-1β converting enzyme, also known as caspase-
1 (Yuan and Horvitz, 2004; Yuan et al., 1993). Surprisingly, although ced-3 and ced-4 
mutants have more somatic cells than wildtype there seems to be no major behavioural 
anomaly in these worms (Ellis and Horvitz, 1986). They exhibit normal locomotion, 
feeding and egg-laying rate, but brood sizes are slightly lower (Ellis and Horvitz, 1986). 
CED-9 is a negative regulator of apoptosis which is structurally similar to mammalian 
Bcl-2, the loss of this gene causes cells that normally survive to undergo apoptosis and is 
lethal (Hengartner and Horvitz, 1994; Hengartner et al., 1992). Over-expression of CED-
9 results in survival of somatic cells that would normally die and these worms have a 
similar phenotype than ced-3 and ced-4 mutants (Hengartner and Horvitz, 1994).  The 
similarity in structure and function between C. elegans and mammalian genes mediating 
programmed cell death reflect evolutionary conservation of the cell death pathway 
(Hengartner, 1997).  
 
Figure 5.1 Core apoptotic pathway in C. elegans. Representation of the interaction 
among proteins in the core apoptotic pathway, which are required for embryonic and 
developmental apoptosis. Genes ced-3 and ced-4 encode the cell death effector proteins 
required for all known C. elegans apoptosis pathways (red box). 
 
Programmed cell death occurs in C. elegans during embryogenesis and larval 
development in somatic cells and exclusively in the germline of adult hermaphrodites 
(Conradt and Xue, 2005; Gumienny et al., 1999; Sulston and Horvitz, 1977). Though the 
death inducing proteins CED-4 and CED-3 are crucial requirements for both somatic and 
germline apoptosis, there are differences in their regulation (Gartner et al., 2008).  
 
5.1.1 Germ cell apoptosis in C. elegans hermaphrodites 
Multicellular organisms rely on apoptosis to rid the body of unwanted and damaged 
cells. Apoptosis is also a hallmark in oogenesis and gastrulation across various species 
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where the germline uses distinct mechanisms to induce the cell death machinery 
(Greenwood and Gautier, 2005). In adult C. elegans all somatic cells are post-mitotic and 
do not undergo apoptosis; the only tissue with replenishing cells is the germline which is 
thus more similar to mammalian tissue (Gartner et al., 2008). One type of germ cell 
apoptosis occurs as part of the oogenesis program whereas a second type of cell death 
occurs in response to DNA damage or environmental insults (Gartner et al., 2008). We 
will refer to the two main categories of apoptosis present in the germline as physiological 
apoptosis (PA) and stress-induced apoptosis (SIA).  
5.1.1.1 Germline physiological apoptosis 
Apoptosis in the germline occurs only in adult hermaphrodites under no 
perceivable external stress and seems to be part of the oogenic program (Gartner et al., 
2008). Activation of CED-4 and CED-3 during physiological apoptosis is different in the 
germline in that inhibition of the pro-apoptotic factor EGL-1 and ced-9(n1950) gain of 
function mutations, both of which block apoptosis in the soma, are not required for germ 
cell apoptosis (Gumienny et al., 1999). The signal that causes the induction of CED-4 
and CED-3 in physiological germline apoptosis is currently not known (Gartner et al., 
2008).   
Physiological germline apoptosis is a reproductive mechanism responsible for the 
removal of at least 50% (Gumienny et al., 1999) or as much as 97% (Jaramillo-Lambert 
et al., 2007) of all oogenic germ cells. In C. elegans germ cells at different stages of 
mitosis and meiosis are connected to each other through a syncytium allowing them to 
share a common cytoplasm (Lints and Hall, 2009c). During programmed cell death 
(PCD) apoptotic cells are quickly engulfed to reduce the spread of apoptotic trigger 
factors to neighbouring cells, whilst the majority of the cytoplasm is exuded to provision 
growing oocytes (Gumienny et al., 1999) (Figure 5.2). It has been proposed that germ 
cells are produced in excess to act as nurse cells, supplying nourishment for developing 
oocytes (Gartner et al., 2008; Gumienny et al., 1999). Germ cell apoptosis takes place in 
the gonad loop just before germ cells differentiate thus allowing germ cells to act as 
cytoplasm “factories” for as long as possible (Gumienny et al., 1999; Wolke et al., 2007). 
In further support, one study found that there is cytoplasmic streaming from the rachis to 
first three oocytes still connected to it, accounting for most of the oocyte enlargement 
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(Wolke et al., 2007). Physiological apoptosis does not occur in male C. elegans, probably 
because sperm, being so small, do not require large amounts of cytoplasm, allowing all 
germ cells to become gametes (Gumienny et al., 1999). Additionally although ced-4 and 
ced-3 mutants are fertile, they produce smaller oocytes and lay more dead eggs, 
indicating that germ cell apoptosis improves oocyte quality (Andux and Ellis, 2008).  
 
 
Figure 5.2 Representation of the nurse cell theory. Physiological apoptosis in worms 
occurs in the “death zone” in the loop region of the distal gonad where germ cells are in 
the pachytene stage. Germ cells are not completely cellularized, instead they are 
connected through the shared rachis.  Image modified from Gartner et al 2008. 
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5.1.1.2 Stress-induced apoptosis 
The finding that apoptosis takes place in the gonad led researchers to test whether 
germ cell apoptosis could be induced by stress. Consequently, separate mechanisms were 
discovered in which apoptosis can be triggered in the germline by genotoxic and 
environmental stressors, starvation and infection probably to prevent the passing on of 
genetic abnormalities to the next generation to preserve resources (Gartner et al., 2008) 
(Figure 5.3).  
   
Figure 5.3 Germline apoptosis genetic pathways in C. elegans. Representation of the 
different mechanisms for germline apoptosis in C. elegans. DNA damage promotes 
germline apoptosis via CEP-1 activity. DNA damage-induced apoptosis and pathogen 
induced apoptosis require EGL-1; it is not known whether pathogen induced apoptosis 
acts via CEP-1. Physiological apoptosis does not require EGL-1 and can activate CED-4 
and CED-3 through an unknown mechanism. Stress-induced apoptosis (osmotic, 
oxidative and heat stress) is EGL-1 independent and acts via MEK-1, SEK-1 and ABL-1 
which may activate physiological apoptosis or act via an alternative mechanism. This 
figure has been modified from Gartner et al, 2008. 
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5.1.1.2.1 DNA damage-induced apoptosis 
Studies examining the effect of inducing DNA damage in C. elegans using ionizing 
radiation found an alternate genetic pathway for apoptosis distinct from physiological 
apoptosis (Gartner et al., 2000). Stress induced apoptotic cells have the same 
morphological characteristics and occur in the same region of the gonad (pachytene) as 
physiological apoptosis (Gartner et al., 2008). Similar to physiological apoptosis, DNA 
damage induced apoptosis has not been observed in the male C. elegans germline 
(Gartner et al., 2000). Germline apoptosis in response to genotoxic stress requires EGL-1 
and CED-9, which are not necessary for physiological apoptosis, implying that the signal 
to activate DNA damage-induced apoptosis is further upstream (Gartner et al., 2000). 
CEP-1, a homologue of the mammalian tumour suppressor p53, is required for DNA 
damage-induced apoptosis but not apoptosis in the soma nor physiological apoptosis 
(Schumacher et al., 2001). CEP-1 acts as a transcriptional activator of pro-apoptotic 
factors that can induce apoptosis via EGL-1 or CED-13 (Schumacher et al., 2005a). 
 
5.1.1.2.2 Other stressors that induce germline apoptosis 
 Programmed cell death also occurs in the germline in response to pathogen 
infection (Aballay et al., 2000). The pathogenic bacteria Salmonella typhimurium and 
Salmonella enterica cause an increase in germline apoptosis which does not occur in ced-
3 and ced-4 mutants (Aballay and Ausubel, 2001; Aballay et al., 2003). Pathogen-
induced germline apoptosis requires EGL-1, MAPK kinase SEK-1 and the p38 
homologue PMK-1 (Aballay and Ausubel, 2001). Colonization of the worms by S. 
typhimurium causes an increase in intact bacteria within the worm which is restricted to 
the lumen of the intestine (Aballay et al., 2000). This implies that a signal from intestinal 
somatic tissue in response to the infection triggers apoptosis in the gonad. Inhibition of 
apoptosis in the worms using ced-3 and ced-4 mutations results in increased sensitivity to 
death by S. typhimurium infection, which suggests germline apoptosis is somehow 
involved in defence against infection (Aballay and Ausubel, 2001).  
 Apoptosis can be induced in the germline by oxidative, heat shock, osmotic and 
starvation stressors through a pathway which does not require CEP-1 and EGL-1 (Salinas 
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et al., 2006). MAPK kinases MEK-1 and SEK-1 in addition to the p53 antagonist tyrosine 
kinase ABL-1 are necessary for germline apoptosis in response to oxidative, osmotic and 
thermal stressors but not starvation which seems to work through an unknown alternate 
mechanism (Salinas et al., 2006). Curiously, ABL-1 represses CEP-1 dependent 
apoptosis, so it is involved in repressing DNA-damage induced apoptosis whilst 
promoting environmental stress induced apoptosis (Deng et al., 2004; Gartner et al., 
2008). Pathogen and DNA damage induced germline apoptosis require EGL-1 while 
physiological and environmental stress induced apoptosis do not. Additionally MAPK 
kinase is also involved in physiological apoptosis. This suggests the possibility that 
environmental stress-induced apoptosis may act via the physiological apoptosis pathway 
or a novel, separate mechanism (Gartner et al., 2008). 
 Bacterial infection, osmotic stress, starvation, heat shock and oxidative stress do 
not challenge the genomic integrity of the germline yet cause an increase in apoptosis. It 
is possible that signals from the somatic tissue cause increased germline apoptosis to 
divert resources to battle the adverse conditions (Gartner et al., 2008). Furthermore, one 
study found that starvation in early adulthood results in removal of all germ cells except 
for a small mitotic germ cell population which is then entirely replenished when placed 
back on food (Angelo and Van Gilst, 2009).  
Based on the hyperfunction theory we hypothesize that germline apoptosis 
continues in the germline after reproduction has stopped, and that it is this quasi-
programmed apoptotic hyperfunction that causes disintegration of the gonad. Results 
described in the previous chapter provide support for this hypothesis. In this chapter, we 
will test this idea further, and examine which type of germline apoptosis is more likely to 
contribute to gonad ageing.  
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5.2 Results 
5.2.1 Gonad disintegration is apoptosis dependent 
We previously found that blocking apoptosis using mutation of ced-3(n717) 
protects the gonad from disintegration suggesting a link between apoptosis in the gonad 
and GD. To test whether this is typically the case for ced-3 alleles we examined germline 
disintegration in ced-3(n1286), ced-3(n2454) and ced-3(n288) mutants. We first used 
SYTO 12 staining to verify effects of these alleles on germline apoptosis measuring 
apoptosis levels on day 1 of adulthood. Previously, only effects of ced-3(n717) on 
germline apoptosis have been tested (Gumienny et al., 1999). All ced-3 alleles examined 
prevented germline apoptosis (Figure 5.4 A).  
 
Figure 5.4 Gonad disintegration is delayed in ced-3(-) mutants. A) SYTO 12 staining 
revealed germline apoptosis is nearly absent in ced-3(n1286), ced-3(n2454), ced-3(n288) 
and ced-3(n717) worms. Data is the mean of 11-20 worms; error bars, SEM, Students t-
test (compared to WT control). Data obtained by J. Hellberg. Scatter diagrams showing 
protective effect of B) ced-3(n1286), C) ced-3(n2454), D) ced-3(n288) on gonad 
disintegration compared to wildtype worms. Statistics were obtained by performing the 
Wilcoxon-Mann Whitney test, n.s.=not significant ***p<0.001, **p<0.01, *p<0.05.  
 137 
 
Then we examined the gonad in ced-3(n1286), ced-3(n2454), and ced-3(n288) 
mutants and found that gonad disintegration is delayed compared to wildtype  in all cases  
(Figure 5.4 B-D). Thus, suppression of gonad degeneration by mutation of ced-3 is a 
robust and reproducible phenomenon. 
The anti-apoptosic factor CED-9 acts by forming a complex with the pro-
apoptotic protein CED-4, sequestering it in the mitochondria (Chen et al., 2000; del Peso 
et al., 2000). In cells undergoing programmed cell death CED-4 is localized in the 
nucleus, thus once CED-4 translocates to the nucleus it activates CED-3 to initiate 
apoptosis (Chen et al., 2000; del Peso et al., 2000).  Mutations in ced-3 and ced-4 
successfully block all somatic programmed cell death (Ellis and Horvitz, 1986). 
Additionally, in ced-4(n1162) mutants germ cell death is inhibited (Gumienny et al., 
1999). We examined the effect of apoptosis defective ced-4(n1162) mutants to determine 
if gonad disintegration is inhibited as in ced-3 mutants and found that it was (Figure 5.5). 
Together these results further suggests that apoptosis is a contributor of gonad ageing in 
hermaphrodite worms. 
 
 
Figure 5.5 Gonad 
deterioration is slowed 
down in ced-4(n116) 
worms. Scatter diagram 
showing protective effect of 
ced-4(n1116) on gonad 
disintegration compared to 
wildtype. Statistics were 
obtained by performing the 
Wilcoxon-Mann Whitney 
test, **p<0.01, *p<0.05. 
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5.2.2 Somatic apoptosis does not influence gonad disintegration 
Apoptosis that occurs in the C. elegans hermaphrodite gonad in the absence of any 
environmental stressors is known as physiological apoptosis (Gumienny et al., 1999). 
This type of germline apoptosis requires the core apoptotic machinery CED-3 and CED-
4, but not death-inhibitor protein CED-9 (Gartner et al., 2008; Gumienny et al., 1999). 
Loss of function (lf) mutations in CED-9 cause cells that would normally survive to 
undergo apoptosis and is embryonic lethal; gain of function (gf) mutation ced-9(n1950)  
blocks apoptosis, resulting in a phenotype similar to ced-3 and ced-4 mutants (Hengartner 
et al., 1992). The ced-9(n1950gf) mutation completely represses somatic apoptosis 
(Hengartner et al., 1992) but not germline apoptosis in hermaphrodite worms (Gumienny 
et al., 1999). To exclude the possibility that somatic apoptosis causes gonad degeneration 
we tested whether ced-9(n1950), which has wildtype levels of gonad apoptosis, but no 
somatic apoptosis, has any effect on gonad ageing. We predicted that due to the presence 
of germline apoptosis the gonad would not be protected from degeneration. As expected, 
there was no difference in the rate of gonad degeneration in ced-9(n1950) compared to 
wildtype, possibly due to similar germline apoptosis levels (Figure 5.6). Furthermore, our 
results suggest that somatic apoptosis does not influence gonad degeneration. 
 
 
Figure 5.6 Effect of the 
gain of function mutation 
ced-9(n1950) on gonad 
degeneration. Diagram 
showing no difference in 
gonad degeneration rate 
between ced-9(n1950) and 
wildtype. Statistics were 
obtained by performing the 
Wilcoxon-Mann Whitney 
test, n.s.=not significant. 
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5.2.3 Increasing apoptosis levels causes faster gonad disintegration 
We have shown that blocking apoptosis using ced-3 and ced-4 mutations slows 
gonad degeneration. We were therefore interested in testing if increasing apoptosis levels 
would result in a faster rate of gonad degeneration. To do so we used the gld-1(op236) 
mutation which causes the upregulation of CEP-1 dependent translation of apoptotic 
factors (Schumacher et al., 2005b). GLD-1 is a translational repressor of CEP-1 related to 
mammalian Quaking proteins (Schumacher et al., 2005b). At 20˚C the gld-1(op236) 
mutation causes a small increase in germline apoptosis levels and this effect is 
dramatically increased in response to radiation (Schumacher et al., 2005b).  The gld-
1(op236) mutation is temperature sensitive causing a massive increase in germ cell 
apoptosis at 25˚C by induction of EGL-1 pro-apoptotic factors via CEP-1 activity, 
independently of DNA damage (Schumacher et al., 2005b).  
We sought to replicate this finding using SYTO 12 staining and found that at 20˚C 
apoptotic levels in the germline were similar between wildtype and gld-(op236) on day 1 
of adulthood, however there was a large increase in apoptosis in gld-1(op236) at 25˚C 
(Figure 5.7 A,C). It is worth noting that in the study conducted by Schumacher et al the 
enhancement in germline apoptosis in gld-1(op236) worms was higher (~13X) than those 
obtained in this study (~4X). Due to high levels of germline apoptosis in gld-1(op236) 
mutants at 25˚C, it is possible that our absolute values are underestimated as stained 
apoptotic germ cells appear in large clumps making it difficult to count individual cells.  
We tested the effect of gld-1(op236) mutation on gonad disintegration at 20˚C. We 
chose this temperature to look at worms with mildly enhanced apoptosis (Schumacher et 
al., 2005b). If apoptosis causes gonad atrophy, the higher apoptosis rates could lead to 
gonad atrophy that occurs too rapidly. We found that GD was accelerated in gld-1(op236) 
worms at this temperature compared to wildtype on day 8 but not day 12 (Figure 5.7 B). 
We also examined worms with a greater enhancement of apoptosis at 25˚C and found that 
GD was greatly accelerated. At this temperature, a significant increase in gonad 
degeneration was seen in even young day 1 adults and this trend continued on day 6 by 
which time all gld-1(op236) worms examined had gonads with a high degree of 
degeneration (class 3-5) (Figure 5.7 D). Our results indicate a positive correlation 
between germline apoptosis levels and rate of gonad disintegration. 
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Figure 5.7 Increasing germline apoptosis results in faster gonad disintegration. A) 
SYTO 12 staining revealed similar apoptosis levels between gld-1(op236) and wildtype 
worms at 20˚C in day 1 adults. B) At 20˚C gonad disintegration is slightly accelerated in 
day 8 gld-1(op236) worms. C) At 25˚C germline apoptosis levels in gld-1(op236) worms 
were three times higher than those observed in wildtype.  D) At 25˚C gonad deterioration 
is greatly accelerated, showing greater decline in gld-1(op236) on day 1 and day 6.  A,C) 
Data is the mean of (n, indicated inside bar); error bars, SEM; Students t-test (compared 
to temperature-matched WT control). B,D) Statistics were obtained by performing the 
Wilcoxon-Mann Whitney test, n.s.=not significant *** = p<0.001, ** = p<0.01, * = 
p<0.05 
 
5.2.4 No evidence that molecular damage is a major contributor to gonad ageing 
It has been suggested that molecular damage causes ageing and age-related 
pathology. If gonad degeneration is the direct result of oxidative damage we would 
expect that treatments that increase protein oxidation should result in faster gonad 
disintegration. We probed whether molecular damage is involved in gonad degeneration 
by using the sod-2(gk257) mutation, which abrogates the main C. elegans mitochondrial 
superoxide dismutase, and 9mM iron supplementation. Both these treatments have been 
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shown to increase protein carbonylation without affecting lifespan (Doonan et al., 2008; 
Van Raamsdonk and Hekimi, 2009; Valentini et al., 2012). We chose treatments that do 
not reduce lifespan to avoid life-shortening broad pathological effects unrelated to ageing 
that could complicate the interpretation of results. We performed oxyblots to verify that 
our treatments increased protein carbonyls and found an increase in protein carbonylation 
on 9mM ferric ammonium citrate (FAC) supplementation. Mutation of sod-2(gk257) also 
increased protein carbonylation though this did not attain significance, possibly due to 
high variability between replicates (Figure 5.8). 
 
Figure 5.8 Increased protein carbonylation in sod-2(gk257) and 9mM FAC treated 
C. elegans. A) Protein oxidation is significantly increased in worms with moderate iron 
supplementation (9mM FAC) and appears increased in sod-2(gk257) worms. B) 
Representative oxyblot showing increase in protein carbonylation for 9mM FAC and sod-
2(gk257) compared to control. Data is the mean of three biological replicates; error bars, 
SEM; Student’s t-test, *p<0.05. Data obtained in collaboration with F. Cabreiro. 
 
We then examined effects of treatments that increase protein oxidation on gonad 
degeneration and found no difference to wildtype control for either sod-2(gk257) mutants 
or 9mM FAC treatment (Figure 5.9 A,B). These results suggest that under standard 
culture conditions gonad degeneration is not caused by increased levels of protein 
oxidation. 
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Figure 5.9 Protein oxidation does not affect gonad deterioration. A,B) Scatter 
diagrams showing no effect of increased protein carbonylation on gonad degeneration for 
sod-2(gk257) mutants nor 9mM FAC treatment. Statistics obtained by performing the 
Wilcoxon-Mann Whitney test, n.s.=not significant. 
 
5.2.5 DNA damage is not a major contributor to gonad degeneration 
One scenario is that gonad degeneration is the result of DNA damage-induced 
apoptosis. This apoptosis pathway in the germline helps to avoid passing on genetic 
aberrations to the offspring. Studies examining the effect of ionizing radiation (IR) on 
germline apoptosis revealed a distinct genotoxic response to checkpoint genes rad-5, mrt- 
2 and him-7 (Gartner et al., 2000). Apoptosis in response to DNA damage has only been 
observed in pachytene stage cells in the germline and has not been observed in somatic 
cells nor in male C. elegans (Gartner et al., 2008).  In this way, DNA-damage induced 
apoptosis may remove any damage caused by SPO-11 induced double strand breaks 
during meiotic crossover, which occurs during pachytene (Dernburg et al., 1998; 
Schumacher et al., 2001). Thus, it is conceivable that an apoptotic programme that exists 
to safeguard the germline from accumulating DNA damage could potentially become a 
quasi-programme in later life.  
 The SPO-11 protein is a meiotic recombination protein which is the homologue of 
yeast Spo11 and is related to Topoisomerases (Dernburg et al., 1998). To test if DNA 
damage-induced apoptosis is the main cause of gonad degeneration we used spo-
11(ok79) mutants that are unable to form double strand breaks, which is a major source of 
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DNA damage during meiosis (Dernburg et al., 1998). Thus, spo-11 mutants should have 
negligible amounts of DNA damage in the germline and should not trigger the DNA-
damage induced apoptotic pathway. Crossing over is not observed in the spo-11(ok79) 
deletion mutants and although homozygote hermaphrodites are behaviourally normal and 
have normal fecundity, 99% of eggs do not hatch and survivors are mostly male  
(Dernburg et al., 1998). The unusual large amount of males arising from self-fertilization 
is indicative of errors in chromosomal segregation, and indeed all chromosomes in spo-
11(ok79) mutants lack chiasmata which link homologous chromosomes during crossover 
(Dernburg et al., 1998; Hodgkin et al., 1979). We found that the spo-11(ok79) mutation 
did not affect the rate of gonad degeneration which argues against a role of DNA 
damage-induced apoptosis in GD (Figure 5.10). 
 
 
Figure 5.10 Little effect of 
DNA damage on gonad 
degeneration. Scatter diagram 
showing no effect of reducing 
DNA damage levels using spo-
11(ok79) on gonad atrophy. 
Statistics were obtained 
performing Wilcoxon-Mann 
Whitney test, n.s.=not 
significant. 
 
 
 
 The p53 transcription factor is a mammalian tumour suppressor necessary to 
activate apoptosis in abnormal cells (Levine et al., 2004). Moreover mutations in p53 
have been implicated in more than 50% of human cancers (Levine, 1997). The C. elegans 
transcription factor CEP-1 is a homologue of mammalian p53 and is required for the 
DNA damage induced apoptosis response (Derry et al., 2001; Schumacher et al., 2001). 
RNAi of cep-1 has been shown to abrogate DNA damage induced apoptosis in response 
to ionizing radiation (Schumacher et al., 2001).  Un-irradiated worms subjected to cep-1 
RNAi and cep-1(gk138) mutants have apoptosis levels similar to wildtype (Pinkston-
 144 
Gosse and Kenyon, 2007; Pinkston et al., 2006; Schumacher et al., 2001), as presumably 
in the absence of genotoxic stress physiological apoptosis still takes place. We used cep-
1(gk138) mutants to test whether in the absence of the mediator for DNA damage 
induced apoptosis gonad degeneration still occurred.  
We found that there was no difference in gonad disintegration on day 1 and 8 
between wildtype and cep-1(gk138) worms. However, a slight protective effect was 
observed on day 12 in cep-1(gk138) worms (Figure 5.11). Thus, the possibility of a slight 
effect of DNA damage on GD cannot be excluded. 
 
Figure 5.11 Little effect of 
CEP-1 dependent DNA-
damage induced apoptosis 
on GD. Diagram showing 
effects on gonad 
degeneration of cep-1(gk138) 
worms. No effect was seen, 
but a slight protective effect 
was observed for cep-
1(gk138) on day 12. Statistics 
were obtained by performing 
the Wilcoxon-Mann Whitney 
test, n.s.=not significant, 
*p<0.05. 
 
5.2.5.1 Stress-induced apoptosis is a minor contributor to gonad 
degeneration 
A separate mechanism for germline apoptosis in response to stressors such as 
osmotic, thermal and oxidative stress has been discovered which is independent of CEP-1 
and EGL-1 and involves the MAPK kinases MEK-1 and SEK-1, and the tyrosine kinase  
ABL-1 (Salinas et al., 2006). ABL-1 has been previously found to be an anti-apoptotic 
factor which negatively regulates CEP-1 (Deng et al., 2004).  However, it seems ABL-1 
can also act as a pro-apoptotic factor in response to non-genotoxic stressors which may 
activate the physiological apoptosis pathway (Salinas et al., 2006) or an alternative 
unknown factor that induces the core apoptotic machinery.  
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Worms with deletion allele abl-1(ok171) have higher levels of basal germline 
apoptosis and are hypersensitive to radiation, and this is lost in the absence of CEP-1 
(Deng et al., 2004). We checked effects of abl-1 and cep-1 on germline apoptosis levels 
and obtained similar results. On control RNAi germline apoptosis was slightly higher in 
abl-1(ok171) mutants than wildtype. When worms were treated with cep-1(RNAi) there 
was no effect on wildtype but the apoptotic enhancement of abl-1(ok171) was lost 
(Figure 5.12 A).  
 
Figure 5.12 Blocking stress-induced germline apoptosis does not reduce germline 
atrophy. A) SYTO 12 staining revealed germline apoptosis levels are higher in day 1 
adult abl-1(ok171) than wildtype. This enhancement is lost if abl-1(ok171) worms are 
subjected to cep-1(RNAi), resulting in levels slightly lower (p=0.07) than wildtype 
control. Data is the mean of (n, indicated inside bar); error bars, SEM; Students t-test 
(compared to WT control),* p<0.05. B) There was no difference in gonad degeneration 
between wildtype on control(RNAi) and cep-1(RNAi) C) Similar rate of gonad 
degeneration was observed between wildtype and  abl-1(ok171) worms. D) Inhibition of 
CEP-1 by RNAi in wildtype and abl-1(ok171) has little effect on gonad degeneration. 
Statistics were obtained by performing the Wilcoxon-Mann Whitney test, n.s.=not 
significan 
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If physiological apoptosis causes gonad degeneration then neither inhibition of cep-
1 or abl-1 should suppress gonad atrophy. We first looked at the effect of inhibiting the 
non-genotoxic SIA response using abl-1(ok171) and saw no effect on gonad degeneration 
(Figure 5.12 C). We also disabled two mechanisms of SIA (DNA damage and stress-
induced) by subjecting abl-1(ok171) worms to cep-1(RNAi) and again saw no effect 
(Figure 5.12 D). We also confirmed, using cep-1(RNAi) the previous finding with cep-
1(gk138) in which there is no major effect of DNA damage-induced suppression on 
gonad disintegration (Figure 5.12 B). We saw no protective effect on day 12 in worms on 
cep-1(RNAi) suggesting that the slightly lower levels of GD observed in the single cep-
1(gk138) trial may not reflect a robust effect.  Taken together these results suggest that 
age-related gonad disintegration is the result of continued physiological apoptosis, not 
stress-induced apoptosis. 
5.2.6 Mutations in daf-2 delay gonad ageing 
The insulin/IGf-1 signalling pathway greatly influences ageing in C. elegans 
through processes that remain poorly understood. Gonad ageing has been previously 
shown to occur at a slower rate in daf-2(-) worms which have reduced IIS (Garigan et al., 
2002). Our working  model suggests that daf-2(-) worms might delay gonad degeneration 
by decreasing germline apoptosis. 
 A previous study examined germline apoptosis in daf-2(e1370) worms at 25˚C and 
found they have an increased rate of apoptosis (Pinkston et al., 2006). However, another 
study quantified germline apoptosis at 20˚C in daf-2(e1370) and found the opposite: 
lower levels of apoptosis in daf-2(-) worms (Perrin et al., 2013). The class 2 allele daf-
2(e1370)  used in both of these studies causes pleiotropic effects such as reduced fertility 
and reduced pharyngeal pumping. We used SYTO 12 staining to measure germline 
apoptosis in the class 2 allele daf-2(e1370) and also the less pleiotropic class 1 allele daf-
2(m577) at 20˚C and 25˚C. daf-2(m577) increases lifespan weakly at 20˚C and robustly at 
25˚C. 
At 20˚C we observed lower levels of apoptosis for daf-2(e1370) on day 1 and 2 of 
adulthood, consistent with the results of Perrin et al (2013). A similar trend was observed 
for daf-2(e1370) at 20˚C where apoptosis levels were lower on day 1, and this pattern 
continued on day 2 but did not reach statistical significance. Germline apoptosis levels in 
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daf-2(m577) were similar to wildtype at both temperatures (Figure 5.13 A,B). These 
results suggest that the lower germline apoptosis levels in daf-2(e1370) mutants are the 
result of its pleiotropic effects. 
The study by Garrigan et al (2002) examined gonad ageing in class 2 allele daf-
2(e1370) and class 1 allele daf-2(mu86) and found that both delay gonad deterioration. 
We sought to replicate this result using daf-2(m577) worms (25˚C) and we were able to 
verify that this allele has a protective effect on GD (Figure 5.13 C). Thus, daf-2(m577) 
animals exhibit less gonad deterioration despite having unaltered levels of germline 
apoptosis. Our results imply that daf-2(m577) inhibits gonad disintegration by a 
mechanism other than reduced apoptosis, which also drives gonad ageing. 
 
Figure 5.13 Gonad ageing is delayed in daf-2(m577) worms. A,B) Germ cell 
measurements using SYTO 12 staining show reduced levels of germline apoptosis in daf-
2(e1370), but not daf-2(m5577) which had levels similar to wildtype. Data is the mean of 
number of worms indicated inside bars; error bars, SEM; Student’s t-test test (compared 
to same day wildtype control) **p<0.01, *p<0.05. C) Gonad disintegration is delayed in 
daf-2(m577) worms compared to wildtype. Statistics were obtained by performing the 
Wilcoxon-Mann Whitney test, n.s.=not significant ***p<0.001, **p<0.01, *p<0.05. Data 
obtained in collaboration with Josephine Hellberg. 
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5.2.7 TOR pathway mutant rsks-1(ok1255) does not affect gonad disintegration 
In addition to the IIS pathway, TOR signalling is also involved in sensing nutrients 
and promoting growth and is a modulator of the ageing process. Inhibition of RSKS-1, a 
homologue of S6 kinase downstream of TOR, modestly increases lifespan in worms 
(Hansen et al., 2007; Kapahi et al., 2010; Pan et al., 2007).  The hyperfunction theory 
proposes that inhibition of IIS and TOR pathways extend lifespan by inhibiting quasi-
programmes (Blagosklonny, 2007, 2008). We therefore tested whether rsks-1(ok1255) 
mutants have a similar pattern of delay in gonad ageing as do daf-2(-) worms. 
We measured germ cell apoptosis using SYTO 12 staining on day 1 of adulthood 
and found that rsks-1(ok1255) mutants had reduced levels of apoptosis compared to 
wildtype (Figure 5.14 A). This is consistent with reduced and delayed fertility in this 
mutant (Selman et al., 2009). However, despite lower levels of germline apoptosis in 
rsks-1(ok1255) mutants gonad disintegration rate in these worms is not different to 
wildtype (Figure 5.14 B).  
 
Figure 5.14 Reduced TOR signalling does not have a protective effect on GD. A) 
Measurement of SYTO 12 stained apoptotic cells show a reduction in germ cell apoptosis 
levels in rsks-1(ok1255) mutants on day 1 of adulthood compared to wildtype. Data is the 
mean of number of worms indicated inside bars; error bars, SEM; Students t-test 
(compared to same day wildtype control) *** p<0.001. B) Scatter diagram showing no 
difference in GD between rsks-1(ok1255) and wildtype worms. Statistics obtained using 
the Wilcoxon-Mann Whitney test, n.s.=not significant.  
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5.2.8 Effect of bacteria on gonad degeneration 
Under standard laboratory conditions C. elegans are cultured on agar plates seeded 
with Escherichia coli strain OP50 as their main food source (Brenner, 1974b). 
Alternatively, when performing RNAi by feeding worms are maintained on E. coli 
containing the L4440 plasmid (Timmons and Fire, 1998). The E. coli strain most used for 
RNAi is HT115 because it lacks RNAse III, improving the efficacy of RNAi (Timmons 
et al., 2001). During experiments conducted on RNAi we noticed a protective effect on 
gonad degeneration. Thus we compared worms on standard agar plates seeded with OP50 
and worms on IPTG agar plates seeded with HT115 containing empty vector L4440. For 
the latter, an antibiotic (carbenicillin) was added to maintain the L4440 plasmid, which 
confers carbenicillin resistance. Worms were examined on day 8 and day 12 and we 
found that maintenance on HT115+L4440+carbenicillin had a protective effect on gonad 
degeneration (Figure 5.15). This could reflect an effect of HT115, or L4440, or 
carbenicillin. 
 
Figure 5.15 Worms on 
control(RNAi) have reduced gonad 
degeneration. Diagram comparing 
gonad degeneration in wildtype 
worms cultured on standard agar 
plates seeded with OP50 versus IPTG 
plates seeded with L4440 
control(RNAi). Statistics were 
obtained bt performing the Wilcoxon-
Mann Whitney test, ***p<0.001, 
*p<0.05. 
 
 
 
 Different E. coli strains can modulate C. elegans lifespan in a process that 
involves sensory perception of food (Maier et al., 2010). Worms maintained on HT115 or 
HB101 show a 15% and 19% increase in lifespan, respectively, compared to those on 
OP50 (Maier et al., 2010). We were curious to test if  HT115, HB101 and OP50 have 
different effects on gonad degeneration. In addition, we tested the effect of a non-E. coli 
bacteria, Bacillus subtilis. Culture of worms on B. subtilis, which is commonly found in 
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soil and thought to be a food source of C. elegans in its natural environment, extends 
lifespan by up to 100% compared to OP50 (Garsin et al., 2003). The lifespan increase 
caused by B. subtilis implies that it may be less pathogenic to C. elegans than E. coli.  
   
Figure 5.16 Bacterial food source has an effect on gonad degeneration. Diagram 
comparing gonad degeneration in wildtype worms cultured on standard agar plates 
seeded with E. coli (OP50, HT115 and HB101) and B. subtilis (no antibiotics). No 
differences in gonad disintegration were observed among E. coli strains. However, 
culture on B. subtilis had a protective effect on gonad ageing compared to OP50 control 
on day 8 and 12. Statistics were obtained by performing the Wilcoxon-Mann Whitney 
test, n.s.=not significant, *** p<0.001, **p<0.01. 
 
 We cultured wildtype worms on standard NGM plates seeded with OP50, 
HT115, HB101 or B. subtilis and found no differences in gonad degeneration between E. 
coli strains (Figure 5.16). This suggests that the differences previously observed between 
OP50 and HT115/L4440 was due to the presence of antibiotics in the latter. However, we 
did observe a strong protective effect of B. subtilis on day 8 and 12, consistent with the l 
increase in worm lifespan observed on this strain. These results are consistent with the 
view  that E. coli is more pathogenic that B. subtilis (Garsin et al., 2003; Sánchez-Blanco 
and Kim, 2011), and suggests that it could be triggering SIA by pathogen-induced 
apoptosis.  
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5.3 Discussion 
5.3.1   Gonad disintegration is mainly driven by physiological germline apoptosis   
Findings during the course of these studies on hermaphrodite gonad disintegration 
strongly support the hypothesis that quasi-programmed germline apoptosis is a 
contributor of gonad ageing in C. elegans.  All known mechanisms for both somatic and 
germline apoptosis require genes CED-3 and CED-4. We examined ced-3(n717), ced-
3(n1286), ced-3(n2454), ced-3(n288) mutants and found that all the alleles examined 
successfully blocked germline apoptosis, which is consistent with previous results 
(Gumienny et al., 1999). We also looked at gonad disintegration in four ced-3 alleles and 
in ced-4(n1162) and found that blocking germline apoptosis markedly slows gonad 
disintegration in all cases. However, all ced-3 and ced-4 mutants examined still showed a 
gradual loss of gonad integrity occurring between day 1 and 12 but at a slower rate than 
wildtype. This implies that while apoptosis is a contributor to gonad ageing other 
unknown factors also play a role. To exclude the possibility that somatic apoptosis 
influences gonad disintegration we tested ced-9(n1950gf), which blocks apoptosis in the 
soma but not physiological germline apoptosis (Gumienny et al., 1999; Hengartner et al., 
1992) and found that their gonads disintegrate at a similar rate as wildtype. This result 
further suggests that germline apoptosis plays a role in gonad degeneration. If blocking 
apoptosis can slow gonad disintegration down, the opposite should also be true and 
increasing apoptosis in the gonad should accelerate gonad ageing. This turned out to be 
true. We examined gld-1(op236) which increase germ cell death via CEP-1 activation 
(Schumacher et al., 2005b) and found that gonad disintegration occurs at a faster rate in 
these worms.  
 A plausible scenario is that DNA-damage induced germ cell death is essential to 
patrol the germline to rid the worm of damaged gametes to prevent passing on genetic 
defects to subsequent generations. The presence of a separate mechanism that activates 
the apoptotic machinery via CEP-1 could suggest another candidate for a quasi-
programme. In our studies we found that inhibition of CEP-1 by RNAi had no 
distinguishable effect on germline apoptotic levels which is consistent with previous 
results (Pinkston-Gosse and Kenyon, 2007; Pinkston et al., 2006; Schumacher et al., 
2001). We also examined gonad disintegration using cep-1(gk138) and cep-1(RNAi) and 
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found little difference in gonad disintegration compared to wildtype. These results imply 
that DNA damage induced apoptosis is not a likely candidate for the main cause of gonad 
degeneration. Because it acts in response to genotoxic stress and is not seen under normal 
conditions it is not likely to become a quasi-programme. That spo-11(ok79) does not 
suppress gonad disintegration supports this interpretation. 
We also examined the effect of oxidative stress on gonad degeneration to 
determine if it has some contribution to this age-related pathology. We used two 
treatments that have been shown to increase protein oxidation without affecting lifespan: 
sod-2(gk257) and 9mM iron supplementation (Van Raamsdonk and Hekimi et al., 2009; 
Valentini et al., 2012). We found that neither intervention affected gonad disintegration. 
This implies that if in fact gonad disintegration is driven by germline apoptosis it is not 
via environmental stress-induced germline apoptosis. Furthermore, environmental 
stressors (oxidative, thermal, and osmotic) require ABL-1 to promote germline apoptosis 
(Salinas et al., 2006). We subjected worms to abl-1(ok171) and found that gonad 
disintegration was not slowed down in these worms, as would be expected if 
environmental stress induced apoptosis was a significant contributor to gonad ageing. 
Additionally we also disabled DNA damage induced germline apoptosis by feeding cep-
1(RNAi) to abl-1(ok171) mutants and found they had wildtype pattern of gonad 
disintegration. Thus gonad disintegration occurs despite blocking two apoptotic stress 
response mechanisms to DNA damage and environmental stressors. Under these 
circumstances germline apoptosis was slightly reduced, yet the apoptotic corpses 
observed must have been generated by physiological apoptosis. 
It is unclear how starvation induces germ cell apoptosis. However, under all 
conditions we examined worms were maintained well-fed. Additionally, they were 
transferred daily throughout the reproductive period so it is highly unlikely that gonad 
disintegration would be the direct result of starvation-induced apoptosis. Gonad 
disintegration is also not likely to be caused by pathogen induced apoptosis because this 
pathway requires EGl-1, which is not necessary for germline apoptosis (Gumienny et al., 
1999). However, it would be interesting to see if infection could affect gonad 
disintegration. The higher levels of GD seen on E. coli than B. subtilis suggest that it 
might. 
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5.3.1.1 Other possible mechanisms for gonad disintegration   
Mutations that reduce IIS can delay the advent of gonad disintegration in C. 
elegans (Garigan et al., 2002). Previous studies have found daf-2(e1370) mutants to have 
higher (Pinkston et al., 2006) or slightly lower (Perrin et al., 2013) levels of germline 
apoptosis. In this study we measured germline apoptosis levels in daf-2(e1370) and daf-
2(m577) and found that daf-2(e1370) had lower germline apoptosis while daf-2(m577) 
had wildtype levels. Thus protection against GD in daf-2 mutants is not necessarily 
accompanied by reduced germline apoptosis. This suggests that the reduced apoptosis in 
daf-2(e1370) worms does not cause their reduced GD rate, and may be due to its 
pleiotropic effects. That both daf-2(-) alleles successfully slow down gonad ageing 
implies the presence of a mechanism other than apoptosis that slows gonad ageing in daf-
2(-) mutants. In support of this ced-3 and ced-4 mutations, which also delay gonad 
ageing, still exhibit an increased loss of gonad integrity with age. Overall, these results 
imply that germ cell death is a contributor of gonad disintegration but that one or more 
other mechanisms also play a role. 
Alternatively, it may be that counting germ cells in the gonad only allows us to 
view part of the puzzle. It could be that it is actually the balance between rate of germ 
cell removal by apoptosis and germ cell production in the distal gonad, that determines 
how fast the gonad will disintegrate. It is possible that daf-2(-) mutants maintain a 
youthful gonad by having germ cells in a higher proliferative state in later life. In support 
of this one study used DAPI to count proliferating germline stem cells (GSC) and found 
that while GSCs are lost as worms age, the percentage decrease is much lower in daf-2 
compared to wildtype worms indicating that proliferative germ cell capabilities may be 
conserved in ageing IIS mutants (Luo et al., 2010). Thus, despite having germ cell 
apoptosis levels similar to wildtype there might be a greater supply of new germ cells 
moving towards the gonad loop, which sustains the gonad and reduces the rate of cell 
loss. One possibility would be to study this further by measuring the mitotic index (i.e. 
the rate of cell division), e.g. by using EdU labelling, where thymidine analogue ethynyl 
deoxyuridine (EdU) is incorporated into dividing cells allowing the mitotic index to be 
measured (Chehrehasa et al., 2009; Michaelson et al., 2010).  It would be of great interest 
to see how germ cell proliferation correlates with apoptosis in daf-2(m577) mutants and 
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see how it compares to wildtype worms. However, a previous study found EdU-labelled 
germ cell nuclei to be significantly reduced in of daf-2(e1370) mutants during L4 stage 
(Michaelson et al., 2010). It would be useful to measure the mitotic index in ageing adult 
worms to see if this same trend is the same in older worms.  
We also examined the TOR pathway mutant rsks-1(ok1255) and found that 
despite lower levels of apoptosis observed on day 1 compared to wildtype, gonad 
disintegration was not delayed. One possibility is that the reduced germ cell death 
observed on day 1 of adulthood is due to a slight delay in development in rsks-1(ok1255) 
mutants relative to wildtype worms (Selman et al., 2009). It would be useful to examine 
day 2 adults to see if germline apoptosis is similar to wildtype. An additional possibility 
is that rsks-1(ok1255) has fewer germ cells so that lower levels of apoptosis observed in 
this mutant actually reflect a balance between germ cell removal and proliferation similar 
to wildtype. One study used DAPI staining to count proliferating germline stem cells and 
found a reduction of 50% in rsks-1(sv31) and rsks-1(ok1255) during L4 and early 
adulthood (Korta et al., 2012). EdU-labelling of rsks-1(sv31) mutants during L4 also 
found reduced mitotic index compared to wildtype (Korta et al., 2012). Thus reduced 
germline proliferation in rsks-1(ok1255) is balanced by having reduced germline 
apoptosis, which could explain the gonad disintegration rate being similar to wildtype. 
However, germline proliferation should be measured in older rsks-1(ok1255) worms to 
rule out the possibility that during ageing proliferative ability is maintained for longer. It 
is also important to note that lifespan increase in rsks-1(ok1255) mutants is modest, about 
10% (Kapahi et al., 2010; Pan et al., 2007) whereas the increase in daf-2(-) is much more 
robust (e.g. 150%) (Kenyon et al., 1993). 
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5.3.2 Quasi-programmed physiological apoptosis causes gonad degeneration 
Taken together our results imply that under normal conditions gonad 
disintegration is caused, at least in part, by continuation of physiological apoptosis, but 
not stress-induced apoptosis. This is consistent with the hyperfunction theory, which 
postulates that ageing is caused by run-on of developmental and reproductive 
programmes in later life, becoming quasi-programmes that cause ageing. Thus, 
physiological germ cell death is a reproductive program in hermaphrodite worms to 
improve oocyte quality that becomes a quasi-programme that causes gonad 
disintegration.  
We previously found that apoptotic corpses persist in later life in post-
reproductive worms. Our results in this chapter would suggest that physiological 
germline apoptosis is a contributor of gonad deterioration. In contrast stress-induced 
apoptosis occurs in response to a condition that is interpreted as noxious to the organism 
(pathogens, environmental stressors) or future generations (genotoxic stress) and as such 
in the absence of the trigger posses no threat of becoming a quasi-programme to promote 
gonad ageing.  
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Chapter 6: Concluding remarks 
 
“It is a capital mistake to theorize before one has data. Insensibly one begins to twist facts 
to suit theories, instead of theories to suit facts” – Sir Arthur Conan Doyle 
The discovery of single gene mutations resulting in large extensions of lifespan in 
model organisms has greatly increased interest in the  biology of ageing. What has been 
considered an unavoidable natural process akin to the wear and tear observed in complex 
inanimate objects (e.g. accumulation of rust in an old car), is thought to be controlled by 
genetic pathways. However, despite advances in finding genes that affect ageing rate the 
nature of the ageing process that such genes influence remains a mystery. 
Mikhail Blagosklonny conceived the hyperfunction theory by incorporating 
findings produced in the last decades from model organisms and reflecting on human 
age-related pathology with which he was familiar given his medical background. The 
TOR pathway promotes growth by increasing protein translation, while decreasing 
autophagy. Mutations that reduce the activity of the TOR pathway or the linked IIS 
pathway, increase lifespan in model organisms (Kapahi et al., 2010; Kenyon, 2010). TOR 
over-activity is also associated with mammalian diseases of ageing such as 
arteriosclerosis, cardiac hypertrophy and type II diabetes (Blagosklonny, 2008). Thus, he 
proposes that activity of these growth-promoting pathways generate age-related 
pathology and death. By combining this information he was able to discern a bigger 
picture, and create a cohesive, plausible theory to explain many aspects of the biology of 
ageing. The theory encompasses evolutionary concepts arguing that developmental and 
reproductive programmes under strong selection to bestow early life fitness are, due to 
waning selective pressure, not switched-off or fine-tuned post-reproduction and become 
quasi-programmes in older animals that generate pathology and death (Blagosklonny, 
2006, 2008). Our main goal for the experimental work described in this thesis was to use 
C. elegans to test this novel theory and establish its validity in explaining pathologies 
observed in ageing C. elegans. We examined age-related changes in the reproductive 
system and sought explanations for their origins.  
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In chapter 3 we examined yolk protein accumulation which had previously been 
shown to be present in high quantities in the body cavities of post-reproductive adult 
hermaphrodites (Herndon et al., 2002). We confirmed that the three C. elegans yolk 
proteins YP170, YP115 and YP88 increased progressively in hermaphrodite worms from 
day 1 to 8 and were maintained at high levels on day 12. This accumulation was not 
observed in long-lived daf-2(-) mutants. We examined other longevity mutants and found 
that this characteristic is only present in IIS pathway mutants. Moreover, our vit-5/vit-6 
RNAi results imply that high yolk levels do not affect mortality. Yolk protein 
accumulation represent a simple quasi-programme: yolk production has no known 
function aside from provisioning oocytes, and its accumulation post-reproduction implies 
the absence of an evolved mechanism to turn off its synthesis.  
In chapters 4 and 5 we studied changes that occur in the hermaphrodite gonad and 
found examples of atrophy (gonad deterioration) and hypertrophy (uterine tumours), 
which are consistent with quasi-programmed ageing. A striking age-related pathology in 
C. elegans is the disintegration of the hermaphrodite reproductive organ – the gonad 
(Garigan et al., 2002). This provides an interesting example as old age in mammals is 
often accompanied by atrophy affecting multiple organs. This phenomenon has 
previously been described but a mechanism of action, to our knowledge, has not been 
proposed. In our studies we found a positive correlation between germline apoptosis and 
gonad disintegration. If apoptosis in the germline is increased the gonad fragments earlier 
and if apoptosis is blocked by ced-3 or ced-4 mutations gonad disintegration is slowed 
down. Furthermore, we could find no evidence of a role of DNA damage or oxidative 
damage on gonad ageing.  
The results in this thesis support the hyperfunction theory as a plausible 
explanation for the emergence of pathologies of the reproductive system in C. elegans. 
However, the age-related phenomena examined in this study did not increase mortality. 
This could imply that other ageing pathologies kill the worm before gonad disintegration 
or yolk accumulation can exert its harmful effect. A possibility is that pathologies that do 
increase mortality are also caused by quasi-programmes. 
The addition of hyperfunction as an alternative to the damage/maintenance 
paradigm provides a new perspective to examine the processes that cause organisms to 
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age (Gems and Partridge, 2013). Mutations in IIS and TOR which extend lifespan, while 
increasing stress response and slowing development and reducing fertility, were thought 
to do so by reducing damage (Partridge and Gems, 2002). However, in light of the 
hyperfunction theories a future course of action would be to look at its effects on growth 
and development and the quasi-programmes that run on from these processes. Further 
examination of possible hyperfunction-driven pathologies in C. elegans and other model 
organisms are crucial to establish the validity of hyperfunction as an ageing theory. 
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Appendix 1 
 
 
Figure A-1. 1 Levels of YP115 and YP88 in daf-2(-) worms. Analysis of YP abundance 
revealed that daf-2(e1370) worms are Yol-d on day 4 for (A) YP115 and (B) YP88. daf-
2(m577) worms are Yol-d on day 4 for (C) YP115 and (D) YP88. Data is the mean of 
three biological replicates (100 worms per replicate); standard error, SEM; Student’s t-
test *p<0.05 (versus age-matched control). 
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Figure A-1. 2 Levels of YP115 and YP88 in age-1 mutants. Analysis of YP abundance 
revealed that age-1(hx546) worms have wildtype levels of (A) YP115 and (B) YP88. 
age-1(mg109) worms did not follow a similar trend as observed in YP170, there was no 
reduction in (C) YP115 and (D) YP88 on day 4. Data is the mean of three biological 
replicates (100 worms per replicate); standard error, SEM; Student’s t-test *** p<0.001 
(versus age-matched control). 
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Figure A-1. 3 Levels of YP115 and YP88 in daf-16(mgDf50); daf-2(m577) worms. 
Analysis of YP abundance revealed that daf-16(mgDf50); daf-2(m577) have wildtype 
levels of (A) YP115 and (B) YP88. This trend is similar to the results of YP170. Data is 
the mean of three biological replicates (100 worms per replicate); standard error, SEM; 
Student’s t-test *p<0.05 (versus age-matched control). 
 
 
 
 
Figure A-1. 4 Levels of YP115 and YP88 in daf-16(mu88); daf-2(e1370) in which 
DAF-16 is driven by its own promoter. Analysis of YP abundance revealed that DAF-
16 is driven by its own promoter results in Yol-d on day 4 for (A) YP115 and (B) YP88. 
Data is the mean of three biological replicates (100 worms per replicate); standard error, 
SEM; Student’s t-test *p<0.05, ***p<0.001 (versus age-matched control). 
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Figure A-1. 5 Levels of YP115 and YP88 in daf-16(mu88); daf-2(e1370) in which 
DAF-16 is expressed in the intestine. Analysis of YP abundance revealed that intestinal 
expression of DAF-16 in daf-16(mgDf50); daf-2(m577) does not reduce YP to 
statistically significant levels in (A,C) YP115 and (B,D) YP88. Data is the mean of three 
biological replicates (100 worms per replicate); standard error, SEM; Student’s t-test 
(versus age-matched control). 
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Figure A-1. 6 Levels of YP115 and YP88 in daf-16(mu88); daf-2(e1370) with DAF-16 
expression in the muscle and neurons. Analysis of YP abundance revealed that 
intestinal expression of DAF-16 in the muscle and neurons in daf-16(mgDf50); daf-
2(m577) does not rescue daf-2(-) Yol-d for (A,C) YP115 and (B,D) YP88. Data is the 
mean of three biological replicates (100 worms per replicate); standard error, SEM; 
Student’s t-test *p<0.05 (versus age-matched control). 
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Figure A-1. 7 Levels of YP115 and YP88 in worms treated with 10µM FUdR. 
Analysis of YP abundance revealed that worms transferred to plates with 10µM applied 
topically at L4 have wildtype levels of for (A) YP115 and (B) YP88. Data is the mean of 
three biological replicates (100 worms per replicate); standard error, SEM; Student’s t-
test (versus age-matched control). 
 
Figure A-1. 8 Levels of YP115 and YP88 in glp-4(bn2) maintained at 15˚C or shifted 
to 25˚C at L4. Analysis of YP abundance revealed that both fertile glp-4(bn2) 
maintained at 15˚C and worms shifted to 25˚C at L4 are Yol-o on day 1 for (A,C) YP115  
but have wildtype YP levels for (B,C) YP88. Data is the mean of three biological 
replicates (100 worms per replicate); standard error, SEM; Student’s t-test *p<0.05 
(versus age-matched control). 
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Figure A-1. 9 Effect of DAF-16 on  levels of YP115 and YP88 in glp-4(bn2) hatched 
at 25˚C. Analysis of YP abundance revealed that germline-less glp-4(bn2) and daf-
16(mgDf50); glp-4(bn2) maintained at 25˚C from hatching have wildtype YP levels for 
(A,C) YP115 and (B,D) YP88. Data is the mean of three biological replicates (100 
worms per replicate); standard error, SEM; Student’s t-test (versus age-matched control). 
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Figure A-1. 10 Levels of YP115 and YP88 in rsks-1(ok1255) worms. Analysis of YP 
abundance revealed that rsks-1(ok1255) have wildtype YP levels for (A) YP115 and (B) 
YP88. Data is the mean of three biological replicates (100 worms per replicate); standard 
error, SEM; Student’s t-test (versus age-matched control). 
 
 
 
 
 
Figure A-1. 11 Levels of YP115 and YP88 in eat-2(ad1116) worms. Analysis of YP 
abundance revealed that rsks-1(ok1255) have wildtype YP levels for (A) YP115. eat-
2(ad1116) worms were Yol-d on day 1 for (B) YP88. Data is the mean of three biological 
replicates (100 worms per replicate); standard error, SEM; Student’s t-test *p<0.05 
(versus age-matched control). 
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Figure A-1. 12 Levels of YP115 and YP88 in nuo-6(qm200) and isp-1(qm150)  
worms. Analysis of YP abundance revealed that nuo-6(qm200) and isp-1(qm150) have 
wildtype YP levels for (A) YP115 and (B) YP88. Data is the mean of three biological 
replicates (100 worms per replicate); standard error, SEM; Student’s t-test (versus age-
matched control). 
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